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Summary 
 
Nowdays there is a plethora of evidence for H2O2-mediated oxidative stress in the 
epidermis as well as in the system in patients with vitiligo (for review see 
(Schallreuter, Bahadoran et al. 2008). Xanthine dehydrogenase / xanthine oxidase 
(XDH / XO) catalyses the oxidative hydroxylation of hypoxanthine to xanthine 
followed by xanthine to uric acid, the last two steps in purine degradation pathway. 
Under oxidative conditions, XDH is converted to XO. The reactions catalysed by this 
enzyme generate H2O2 and O2
•-, yielding in the presence of ROS accumulation, 
allantoin from uric acid. Therefore XO has been considered a major biologic source of 
oxygen-derived free radicals in many organs. The presence of XO in the human 
epidermis has not been shown so far. In this study several techniques were utilised to 
nail the presence and activity of XO in epidermal melanocytes and keratinocytes.   
The enzyme is regulated by H2O2 in a concentration dependent manner, where 
concentrations of 10-6M upregulate activity. Importantly, the results showed that the 
activity of XO is little affected by H2O2 in the mM range. H2O2-mediated oxidation of 
tryptophan and methionine residues in the sequence of XO yields only subtle 
alterations in the enzyme active site. These findings are in agreement with enzyme 
kinetics in the presence of 10-3M H2O2. Since uric acid is the end product of XO 
activity and this can be oxidised to allantoin by H2O2, we wanted to know whether 
allantoin is formed in the epidermis of patients with vitiligo. In order to address this 
issue, we utilised HPLC/mass spectrometry analysis. Analysis of epidermal cell 
extracts from suction blister tissue identified the presence of allantoin in patients with 
acute vitiligo, while this product was absent in healthy controls. In conclusion, our 
results provide evidence for functioning epidermal XO in the human epidermis which 
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can be a major source for the production of H2O2 contributing to oxidative stress in 
vitiligo. 
In addition, this thesis also demonstrates for the first time the presence of XO in 
melanosomes, and we showed that both 7BH4 and 7-biopterin inhibit XO activity in a 
concentration dependent manner. Moreover, XO has the potential to bind to 6/7BH4 
and 6/7-biopterin from the pterin/tyrosinase inhibitor complex. This discovery adds 
another receptor independent mechanism for regulation of tyrosinase within the 
melanocyte similar to α/β-MSH as shown earlier (Moore, Wood et al. 1999; Spencer, 
Chavan et al. 2005).  
 
Since the entire epidermis of patients with vitiligo is under H2O2-mediated oxidative 
stress, oxidative DNA damage would be highly expected. This thesis shows for the 
first time that epidermal 8-oxoG levels as well as plasma level of this oxidised DNA 
base are significantly increased in patients compared to healthy controls. We have 
shown that epidermal cells from patients with vitiligo respond to oxidative DNA 
damage via the overexpression of p21 and Gadd45α leading to a functioning 
increased short-patch base-excision repair (BER), while increased apoptosis can be 
ruled out due to lower caspase 3 and cytochrome c response compared to healthy 
controls. Our results show that patients develop effective DNA repair machinery via 
hOgg1, APE1 and DNA polymeraseβ. Taking into consideration that these patients do 
not have an increased prevalence for solar-induced skin cancers, our data suggest that 
BER is a major player in the hierarchy to combat H2O2-mediated oxidative stress 
preventing ROS-induced tumourigenesis in the epidermis of these patients.  
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1.0  INTRODUCTION 
 
1.1  The human skin 
 
1.1.1  Structure 
The human integumentary system including skin and its appendages is the largest and 
heaviest organ of the body with thickness ranging from 1.5 to 4 mm. The size of the 
skin is around 2 m2 in area constituting almost 6% of the total body weight (5 to 6 
kg). It is made up of different layers of tissues guarding underlying muscles and 
organs. The importance of this organ in retaining normal homeostasis can be pointed 
out through its multiple functions. The skin plays the first line of defense against 
external pathogens, mechanical injuries and dehydration. It is also involved in 
insulation and temperature regulation of the body, reception of environmental 
messages through a variety of nerve endings, provision of a waterproof barrier, 
excretion via sweat glands, and protection via absorption of ultraviolet radiation 
(UVR) by the pigmentary system. Moreover, the skin contains an immuno-regulatory 
network and this organ plays an important role in psycho-emotion (Holbrook and 
Wolff 1993; Gartner 2001; Elias 2005; Tobin 2006). 
Histologically, human skin consists of two tissue types. The external layer is a 
stratified non-vascularised epidermis with an underlying basement membrane and the 
internal connective tissue layer, the dermis. Both epidermis and dermis collaborate 
with each other to maintain the properties of both tissues. Below these layers lies the 
hypodermis or subcutis (subcutaneous adipose layer), which is usually not classified 
as a layer of skin (Holbrook and Wolff 1993; Gartner 2001; Tobin 2006).  
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1.1.2  The epidermis 
The epidermis, the outer layer of the skin which is continuously being cornified and 
rejuvenated in 28-30 days cycle, is made up of an ectodermally derived (Weiss and 
Zelickson 1975) stratified squamous keratinised epithelium with an underlying basal 
lamina, approximately 0.4 mm (eyelids) to 1.5 mm (palms and soles) thick (Holbrook 
and Wolff 1993). Keratinocytes in different stages and positions form the majority of 
cells, constituting the epidermis. Melanocytes, Langerhans cells and Merkel cells are 
other cells present at different levels. The basement membrane separates the 
epidermis from the dermis (Holbrook and Wolff 1993; Gartner 2001). Due to cell 
differentiation of keratinocytes five morphologically distinct strata are identified 
(Holbrook and Wolff 1993; Gartner 2001). 
 
1.1.2.1  Stratum basale 
The stratum basale (or synonym stratum germinativum) is directly over the basement 
membrane of the epidermis immediately above the dermis. This layer consists of a 
single layer of undifferentiated mitotically active, tall, cuboidal columnar epithelial 
cells with a large nucleus. Their cytoplasm can contain pigmented melanosomes 
transferred from neighbouring melanocytes. The keratin filaments are formed into 
fine bundles in the vicinity of the nucleus. This layer is responsible for proliferation 
by generating new cells. With the beginning of differentiation, the stratum spinosum 
is formed (Holbrook and Wolff 1993; Gartner 2001).  
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1.1.2.2  Stratum spinosum 
The stratum spinosum consists of polyhedral KCs and it is located above the stratum 
basale. The cytoplasm of the cells in this layer of the epidermis contains the same 
cellular organelles as the cells in the basale layer as well as a rounded nucleus. 
Moreover, large bundles of intermediate filaments (cytokeratin) compared to cells in 
the stratum basale exist in their cytoplasm (Holbrook and Wolff 1993; Gartner 2001). 
 
1.1.2.3  Stratum granulosum 
This stratum consists of 1-2 rows of flattened keratinocytes which are still 
metabolically active and they still have a nucleus. Their cytoplasm is characterised by 
large and irregularly shaped keratinohylin granules in which bundles of keratin 
filaments pass through. Programmed destruction of these cells yields differentiated 
cornified cells accompanied by the loss of the nucleus as well as other cellular 
organelles except keratin filaments (Holbrook and Wolff 1993; Gartner 2001).   
 
1.1.2.4  Stratum lucidum 
This layer is present only in thick skin (palms and soles), consisting of a thin layer of 
flattened cells sitting above the stratum granulosum. The cells in this layer lack 
cytoplasmic organelles and nuclei, but they contain densely packed keratin filaments 
(Gartner 2001). 
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1.1.2.5  Stratum corneum 
This layer is the most superficial layer of the skin and is composed of several layers of 
flattened and keratinised (cornified) cells without nuclei and organelles but filled with 
keratin filaments. This layer of the epidermis provides mechanical protection to the 
skin and plays a major role as barrier (Holbrook and Wolff 1993; Gartner 2001; Elias 
2005).  
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1.1.3  The keratinocyte  
Keratinocytes are derived from the superficial ectoderm. They form the largest 
population of cells present in the epidermis. These cells all contain keratin filaments 
in their cytoplasm giving structure and forming desmosomes (desmosomal junctions) 
with neighbouring cells (Koch and Roop 2004). Keratinocytes are continuously 
keratinised, turning over and finally sloughing off from the surface of the epidermis 
(Gartner 2001). Therefore they need to be renewed. As a result, they are highly 
mitotically active in the basal layer of the epidermis. The epidermal turnover takes 
approximately 28-30 days. The keratin pairs in the cells indicate the position of the 
cells in epidermis and also their status of differentiation. There are different keratins 
expressed in different layers of the epidermis. Keratin 5 and 14 are expressed in the 
stratum basale whereas keratin 1 and 10 exist in suprabasal layers (Koch and Roop 
2004). Keratinocytes, both differentiated and undifferentiated, release numerous 
factors which could stimulate the melanocyte in a paracrine fashion by binding to 
their respective receptors on the melanocyte membrane leading in turn to changes in 
melanocyte proliferation, differentiation, dendritogenesis and melanin synthesis 
(Prunieras 1969; Yaar and Gilchrest 1991; Yaar, Grossman et al. 1991; Yada, Higuchi 
et al. 1991; Imokawa, Yada et al. 1992; Schallreuter, Wood et al. 1992; Imokawa, 
Yada et al. 1996; Abdel-Naser 1999; Imokawa 2004; Hirobe 2005; Schallreuter, 
Kothari et al. 2007). 
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1.1.4  The melanocyte 
Melanocytes are the pigment synthesising cells, giving the skin its colour. These 
dendritic cells are derived from melanoblasts originating from the neural crest 
(Cramer 1991). Melanocytes reside in the stratum basale among the other cells with 
the average density of 1000 to 2000 melanocytes/cm2. Although this density varies in 
different regions of the human skin, the total number of melanocytes in different 
racial groups is somewhat constant (Thody 1993). Melanocytes are round to columnar 
cells with a pale-staining cytoplasm and an ovoid nucleus. Their elongated dendrites 
extend among neighbouring epidermal cells, facilitating the transfer of melanosomes 
(the specific organelle where melanin is synthesised) to the keratinocytes. In this way, 
melanin is distributed into the suprabasal layers of the epidermis (Holbrook and Wolff 
1993; Thody 1993; Gartner 2001). In human epidermis, approximately 36 basal and 
suprabasal keratinocytes are functioning in close working relationship with one 
melanocyte. This organisation is called “epidermal melanin unit (EMU)” (Fitzpatrick 
and Breathnach 1963; Fitzpatrick, Miyamoto et al. 1967). Both cell types are in close 
symbiotic relation during melanogenesis (Fitzpatrick and Breathnach 1963; Hadley 
and Quevedo 1966).  
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1.1.5  Langerhans cells and Merkel cells 
Langerhans cells are also dendritic cells which are primarily located in suprabasal 
layers. They originate from precursors in the bone marrow and account for 2 to 8 
percent of the epidermal cell population. These cells are a part of a mononuclear 
phagocyte system and involved in a variety of T-cell responses. Langerhans cells 
function in the immune response, they are responsible for the recognition, uptake, 
processing and presentation of foreign antigens to T-lymphocytes present in the 
lymph nodes in their vicinity. Furthermore, it has been proposed that the Langerhans 
cells, melanocytes and keratinocytes form an “epidermal tripod” which is 
characterised by functional interaction (Holbrook and Wolff 1993; Gartner 2001).     
 
Merkel cells are other dendritic cells which are scattered among the keratinocytes of 
the stratum basale. These cells are differentiated from epithelial cells in the early 
human fetus. Unmyelinated sensory nerves traverse the basal lamina to approach the 
Merkel cells, forming Merkel cell-neurite complexes which function as 
mechanoreceptors. Apart from that, the Merkel cell function is still unclear (Holbrook 
and Wolff 1993; Gartner 2001). 
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Figure 1  
The structure of human epidermis  
The picture illustrates different cell types and layers in the epidermis (modified from 
(Christophers and Braver 1987). 
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1.1.6  The dermis  
The dermis (synonym Corium) makes up the bulk of the skin and it derives from the 
mesoderm. The dermis is tightly connected to the epidermis by a basement 
membrane. The thickness of the dermis varies from 0.6mm in the eyelids to 3mm on 
the palms and soles (Gartner 2001). The dermis is composed of a combination of 
fibrous, filamentous and dense irregular collagenous connective tissues, which 
altogether support the epidermis and connect the skin to the underlying hypodermis. 
These tissues also give the skin its elasticity, flexibility and strength. The major types 
of fibrous connective tissues in the dermis are collagen and elastin. The dermis also 
contains the neural and vascular networks, lymphatic systems and its appendages 
including sebaceous and sweat glands, hair follicles and nails. The most abundant 
cells in the dermis are fibroblasts, besides macrophages and mast cells. In addition, 
blood-derived cells including plasma cells and leukocytes can enter the dermis in 
response to various stimuli. On the basis of different types of fibrous connective tissue 
organisation, cell density and nerve and vascular patterns dermis is divided into two 
layers. The upper layer adjacent to the epidermis is the papillary layer and is 
composed of small bundles of small-diameter collagen fibrils. The deeper layer is the 
reticular layer is much denser compared to the papillary layer and is made up of large 
bundles of large-diameter collagen fibrils which accounts for the most thickness of the 
dermis and also skin on the whole.  The papillary dermis has a higher metabolic 
activity compared to the reticular dermis due to its high density of mesenchymally 
derived fibroblasts which are responsible for synthesis and degradation of collagen 
and also fibrous and non-fibrous connective tissue matrix proteins. The border 
between the two regions is distinguished with a straight plane of vessels and the 
subpapillary plexus (Holbrook and Wolff 1993; Gartner 2001). 
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1.1.7  The hypodermis (subcutis) 
Conventionally, the hypodermis is the subcutaneous adipose layer underlying directly 
the dermis. It is composed of fibrous dermal connective tissue containing varying 
amounts of adipose tissue (Holbrook and Wolff 1993; Gartner 2001). 
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1.2  Skin colour 
 
1.2.1  History 
The first recorded document about a human pigmentation disorder, most likely 
vitiligo, dates back to around 2200 BC. From that time, the origins of skin and hair 
colour were an enigma and it was just with the discovery of melanocytes in the 19th 
century that this unsolved mystery was uncovered. This significant discovery allowed 
investigators to find out more about the melanocytes’ origin and development, the 
structure of melanosomes, their translocation into neighbouring keratinocytes as well 
as the epidermal melanin unit. These discoveries then justified the differences 
between human skin phototypes (Westerhof 2006). 
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1.2.2  Inherited versus induced skin colour 
The differences in human skin colour are due to variation in epidermal melanin 
synthesis which can be attributed to many factors such as climates, genetic 
architecture and also ultraviolet radiation (UVR). Thus the majority of scientists agree 
that the differences in human skin colour reflect biological adaptations to some aspect 
of the environment (Jablonski and Chaplin 2000; Barsh 2003). In principle, the human 
skin colour is genetically determined and that is generally called “constitutive skin 
colour” (Bennett and Lamoreux 2003). However, it is important to note that inherited 
skin colour can be also influenced by certain environmental factors such as long-term 
exposure to UV light. Increase in melanin formation due to external stimuli is termed 
facultative skin pigmentation (Kaidbey and Kligman 1978; Yamaguchi, Takahashi et 
al. 2006; Miyamura, Coelho et al. 2007; Yamaguchi, Brenner et al. 2007). Due to 
higher UV radiation in tropical areas dark skin has emerged to provide more 
protection against the harmful effects of UV radiation, such as sunburn and skin 
cancer (Fitzpatrick 1965). In regions with low UV exposure mostly fair skin is present 
to allow UV-induced biosynthesis of vitamin D3 to occur (Harris, Soteriades et al. 
2000; Jablonski and Chaplin 2000). Pigmentation in response to UV light is 
commonly known as tanning (Fitzpatrick, Becker et al. 1950; Eller and Gilchrest 
2000). Two different mechanisms of tanning are known: immediate tanning and 
delayed tanning. Immediate tanning can occur within minutes after exposure to UVA 
(320-400nm) and is believed to be due to oxidation and/or polymerization of existing 
melanin. Delayed tanning takes several days or longer to become apparent mirrors the 
pigmentary response to UVB (280-320nm) by the increase in de novo production of 
melanin via the melanogenic pathway (Tadokoro, Yamaguchi et al. 2005; Young 
2006; Wolber, Schlenz et al. 2008).  
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1.2.3  Classification  
Human skin colour formed the basis for 6 categories. Fitzpatrick used two parameters 
for this classification (Fitzpatrick 1988) based on the ability of skin to tan (the result 
of exposure to ultraviolet radiation) and the inherited skin colour (white, brown or 
black skin). According to this classification, skin phototype Ι is very sensitive to 
ultraviolet light, burns easily and never tans. People who have skin phototype I have 
the greatest chance of experiencing photoaging and developing skin cancer. Skin 
phototype ΙΙ is also very sensitive to ultraviolet light and burns easily but tans 
minimally. People with skin phototype II are also in the high risk category for 
photoaging and skin cancer. Skin phototype III is rather sensitive to ultraviolet light, 
burns moderately and gradually tans to light brown. People with Skin Phototype III 
also are in the high risk category for photoaging and skin cancer but are not as 
susceptible as those with types I and II. Skin Phototype IV burns minimally and 
always tans well to moderately brown. People with skin phototype IV have slightly 
less of a chance of getting photoaging and skin cancer but are still commonly 
diagnosed with these diseases. Skin Phototype V rarely burns but tans easily to dark. 
People with skin phototype V have much less of a chance to develop photoaging and 
skin cancer although it is still a possibility. And finally skin phototype VI never burns 
and always tans darkly. Individuals with this skin phototype are still susceptible to 
photoaging and skin cancer (Fitzpatrick 1988). In this context it is noteworthy that 
skin colour is not the only basis for effective UV-response. It is possible that even 
dark skin can experience sunburn. It is also possible that dark skin can be sensitive to 
sun (KUS personal communications). These observations suggest that pigment is not 
the only defence mechanism against UV radiation. 
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1.2.4  Different types of pigment 
Three different pigments contribute to skin colour; i.e. carotenoids, haemoglobins and 
melanins. Nevertheless, melanin which is present in melanocytes and keratinocytes 
accounts for most of the variation in the visual appearance of human skin (Fitzpatrick, 
Becker et al. 1950; Szabo 1954; Stamatas and Kollias 2004; Miyamura, Coelho et al. 
2007).  
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1.2.4.1  Melanin 
Melanin pigments, which are polymorphous biopolymers, are synthesised from the 
metabolism of the amino acid L-phenylalanine in melanogenesis (Schallreuter and 
Wood 1999). There are a number of different types of melanin including eumelanin, 
pheomelanin, neuromelanin, and mixed melanin pigment which differ in proportions 
and bonding patterns (Prota, Crescenzi et al. 1970; Prota and Thomson 1976; Prota 
and d'Ischia 1993; Prota 2000). Eumelanin accounts for brown/black hair whereas 
pheomelanin is in association with red/blond hair. However, only small differences in 
melanin production can remarkably affect hair colouration (Prota and Thomson 1976; 
Prota 1992; Prota 2000; Slominski, Tobin et al. 2004; Tobin 2006). Both eumelanin 
and pheomelanin exist in the human epidermis and they can be produced within the 
same melanocyte (Thody, Higgins et al. 1991; Jimbow, Lee et al. 1993; Le Pape, 
Wakamatsu et al. 2008). Neuromelanin is a dark pigment which is produced in the 
substantia nigra or dark matter of the human brain but is also present in the locus 
coeruleus of the human brain (Prota and d'Ischia 1993). The common structural 
property among all types of melanins is arrangement of repeating units linked by 
carbon-carbon bonds. Nevertheless, there are differences in their chemical, structural 
and physical properties (Prota 1992; Prota 1995; Ito 2003; Slominski, Tobin et al. 
2004). 
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1.2.4.1.1  Eumelanin 
Eumelanin is primarily formed from the metabolism of L-tyrosine which is produced  
from L-phenylalanine by intracellular phenylalanine hydroxylase (EC 1.14.16.1, 
PAH) (Schallreuter and Wood 1999). This pigment behaves like a potent anti-oxidant 
defence for melanocytes as it has semiquinone units in its structure responsible for its 
redox status with both reducing and oxidising capabilities towards oxygen radicals, 
thus protecting the cell from UV-induced oxidative damage by scavenging UV-
generated ROS (Sarna and Sealy 1984; Korytowski, Kalyanaraman et al. 1986; Wood 
and Schallreuter 1991; Tobin and Thody 1994; Prota 1995; Sarna 1998; Gutteridge 
and Halliwell 2000). Moreover, eumelanin is the most photo-protective melanin 
despite its sun protection factor (SPF) is only 1-2 (Kaidbey and Kligman 1978; Hill 
1992; Wood, Jimbow et al. 1999; Kadekaro, Kavanagh et al. 2003). Additionally, 
melanin has the ability to chelate cations; it can bind to iron and copper ions 
preventing the Haber-Weiss reaction to occur, in which metal ions react with H2O2 to 
generate OH•  radicals (Goldstein and Czapski 1986). 
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1.2.4.1.2  Pheomelanin 
Pheomelanin is yellow to reddish-brown pigment and is abundant particularly in large 
quantities in blond and red hair (Prota, Crescenzi et al. 1970; Chedekel, Smith et al. 
1978). It is formed by a deviation in the eumelanin pathway. The formation of 
pheomelanin is due to the high concentration of L-cysteine and glutathione which are 
actively transported through the melanosomal membrane. The conjugation of this 
amino acid with dopaquinone leads to the formation of cysteinyldopa which serves as 
the starting point of pheomelanogenesis (Slominski, Tobin et al. 2004). Pheomelanin 
is photo-labile with photolysis products including mostly singlet oxygen followed by 
superoxide anion (O2
•-), hydroxyl radicals (OH•) and hydrogen peroxide (H2O2) 
(Wood, Jimbow et al. 1999). Unlike eumelanin, this pigment is actually phototoxic 
rather than having a photoprotective role. Therefore, it may contribute to UV-induced 
skin damage (Thody, Higgins et al. 1991). 
 
1.2.4.1.3  Neuromelanin 
Neuromelanin is present in the substantia nigra and locus coeruleus of the human 
brain. This pigment is synthesised by polymerisation of dopamine with L-cysteine 
(Bazelon, Fenichel et al. 1967; Prota and d'Ischia 1993; d'Ischia and Prota 1997). 
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1.3  Melanogenesis 
 
Melanogenesis (pigmentation) occurs in melanocytes within specialised intracellular 
organelles called melanosomes. This event involves a sequence of oxidoreduction 
reactions and intramolecular transformations which finally leads to the synthesis and 
deposition of melanin.  
 
1.3.1  The melanosome 
Melanosomes are lysosome-related organelles in the melanocytes in which the 
biosynthesis of melanin pigments occur. These spherical, membrane-coated vesicles 
are originated from the endoplasmic reticulum. They were first described by Seiji in 
1961 as organelles where the pigment is packaged (Seiji, Fitzpatrick et al. 1961; Seiji, 
Shimao et al. 1961; Orlow 1995; Barral and Seabra 2004). The size of melanosomes 
varies among human races and is genetically determined. Black skin contains larger 
melanosomes compared to other lightly pigmented skin. Melanosomes mature in a 
four staged process corresponding to the degree of melanisation and morphology. In 
stage Ι of eumelanogenesis melanosomes (eumelanosomes) are spherical vesicles 
containing a poorly organised internal structure. In stage ΙΙ melanosomes become 
ellipsoidal with a well developed internal structure containing organised lamellae and 
microvesicles but without melanin formation. In pheomelanosomes melanin is 
synthesised already in this stage. In stage ΙΙΙ melanisation begins on the lamellae and 
melanosomes have a well organised internal structure with the accumulation of 
melanin. Melanosomes in stage IV are completely filled with melanin (Holbrook and 
Wolff 1993; Thody 1993; Slominski, Tobin et al. 2004).  
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1.3.2  Melanosomal transfer to neighbouring keratinocytes 
Visible pigmentation requires the transfer of melanin granules from melanocytes to 
neighbouring keratinocytes; the process in which melanin pigments are dispersed 
throughout the basal and suprabasal layers. Melanosomal translocation was first 
described by Prunieras in 1969 (Prunieras 1969). Although there have been many 
attempts to study this process over the past 40 years, the exact mechanism(s) involved 
in this complex phenomenon is yet to be understood. Once fully melanised and 
matured, the melanosomes are moved from the perikaryon of the melanocytes to the 
tip of their dendrites which are in contact with associated keratinocytes in each 
epidermal melanin unit. Mammalian melanocytes contain 10nm intermediate 
filaments in their cytosol described as “microtrabeculae” (Schliwa, Euteneuer et al. 
1979) which are longitudinally located in the dendrites (cytoskeleton) and they 
specifically transfer the melanosomes from the perikaryon onto the dendrites. 
Previous reports have suggested that melanosomes move bi-directionally along the 
mentioned microtubules (Barral and Seabra 2004). Subsequently, the melanosomes 
travel from the dendrites into the keratinocytes. To date, three hypotheses have been 
suggested. Once melanosomal translocation to keratinocytes is initiated, keratinocytes 
may phagocytose the melanosome-filled dendritic tips of melanocytes (Cruickshank 
and Harcourt 1964; Mottaz and Zelickson 1967; Klaus 1969; Okazaki, Uzuka et al. 
1976; Yamamoto and Bhawan 1994). The other hypothesis is that melanosomes may 
be directly released into the keratinocytes by melanocytes via a temporary membrane 
fusion and opening a cytoplasmic channel (Garcia, Flynn et al. 1983). Another 
hypothesis is that melanocytes first discharge the melanosomes into the extracellular 
space and then keratinocytes phagocytose them (Swift 1964; Yamamoto and Bhawan 
1994). Once the translocation of matured melanosomes into keratinocytes is 
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completed, they interact with lysosomes of keratinocytes. Then while the 
keratinocytes are moving towards the skin surface, melanosomes are degraded within 
secondary lysosomes by lysosome hydrolase (Holbrook and Wolff 1993).    
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1.3.3  Melanin biosynthesis 
The biosynthesis of melanin involves a series of complex events. The velocity and 
specificity of this process are under the regulation of many enzymes including 
phenylalanine hydroxylase (EC 1.14.16.1, PAH), tyrosine hydroxylase (EC 1.14.16.2, 
TH) and tyrosinase (EC 1.14.18.1, Tyr) (Fitzpatrick, Becker et al. 1950; Lerner and 
Fitzpatrick 1950; Fitzpatrick and Lerner 1954; Fitzpatrick, Seiji et al. 1961; 
Fitzpatrick 1965; Prota and Thomson 1976). The availability of the amino acid L-
tyrosine initiates melanin biosynthesis. This amino acid can either be transported from 
the extracellular space into the melanocytes through the plasma membrane via 
facilitated diffusion rather than active transport (Schallreuter and Wood 1999) and 
further from the cytosol into the melanosomes (Potterf, Muller et al. 1996; Potterf and 
Hearing 1998), or can be formed in the melanocytes by hydroxylation of L-
phenylalanine via intracellular phenylalanine hydroxylase in the presence of the 
cofactor (6R)-L-5, 6, 7, 8 tetrahydrobiopterin (6BH4) (Kaufman 1957; Kaufman 1958; 
Kaufman 1959; Schallreuter and Wood 1999). Because L-tyrosine is highly 
demanded for melanogenesis to proceed and this demand is not fully provided by 
facilitated diffusion since its serum levels are too low (Schallreuter, Chavan et al. 
2005), thus  the amino acid L-phenylalanine is actively taken up by melanocytes from 
the extracellular space via a large neutral amino acid transporter type 1 (LAT-1) or 
type 2 (LAT-2) to be converted to L-tyrosine via intracellular PAH (Schallreuter and 
Wood 1999). Therefore L-tyrosine pool in melanocytes is mainly supplied by the 
hydroxylation of L-phenylalanine to L-tyrosine via intracellular PAH (Schallreuter 
and Wood 1999). Taken together, melanogenesis can be initiated either directly from 
the hydroxylation of intracellular L-tyrosine to L-DOPA, or from the hydroxylation of 
L-phenylalanine to L-tyrosine. L-DOPA is a precursor for the synthesis of both 
 46 
melanins and catecholamines via separate pathways. It has been shown that both 
human melanocytes and keratinocytes hold the full capacity for catecholamine 
biosynthesis (Schallreuter, Wood et al. 1992; Gillbro, Marles et al. 2004). The type of 
melanin synthesised is determined by the enzymatic archive available for the 
melanocytes. For instance, in central nervous system, L-DOPA is either 
decarboxylated by aromatic amino acid decarboxylase (AAD) to produce 
catecholamines or oxidised to form neuromelanins (for review see (Slominski, Tobin 
et al. 2004). The hydroxylation of L-tyrosine to L-DOPA via tyrosine hydroxylase I is 
an obligatory and rate-limiting step in melanin biosynthesis (Marles, Peters et al. 
2003). L-DOPA is then oxidised to dopaquinone, the pathway which is common in 
eumelanogenesis and pheomelanogenesis (Prota 1992; Prota 2000). The formation of 
eu- or pheomelanin is directly determined by the presence/absence of cysteine which 
is actively transported through the melanosomal membrane via the cysteine/glutamate 
exchangers (Sato, Ito et al. 1987; Benathan, Virador et al. 1999; Potterf, Virador et al. 
1999). When the concentration of cysteine or glutathione is high, it is conjugated to 
dopaquinone yielding to the formation of pheomelanin (Prota 1995; Ito 2003). In 
eumelanogenesis, dopaquinone is further transformed to leukodopachrome, followed 
by a series of oxidoreduction reactions as well as polymerisation which finally leads 
to the formation of eumelanin (Pawelek 1991; Prota 1992; Ito 2003). 
 
 
 
 
 
 
 47 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2  
Melanogenesis pathways 
The modified Raper-Mason scheme for the biosynthesis of eumelanin and pheomelanin from 
L-phenylalanine in the presence of 6BH4, PAH, TH and tyrosinase. PAH: Phenylalanine 
hydroxylase (Schallreuter and Wood 1999), TH: tyrosine hydroxylase, TYR: Tyrosinase, 
TRP1&2: Tyrosine Related Protein 1&2, 6BH4:  (6R)-L-erythro 5, 6, 7, 8 
tetrahydrobiopterin.  
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1.3.3.1  Phenylalanine hydroxylase 
Phenylalanine hydroxylase (PAH) catalyses the hydroxylation of the amino acid L-
phenylalanine to L-tyrosine. The enzyme’s activity depends on the presence of 
tetrahydrobiopterin as cofactor and molecular oxygen (dioxygen) as additional 
substrate (Kaufman 1958; Kaufman and Levenberg 1959; Teigen and Martinez 2003). 
The active site of this enzyme contains an iron atom, where it binds directly to 
dioxygen to be activated. Therefore, the transformation of the iron atom from the 
ferric form to the ferrous form is essential for the activation of the enzyme (Teigen, 
Froystein et al. 1999; Teigen and Martinez 2003). Also, activation of the enzyme 
needs pre-incubation with the substrate which enables phosphorylation of amino acid 
Serine-16 as well as tetramerisation of the protein to occur (Daubner, Hillas et al. 
1997; Miranda, Teigen et al. 2002; Miranda, Thorolfsson et al. 2004). Moreover, the 
natural cofactor tetrahydrobiopterin (6BH4) is involved in pre-reduction of the active 
site of the enzyme (Teigen and Martinez 2003). This cofactor regulates the enzyme 
activity as well as being essential in catalysis (Schallreuter, Wood et al. 1994; 
Schallreuter, Slominski et al. 1998) and recently it has been indicated that 6BH4 has a 
chaperone-like effect on PAH synthesis by protecting it from degradation via 
shielding the active site from ROS (Pey, Perez et al. 2004) and also from enzyme 
auto-activation (Thöny, Ding et al. 2004). Hence PAH is under absolute control by the 
6BH4 concentration in the cytosol of melanocytes.  
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1.3.3.2  Tyrosine hydroxylase 
Tyrosine hydroxylase is the rate-limiting enzyme in catecholamine biosynthesis 
(Nagatsu, Levitt et al. 1964). It is responsible for catalysing the hydroxylation of the 
amino acid L-tyrosine to L-DOPA which is a precursor to dopamine in the process of 
the adrenaline (epinephrine) synthesis. The same as PAH, this enzyme is iron-
containing and tetrahydrobiopterin-dependent which uses molecular oxygen to 
hydroxylate its substrate (Ellenbogen, Taylor et al. 1965; Fitzpatrick 1999; Dunkley, 
Bobrovskaya et al. 2004). In order for the enzyme to become catalytically active, in 
the presence of O2, 6BH4 reduces the iron atom from the ferric form (Fe
3+) to ferrous 
form (Fe2+) in its active site. Furthermore, only recently it has been indicated that the 
phosphorylation of TH at Serine-40 increases the enzyme’s activity in vitro, in situ 
and in vivo (Dunkley, Bobrovskaya et al. 2004). It has been reported that the human 
epidermis express only a functioning TH isoform I, while the other isoforms are 
absent (Marles, Peters et al. 2003). The enzyme is sitting site by site with tyrosinase. 
TH I activity has been identified in melanosomes. Since tyrosinase requires L-DOPA 
for activation, it has been proposed that TH I activity is tightly coupled to tyrosinase 
in melanosomes to initiate melanogenesis (Marles, Peters et al. 2003).   
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1.3.3.3  Tyrosinase    
 
Mammalian tyrosinase is a melanosomal membrane bound and copper-containing 
enzyme which holds a central position in melanin biosynthesis (Lerner, Fitzpatrick et 
al. 1948; Fitzpatrick, Becker et al. 1950; Wang and Hebert 2006). This enzyme was 
discovered for the first time by Bourquelot and Bertrand in 1896 (Raper and Wormall 
1923), but it was Raper who discovered that melanin is formed from L-tyrosine via 
tyrosinase (Raper and Wormall 1923; Happold and Raper 1925; Raper and Wormall 
1925; Raper 1926; Raper 1927). This enzyme which is found in epidermal 
melanocytes as well as the pigment epithelia of the retina, iris, and ciliary body of the 
eye, catalyses three distinct reactions in the melanogenic pathway; hydroxylation of 
L-tyrosine to L-DOPA  followed by the rapid oxidation (dehydrogenation) of the 
latter to L-DOPAquinone (Lerner, Fitzpatrick et al. 1948; Pomerantz 1966), and also 
oxidation (dehydrogenation) of 5, 6 dihydroxyindole (DHI) and 5, 6 dihydroxyindole-
2-carboxylic acid (DHICA) into the eumelanin precursors indole-5, 6-quinone and 
indole-5, 6-quinone carboxylic acid respectively (Korner and Pawelek 1982; Wang 
and Hebert 2006). Furthermore, tyrosinase can also react with UV light generated 
oxygen radicals such as superoxide anion (Wood and Schallreuter 1991; Prota 1992). 
Tyrosinase mRNA shows no difference in different skin phototypes (Fitzpatrick 
classification), thus its protein expression in the epidermis among all human skin 
phototypes does not vary (Iwata, Corn et al. 1990; Iozumi, Hoganson et al. 1993). 
Hence, the formation of melanin depends either on the substrate supply or on 
metabolic inhibitors and activators of this enzyme (Wood and Schallreuter 1991; 
Iozumi, Hoganson et al. 1993). The active site of tyrosinase contains two copper 
atoms which introduce dioxygen into the substrates (tyrosine or L-DOPA) (Lerner, 
Fitzpatrick et al. 1950; Wang and Hebert 2006; Ullrich and Hofrichter 2007). Inactive 
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form of the enzyme requires the reduction of these two copper atoms (from Cu2+ to 
Cu1+) in order to become fully activated (Lerner, Fitzpatrick et al. 1950) and in this 
reduction step, L-DOPA is the most efficient electron donor necessary to start the 
hydroxylation process of L-tyrosine although other compounds such as ascorbic acid, 
dopamine and superoxide anion radicals are potentially able to activate the enzyme 
(Wood and Schallreuter 1991). As stated above TH isoenzyme Ι is expressed in the 
melanosomal membrane of the human melanocytes side by side with tyrosinase 
(Marles, Peters et al. 2003). This implies a coupled reaction, where L-DOPA 
produced by this isoform of TH facilitates tyrosinase activation which consequently 
initiates melanogenesis (Marles, Peters et al. 2003). However, it was shown when O2
•- 
replaced O2 as substrate, the activation of tyrosinase to oxidise L-tyrosine to 
dopachrome was 40-fold increased but this increase depends on the removal of H2O2 
from the reaction mixture by catalase (Wood and Schallreuter 1991). This observation 
highlights the role of UV-generated O2
•- in melanogenesis (Wood and Schallreuter 
1991).  
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1.3.3.3.1  Tyrosinase activity is pH dependent    
Tyrosinase activity is tightly related to pH. Almost at neutral pH the enzyme displays 
maximum enzymatic activity with little activity below pH 5 (Hearing and Ekel 1976; 
Townsend, Guillery et al. 1984; Saeki and Oikawa 1985; Ancans, Hoogduijn et al. 
2001; Ancans, Tobin et al. 2001; Watabe, Valencia et al. 2004; Wang and Hebert 
2006). Therefore, due to the existence of acidic pH (as low as 5) in pre-melanosomes 
(Bhatnagar, Anjaiah et al. 1993; Puri, Gardner et al. 2000), neutralization of the 
normally acidic environment seems vital for tyrosinase activity (Ancans and Thody 
2000). For this purpose, melanosomes own a proton pump that regulates 
intramelanosomal pH (Ancans, Hoogduijn et al. 2001). By pumping H+ out from the 
melanosomes, the pH switches from 5 to 6.8 initiating melanogenesis which, in turn is 
optimal for tyrosinase activity where lower pH is optimal for TH function (Ancans, 
Hoogduijn et al. 2001; Ancans, Tobin et al. 2001; Watabe, Valencia et al. 2004).  
 
1.3.3.3.2  Tyrosinase activity is influenced by 6BH4   
The cofactor 6BH4 has been reported to down regulate tyrosinase activity by an 
uncompetitive mechanism only when L-tyrosine is substrate whereas when L-DOPA 
is substrate, 6BH4 does not inhibit tyrosinase activity. This indicates that there are two 
separate binding sites for L-tyrosine and L-DOPA on this enzyme (Wood, 
Schallreuter-Wood et al. 1995; Olivares, Garcia-Borron et al. 2002). The tyrosinase-
6BH4 inhibitory complex can be reactivated by α-MSH binding directly to 6BH4 
(Moore, Wood et al. 1999; Schallreuter, Moore et al. 1999). Moreover, it was shown 
that UVB light oxidises 6BH4 to 6-biopterin, reactivating tyrosinase. This is 
considered as a ‘photo-switch’ allowing melanogenesis to proceed (Schallreuter, 
Wood et al. 1998). 
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1.4  Pteridines in pigmentation 
 
Pteridines were discovered more than 100 years ago, when Sir Frederick Gowland 
Hopkins isolated two distinct yellow and white pigments from butterfly wings, but 
Wieland and Schöpf were the first who introduced those pigments as “pteridines” in 
1925 for the first time and named them xanthopterin and leucopterin according to 
their colours. These chemical compounds perform many roles in colouration in the 
biological world. Pterins also function as cofactor in enzymatic catalysis. 
Tetrahydrobiopterin, the major pterin in vertebrates, is involved in the hydroxylation 
of aromatic compounds and synthesis of nitric oxide. Molybdopterin, which contains 
pterin and molybdenum is involved in biological hydroxylations (Nichol, Smith et al. 
1985). 
 
1.4.1  6BH4 in the human epidermis 
The importance of this cofactor in the human epidermis has been demonstrated by 
Schallreuter and colleagues in 1994. Both epidermal melanocytes and keratinocytes 
hold the full capacity to synthesise and recycle 6BH4 (Schallreuter, Wood et al. 1994). 
6BH4 plays three major roles in melanin biosynthesis in order to regulate the supply 
of the melanin precursors and substrates. It functions as an essential cofactor for PAH 
and TH isoform I and it is a potent uncompetitive inhibitor for tyrosinase. But this 
inhibition is reversible by UVB photo-oxidation of the pterin ring in the presence of 
O2 from 6BH4 to quinonoid dihydropterin (qBH2) followed by the formation of 7, 8 
dihydropterin (BH2), and finally to 6-biopterin in addition to the production of O2
•-
(Kaufman 1957; Kaufman 1959; Kaufman and Levenberg 1959; Moore, Wood et al. 
1999). It must be noted that neither qBH2 nor BH2 binds or inhibits tyrosinase (Wood, 
 54 
Schallreuter-Wood et al. 1995). Also, 6BH4 plays an important role as a cofactor in 
the synthesis of neurotransmitters serotonin and the catecholamines (Kaufman 1957; 
Kaufman 1959; Kaufman and Levenberg 1959). This cofactor is the immediate 
electron donor for hydroxylation of the amino acids phenylalanine, tyrosine and 
tryptophan in the presence of molecular oxygen. 6BH4 is synthesised de novo by three 
enzymes: GTP cyclohydrolase I, 6-pyruvoyl-tetrahydropterin synthase and sepiapterin 
reductase (Nichol, Smith et al. 1985; Kaufman 1997; Thöny, Auerbach et al. 2000). 
 
1.4.2  7BH4 in the human epidermis 
(7R)-L-erythro-5, 6, 7, 8 tetrahydrobiopterin (7BH4), the abiogenic isomer of 6BH4 is 
produced nonenzymatically in very low levels during the recycling process of this 
cofactor (Curtius, Alder et al. 1990). These two isomers can directly control 
tyrosinase activity via a specific binding domain on the enzyme. 7BH4, however, is 
twice as effective as 6BH4 in inhibiting tyrosinase activity (Wood, Schallreuter-Wood 
et al. 1995). Moreover, under certain pathologic conditions in the epidermis such as 
vitiligo, due to defective de novo synthesis, recycling and regulation of 6BH4, 7BH4 
can accumulate to mM concentrations inhibiting PAH activities by a competitive 
mechanism thus preventing the turnover of L-phenylalanine to L-tyrosine resulting in 
a build up of L-phenylalanine in the epidermis (Davis, Ribeiro et al. 1992; 
Schallreuter, Wood et al. 1994; Pey, Martinez et al. 2006). The presence of 7BH4 in 
the melanosome in physiological concentrations has been shown. However, α-MSH 
cannot reactivate the tyrosinase-7BH4 inhibitor complex. But β-melanocyte 
stimulating hormone (β-MSH) can bind 7BH4 reactivating tyrosinase from the 
inhibitor complex (Spencer, Chavan et al. 2005). These findings highlight the role of 
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7BH4 in the regulation of melanogenesis suggesting for the first time physiological 
function for this protein. 
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1.5  Oxidative stress 
 
Helmut Sies coined the term oxidative stress for the first time in 1985, which defines 
the disturbance in prooxidant-antioxidant balance in favour of the former, indicating 
the damage to cells and thereby to the organs and tissues of those cells (Cadenas and 
Sies 1985; Sies and Cadenas 1985). This condition is caused by reactive oxygen 
species (ROS), very small and highly reactive molecules due to their unpaired 
electrons. These include superoxide anion (O2
•-), singlet oxygen, hydroxyl radical 
(OH•) and hydrogen peroxide (H2O2). ROS are generated in cells by several 
mechanisms (Halliwell 1989; Halliwell and Gutteridge 1989; Smith, Marks et al. 
2004). H2O2 is a very reactive molecule, however, O2
•- and H2O2 can also generate 
hydroxyl radical (OH•) which is a much more reactive ROS especially in the presence 
of transition metals such as iron or copper and this happens through the Fenton 
reaction and the Haber-Weiss reaction (Haber and Weiss 1932; Goldstein and Czapski 
1986). ROS are generally formed as natural byproducts of the normal metabolism of 
oxygen. Therefore low levels of ROS are continuously present in cells under 
physiological conditions (Thannickal and Fanburg 2000). However, the cellular redox 
status is precisely regulated and living cells are capable to maintain ROS within non-
toxic levels via their antioxidant defence machinery which consist of multiple 
enzymatic and non-enzymatic systems. The toxic effects of ROS become evident 
when the rate of their generation exceeds the defence capacities of cells (Cadenas and 
Sies 1985; Halliwell 1989; Poli, Leonarduzzi et al. 2004; Glantzounis, Tsimoyiannis 
et al. 2005). 
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1.5.1  Oxidative stress in the human epidermis 
Human skin is in continuous contact with endogenous and exogenous ROS produced 
by physical, chemical and biological reactions. Therefore it requires neutralising 
mechanisms to regulate its redox status and subsequently to maintain its redox 
homeostasis. These mechanisms include enzymes such as superoxide dismutase, 
glutathione reductase, glutathione peroxidase, thioredoxin reductase, thioredoxin 
peroxidase and catalase and non-enzymatic systems including small trapping 
molecules such as thiols (glutathione and thioredoxin) vitamins C and E, the amino 
acids L-methionine and L-tryptophan, 6- and 7-tetrahydrobiopterins and lipoic acid 
(Schallreuter 2005). Moreover, melanin itself contains free radical traps. Here it is 
noteworthy to mention that there is a close correlation between skin colour and 
individual free radical defence capacity as darker skin phototypes (Fitzpatrick 
classification) express significantly more effective mechanisms against UV induced 
damage (Schallreuter 2005). The most potent ROS is the hydroxyl radical (OH•) as it 
reacts with nucleotide bases causing in turn irreversible damage to DNA. ROS also 
react with fatty acids and amino acids leading finally to disturbance in the cell 
membrane and protein function, enzyme deactivation and disruption of transcription 
(Smith, Marks et al. 2004). This radical is produced from H2O2 by the Fenton and 
Haber-Weiss reaction (Haber and Weiss 1932; Goldstein and Czapski 1986): 
 
 
 
 
                      
 
Fenton reaction: H2O2 + Fe
2+ OH•+ OH- + Fe3+
Haber-Weiss reaction: H2O2 + O2
•- OH•+ OH- + O2
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As shown above the production of OH• in the epidermis depends on the presence of 
H2O2 and this highlights the role of H2O2 in the skin. Therefore it is noteworthy to 
mention that although H2O2 is not a free radical, it is a strong reactive oxidising agent 
that can generate OH• in the presence of transition metals i.e. Fe2+ (Goldstein and 
Czapski 1986).  
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1.6  Vitiligo  
 
1.6.1  What is Vitiligo? 
Vitiligo is a disfiguring, progressive and acquired idiopathic non-infectious skin and 
hair disorder characterised by depigmented lesions as white patches with variable 
size, shape and location (Lerner 1959; Lerner and Nordlund 1978; Le Poole and 
Boissy 1997; Westerhof, Njoo et al. 1997; Schallreuter 2005; Schallreuter, Bahadoran 
et al. 2008). The incidence of vitiligo is 0.5 to 2% worldwide and the precise 
aetiology is complex and not fully understood. The exact mechanisms involved in the 
occurrence of the disease are still a matter of controversy, however, a number of 
hypotheses have been put forward, mainly the autoimmune, neural, genetics and 
oxidative stress. All of these theories are related primarily to the loss of functional 
melanocytes leading to a lack of melanin production (Westerhof and d'Ischia 2007; 
Schallreuter, Bahadoran et al. 2008). This depigmentation disorder can occur 
anywhere on the body, regardless of sex or race and can involve the entire epidermis. 
Also the course of the disease is different in individuals (Bystryn 1997; Castanet and 
Ortonne 1997; Tobin, Swanson et al. 2000; Passeron and Ortonne 2005; Schallreuter 
2005). Vitiligo is defined by the disturbance in the function of some or all of 
melanocytes in the epidermis leading to the appearence of white cutaneous spots 
(Bystryn 1997; Passeron and Ortonne 2005; Schallreuter 2005). Wood’s light (UVA 
351nm) is utilised in order to diagnose vitiligo due a distinct fluorescence in 
depigmented lesions which is owed to the presence of oxidised pteridines 
(Schallreuter, Wood et al. 1994).  
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1.6.2  The autoimmune hypothesis 
The autoimmune hypothesis suggests there are specific auto-antibodies involved in 
the progress of the disease as it has been indicated that these auto-antibodies exist in 
patients with vitiligo against specific antigens on the melanocyte cell surface leading 
to their destruction (Naughton, Eisinger et al. 1983; Kemp, Waterman et al. 2001; 
Kemp, Waterman et al. 2002).  
 
1.6.3  The neural hypothesis 
This hypothesis states that the released catecholamines from nerve endings disturb the 
pigment. It is believed that these neural end products are involved in 30% of patients 
with vitiligo (Bose 1994). 
 
1.6.4  The autocytotoxicity hypothesis 
Autocytotoxicity or the Self Destruction is another hypothesis for the incidence of 
vitiligo. This hypothesis believes that some of the phenolic and catecholic compounds 
as well as free radicals which are formed from the complex oxidation reactions in the 
process of melanin biosynthesis can be toxic for melanocytes initiating apoptosis 
(Boissy and Manga 2004; Westerhof and d'Ischia 2007). 
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1.6.5  Vitiligo, a model for oxidative stress  
Over the last decade vitiligo has been used as a model disease for oxidative stress 
(Schallreuter, Wood et al. 1991; Schallreuter, Wood et al. 1994; Maresca, Roccella et 
al. 1997; Schallreuter 2005; Dell'anna and Picardo 2006; Schallreuter, Bahadoran et 
al. 2008). In particular it has been shown that H2O2 plays a major role in the 
pathogenesis of this disease. Numerous sources of H2O2 generation have been 
identified and it has been shown in vivo that epidermal H2O2 concentration can be in 
the mM range (Schallreuter 2005; Schallreuter, Bahadoran et al. 2008). It has been 
well documented that the entire epidermis of patients with vitiligo is under oxidative 
stress (Schallreuter, Moore et al. 1999). Not only melanocytes, but keratinocytes and 
Langerhans cells are disturbed in this disease as well. Moreover, catalase (EC 
1.11.1.6) levels have been shown to be significantly reduced in both lesional and non-
lesional epidermis of patients (Schallreuter, Wood et al. 1991; Schallreuter, Moore et 
al. 1999). Maresca et al. also reported a similar observation under in vitro condition 
using MCs originated from non-lesional epidermis of patients with vitiligo (Maresca, 
Roccella et al. 1997). Under normal physiological conditions, catalase 
disproportionates H2O2 to H2O and O2 (Aronoff 1965). In addition, the activity of 
glutathione peroxidase (EC 1.11.1.9), an important enzyme for the efficient removal 
of H2O2 in the presence of low catalase is also disturbed along with thioredoxin 
reductase (EC 1.8.1.9) activity, resulting in the accumulation of higher concentrations 
of H2O2 (Schallreuter, Pittelkow et al. 1986; Schallreuter, Hordinsky et al. 1987; 
Beazley, Gaze et al. 1999). Another target for H2O2-mediated oxidation is L-
methionine. This amino acid is one of the most prone amino acids to oxidation 
yielding methionine sulfoxide. Under normal physiological conditions, the oxidized 
amino acid is reduced by methionine sulfoxide reductase A/B (EC 1.8.4.11, 
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MSRA/B) (Ogawa, Sander et al. 2006; Schallreuter 2006; Schallreuter, Rübsam et al. 
2006). It has been documented that the level of these enzymes is considerably lower 
in vitiligo (Ogawa, Sander et al. 2006; Schallreuter, Rübsam et al. 2008). It has been 
also shown that MSRA/B themselves are targeted by H2O2-mediated oxidation, thus 
affecting the repair of oxidised proteins and peptides (Schallreuter, Rübsam et al. 
2008).  
Furthermore, it has been demonstrated that the epidermis of patients contains oxidised 
pterins (Schallreuter, Wood et al. 1994). The accumulation of these fluorescent 
compounds in the epidermis of patients with vitiligo is due the defective de novo 
synthesis/recycling/regulation of 6BH4, the essential cofactor for melanogenesis, 
which subsequently leads to the accumulation of its abiogenic isomer, 7BH4. It has 
been shown that µM concentration of 7BH4 inhibit PAH resulting to the prevention of 
the turnover of L-phenylalanine to L-tyrosine leading in turn to L-phenylalanine build 
up in the epidermis (Davis, Ribeiro et al. 1992; Schallreuter, Zschiesche et al. 1998). 
It has also been reported that H2O2 deactivates pterin-4α-carbinolamine dehydratase 
(EC 4.2.1.96, PCD) in both epidermal melanocytes and keratinocytes. PCD is the rate 
limiting recycling enzyme in 6BH4 biosynthesis (Schallreuter, Wood et al. 1994; 
Schallreuter, Moore et al. 2001). A low PCD enzyme activity also results in the 
accumulation of the isomer 7BH4 (Schallreuter, Wood et al. 1994). Moreover, it has 
been shown that the final step of 6BH4 recycling is decreased due to deactivation of 
dihydropteridine reductase (EC 1.6.99.7, DHPR) since H2O2 oxidises L-methionine 
residues in the structure of this enzyme resulting in an altered NADH binding site 
which consequently leads to enzyme deactivation (Schallreuter, Moore et al. 2001; 
Hasse, Gibbons et al. 2004).  
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In this context, it is noteworthy that H2O2-mediated oxidation of other proteins and 
peptides such as calmodulin, POMC peptides, acetlycholinesterase (EC 3.1.1.7, 
AchE), butyrylcholinesterase (EC 3.1.1.8, BchE), affects their normal biological 
functionality in the epidermis of patients (Schallreuter and Pittelkow 1988; 
Schallreuter, Elwary et al. 2004; Schallreuter, Gibbons et al. 2006; Schallreuter and 
Elwary 2007; Schallreuter, Gibbons et al. 2007; Spencer, Gibbons et al. 2007; 
Spencer, Gibbons et al. 2008).  
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Table 1 
H2O2 Production in the Human Epidermis in the mM Range 
 
 
 
 
 
         Sources 
 
Epidermal sources and targets 
 
UVA/UVB 
(Schallreuter, Bahadoran et al. 
2008)   
 
 
sunlight 
Pheomelanin 
(Schallreuter, Bahadoran et al. 
2008) 
 
                 
melanosomes 
TNF-α 
(Schallreuter, Bahadoran et al. 
2008) 
 
physical/chemical stress to the human epidermis, 
acts via the mitochodrial SOD 
                                                                 
TGF-β 
PDGF                                  
EGF 
(Thannickal, Day et al. 2000; 
Thannickal and Fanburg 2000) 
 
                                                                 
 
epidermal melanocytes and keratinocytes 
 
TYR 
TH 
(Marles, Peters et al. 2003; 
Wood, Chavan et al. 2004)  
 
 
epidermal melanocytes and keratinocytes 
 
 
 
PAH 
(Schallreuter, Wood et al. 1994) 
 
epidermal melanocytes and keratinocytes 
 
  
MAO-A 
(Schallreuter, Wood et al. 1996)              
 
 
catecholamine degradation in the human epidermis 
Photo-oxidation 
of pterins 
(Rokos, Beazley et al. 2002) 
 
 
                   epidermal melanocytes and keratinocytes 
 
Aromatic steroids 
(estrogens, 
progestrones                     
and androgens) 
(Thornton 2002; Schallreuter, 
Bahadoran et al. 2008)  
 
 
Via the oxidation by cytochrome P450 
in both  epidermal melanocytes and keratinocytes 
NADPH-oxidase 
(oxygen burst) 
(Yu 1994) 
 
activation of epidermal leucocytes and macrophages due to 
inflammation 
 
NOS 
(Landmesser, Dikalov et al. 
2003)    
 
epidermal melanocytes and keratinocytes 
XO 
 (Shalbaf, Gibbons et al. 2008)  
 
epidermal melanocytes and keratinocytes 
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Table 2 
Effect of H2O2-mediated oxidation on proteins (enzymes, albumin), peptides and 
hormones (aromatic steroids) transcription (protein expression) in the human 
epidermis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enzymes 
 
      mM H2O2 
 
                   
                 µM H2O2 
Catalase 
(Schallreuter, Bahadoran et al. 
2008) 
GR 
(Schallreuter, Bahadoran et al. 
2008) 
TR  
(Schallreuter, Pittelkow et al. 
1986; Schallreuter and Wood 
2001) 
MSRA 
MSRB 
(Schallreuter 2006) 
TYR 
(Wood, Chavan et al. 2004; 
Wood, Decker et al. 2009) 
 
 
Oxidation of the structure 
yields  
-loss of functionality 
-impaired functionality 
and  
Deactivation 
 
 
 
 
 Up-regulation of transcription 
 
 
Cholinergic system 
AchE 
(Schallreuter, Elwary et al. 
2004) 
BchE 
(Schallreuter, Gibbons et al. 
2006) 
 
Oxidation of the structure 
yields  
-loss of functionality 
-impaired functionality 
and  
Deactivation 
 
 
 
Up-regulation of transcription 
and enzyme activity 
 
 
Adrenergic system 
 
TH 
(Marles, Peters et al. 2003) 
PAH 
 
 
Oxidation of the structure 
yields  
-loss of functionality 
-impaired functionality 
and  
Deactivation 
 
 
 
 
Up-regulation of transcription 
and enzyme activity  
 
6BH4 synthesis/ 
recycling 
 
GTP-CHI 
(Chavan, Beazley et al. 2009) 
PAH 
(Chavan, Gillbro et al. 2006) 
PCD 
(Schallreuter, Moore et al. 
2001) 
DHPR 
(Hasse, Gibbons et al. 2004) 
 
 
 
Oxidation of the structure 
yields  
-loss of functionality 
-impaired functionality 
and  
Deactivation 
 
 
 
 
 
 
 
   Up-regulation of transcription 
 
        
6BH4 
(Schallreuter, Wood et al. 
1994; Schallreuter, Moore et 
al. 2001; Rokos, Beazley et al. 
2002; Hasse, Gibbons et al. 
2004) 
 
Oxidation of the cofactor 
 
 
Works as a cofactor 
 
Hormones 
(Schallreuter, Chiuchiarelli et 
al. 2006) 
Estrogen 
Progestrone 
Androgen 
 
Via oxidation to ortho-quinone by 
cytochrome P450 which in turn 
causes DNA-damage 
 
 
Work as hormones 
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                                            No structural change, 
      p53                                   enhanced p53-DNA binding                            NO change 
        (Salem 2009)                         capacity                                                         
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
POMC-peptides 
PC1, PC2, Furin 
(Spencer, Gibbons et al. 2006) 
 
 
       
     mM H2O2 
 
                   
                  
                   µM H2O2 
 
α-MSH 
β-endorphin 
ACTH 
 
H2O2-mediated oxidation changes 
the structure yielding loss of the 
function 
 
 
Up-regulation of transcription 
of POMC 
                      
Albumin 
(Rokos, Moore et al. 2004) 
(Hasse, Kothari et al. 2005) 
 
 
Structural changes 
              
 
Up-regulation of transcription 
 
XO 
(Shalbaf, Gibbons et al. 2008) 
 
             Structural changes                  Up-regulation of transcription 
              (minor oxidation)  
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1.7  Xanthine oxidase 
 
In the human epidermis H2O2 can be generated by several mechanisms (Table 1). 
Xanthine oxidase (EC 1.1.3.22, XO) is one of these mechanisms which is able to 
produce H2O2 from the degradation products of released purine bases (Dixon and 
Lemberg 1934; McCord and Fridovich 1968; Olson, Ballow et al. 1974).  
 
1.7.1  Xanthine oxidoreductase enzymes (XOR) 
XO belongs to the family of the mononuclear molybdopterin cofactor containing 
enzymes and was isolated for the first time by the Austrian biochemist Franz 
Schardinger in 1902 from bovine milk and was described as aldehyde reductase 
(Schardinger 1902). In 1920, Frederick Gowland Hopkins, isolated and reported a 
xanthine-oxidising enzyme from bovine milk (Hopkins 1920). However, it was 
Malcolm Dixon in 1926 who showed that the enzyme discovered by Schardinger was 
identical to the one reported by Hopkins (Dixon 1926). This enzyme exists in 
different species from bacteria to man (Morgan 1926; Richert and Westerfeld 1951; 
Al-Khalidi and Chaglassian 1965) and also in the various tissues of mammals 
(Roberts 1936; Parks and Granger 1986; Sarnesto, Linder et al. 1996). XO performs 
its role in terminal oxidation of all purine bases as the rate-limiting enzyme in purine 
degradation pathways (Dixon and Lemberg 1934; Parks and Granger 1986). In these 
pathways, XO catalyses the oxidative hydroxylation of hypoxanthine to xanthine 
followed by xanthine to uric acid, the last two steps in the catabolic metabolism of 
purine bases in mammals leading to the formation of uric acid (Figure 3). These 
catalytic reactions are accompanied by the generation of H2O2 and O2
•- (Dixon and 
Lemberg 1934; Morell 1952; McCord and Fridovich 1968; Olson, Ballow et al. 
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1974), hence XO has been considered a major biologic source of ROS in many organs 
causing oxidative stress (Manson, Anthenelli et al. 1983; Im, Shen et al. 1984; 
Chambers, Parks et al. 1985; Parks and Granger 1986; Picard-Ami, MacKay et al. 
1991; Glantzounis, Tsimoyiannis et al. 2005).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3  
Purine degradation pathway 
Uric acid/allantoin formation from guanine and adenine nucleotides requires XO and 
produces H2O2 (Pi = inorganic orthophosphate, IMP = inosine monophosphate). 
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In humans a single gene encodes xanthine oxidoreductase enzymes (XOR) and its 
locus maps to chromosome 2p22 (Ichida, Amaya et al. 1993; Xu, Zhu et al. 1994; 
Garattini, Mendel et al. 2003). Mammalian XOR enzyme exists in two forms: 
xanthine dehydrogenase (EC 1.1.1.204, XDH) and XO. The two proteins have similar 
molecular weights and composition of redox centres (Hille and Nishino 1995). In 
normal physiological conditions XOR is found in the dehydrogenase form in the cell, 
however, under oxidising conditions, XDH can be immediately converted to the 
oxidase form, XO (Green 1934; McKelvey, Hollwarth et al. 1988; Hille and Nishino 
1995; Nishino, Nakanishi et al. 1997; Enroth, Eger et al. 2000; Glantzounis, 
Tsimoyiannis et al. 2005). 
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1.7.2  The general structure of XOR enzymes 
XOR enzymes all consist of approximately 1,333 amino acid residues. The basic 
structure of these enzymes is a monomer composed of three main domains. A small 
N-terminal 20 kDa domain (residues 1 to 165) contains two iron-sulfur centres, which 
are connected to a central 40 kDa FAD (flavin adenine dinucleotide) domain (residues 
226 to 531) by a segment consisting of residues 166 to 225. The FAD centre is then 
connected to the large third domain, a C-terminal 85 kDa molybdopterin domain 
(residues 590 to 1,332) by another segment consisting of residues 532 to 589. The 
molybdopterin domain is close to the interfaces of the Fe/S and FAD binding 
domains. The three domains altogether give rise to a total molecular weight of 
approximately 145 kDa per monomer (Enroth, Eger et al. 2000). The Fe/S centres are 
coordinated to four cysteine residues, 113, 116, 148, 150, located close to the flavin 
ring. Thus, the active form of xanthine oxidase is a homodimer with 290kDa 
molecular mass (Enroth, Eger et al. 2000). The redox–active centres of XOR enzymes 
has therefore the same constitution: a pterin cofactor attached to the molybdenum via 
a dithiolene linkage, two 2Fe/2S centres and one FAD which altogether are organised 
in a linear fashion ideal for electron transfer (Huber, Hof et al. 1996; Kisker, 
Schindelin et al. 1997; Romao, Knablein et al. 1997; Kisker, Schindelin et al. 1998; 
Enroth, Eger et al. 2000; Nishino and Okamoto 2000; Hille and Anderson 2001). The 
oxidation of xanthine takes place at the molybdopterin centre, and reducing 
equivalents are transported via iron-sulfur centres to FAD, where physiological 
oxidation occurs. Therefore, the electrons from the substrate are passed into the 
molybdenum centre and afterwards through Fe/S clusters, and eventually into the 
FAD centre in the course of a reductive half reaction (Olson, Ballou et al. 1974; Hille 
 71 
1991; Hille and Anderson 1991; Kisker, Schindelin et al. 1997; Enroth, Eger et al. 
2000).  
 
1.7.2.1  The role of the molybdopterin cofactor (moco) 
The molybdopterin cofactor plays an essential role in a variety of enzymes named 
hydroxylases or oxotransferases (Kisker, Schindelin et al. 1997; Kisker, Schindelin et 
al. 1998; Hille 2002; Garattini, Mendel et al. 2003; Hille 2005). It is a non-planar 
tricyclic structure consisting of a pterin nucleus which is fused to a pyran ring and 
attached to the molybdenum via a dithiolene sulfur groups (Rajagopalan 1991; 
Romao, Archer et al. 1995; Kisker, Schindelin et al. 1997). The active form of XO 
contains a Mo=S ligand since the replacement of the sulfur with oxygen results in a 
catalytical inactive form of the enzyme (Massey and Edmondson 1970). In this 
cofactor, molybdenum catalyses an oxo-transfer reaction accompanied by electron 
transfer from substrates to other cofactors, such as Fe/S centres and FAD (Kisker, 
Schindelin et al. 1998). The cycling between the fully oxidised state of the 
molybdenum atom(MoVΙ) and the fully reduced form (MoΙV) is common in all the 
reactions catalysed by molybdenum cofactor containing enzymes (Hille and Massey 
1981; Hille and Sprecher 1987; Hille 1991; Hille and Anderson 1991; Hille and 
Massey 1991; McWhirter and Hille 1991; Hille, Kim et al. 1993; Kim and Hille 1993; 
Ryan, Ratnam et al. 1995; Kisker, Schindelin et al. 1997; Xia, Dempski et al. 1999; 
Stockert, Shinde et al. 2002; Choi, Stockert et al. 2004). It has been documented that 
although the molybdopterin cofactor is not directly involved in catalysis, it still has 
numerous hydrogen bonding to the protein which associate in transferring electrons 
out of the molybdenum centre. Crystallographic information of different molybdenum 
containing enzymes show that these hydrogen bonding from the distal amino group of 
 72 
the molybdopterin cofactor to a cysteine residue of the iron-sulfur centre have been 
organised in line suitable for electron transfer (Hille 2002). The general reaction 
which is catalysed by molybdenum hydroxylases enzymes such as XO and XDH is 
shown below (Kisker, Schindelin et al. 1998): 
 
 
 
        
      
 
Rather than O2, H2O is utilised by these enzymes as the ultimate source of oxygen 
atom incorporated into the product. Therefore, the hydroxyl group introduced into the 
substrate is derived from H2O and the electrons introduced into the enzyme may be 
transferred to any of the specific physiological electron acceptors such as O2 (in XO) 
or NAD+ (in XDH) (Rajagopalan and Johnson 1992; Choi, Stockert et al. 2004). 
Hence molybdenum hydroxylases are able to generate reducing equivalents rather 
than consume them in the reactions which they catalyse (Hille and Massey 1986; 
Choi, Stockert et al. 2004).  
 
 
 
 
 
 
 
RH + H2O → ROH + 2e
- +2H+
XO
(RH = aldehyde or aromatic heterocycle)
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1.7.2.2  Important amino acid residues involved in catalysis 
The specific amino acid residues which may play significant catalytic role have been 
identified. Glu1261 (Glutamine) has been reported to be the foremost amino acid 
identified as a candidate in the active site of the enzyme which initiates the catalytic 
reaction. It has been also speculated that Glu802 which is situated directly above the 
substrate binding site between Phe1009 (phenylalanine) and Phe914 may be also 
involved in catalysis (Bray and Malmstrom 1964; Choi, Stockert et al. 2004). 
 
                                   
 
 
 
 
 
 
 
 
 
 
 
Figure 4  
Structure of the active site of XO, with amino acid residues likely to be involved in 
catalysis  
Glu1261 has been suggested to be the most significant amino acid in the active site of XO 
which initiates catalysis. Glu802 may also be involved in catalysis (Choi, Stockert et al. 2004). 
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1.7.3  XO and XDH 
As stated earlier, XOR enzymes exist in two inter-convertible forms; XDH and XO. 
Under physiological conditions XOR enzyme is only transcribed as dehydrogenase 
form (XDH) but it is readily converted to its oxidase form (XO) either by proteolysis 
or oxidation of cysteine residues (Green 1934; McKelvey, Hollwarth et al. 1988; Hille 
and Nishino 1995; Nishino, Nakanishi et al. 1997; Enroth, Eger et al. 2000; 
Kuwabara, Nishino et al. 2003). The conversion of XDH to XO has been implicated 
in diseases characterised by oxygen-radical-induced tissue damage such as ischemia 
reperfusion injury (McCord 1985; Hille and Nishino 1995) and oxidative stress in the 
human epidermis as observed in vitiligo (Schallreuter 2005; Shalbaf, Gibbons et al. 
2008). These two enzymes have similar molecular weights and composition of redox 
centres (Hille and Nishino 1995; Hille 1996). XDH has a greater affinity for oxidised 
nicotinamide adenine dinucleotide (NAD+) as the electron acceptor when catalysing 
the hydroxylation of hypoxanthine to xanthine and the latter to uric acid to produce 
NADH. The reduction of NAD+ occurs through the FADH2 cofactor (McKelvey, 
Hollwarth et al. 1988; Enroth, Eger et al. 2000; Nishino, Okamoto et al. 2005). 
However, it has been reported that XDH itself is capable of generating considerable 
amounts of O2
•-, although under normal conditions NAD+ would be expected to 
effectively compete with O2 for reduced enzyme (Hille and Nishino 1995). 
Furthermore, as mentioned earlier XDH uses H2O as the source of oxygen introduced 
into the product (Enroth, Eger et al. 2000). XO, however, utilises O2 instead of NAD
+ 
leading to the formation of free O2
•- (Olson, Ballow et al. 1974) which is 
subsequently converted to H2O2 through spontaneous disproportionation or by 
superoxide dismutase activity (Horecker and Heppel 1949; McCord and Fridovich 
1968). H2O2 can react with iron via the Fenton reaction to produce OH
• (Beauchamp 
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and Fridovich 1970; Bannister, Bannister et al. 1982; Parks and Granger 1983; 
Britigan, Pou et al. 1990; Hille and Nishino 1995; Glantzounis, Tsimoyiannis et al. 
2005).  
 
1.7.4  Conversion of XDH to XO 
As stated above under certain conditions, the XDH can be readily converted to 
oxidase by reversible oxidation of two cysteine residues (Cys535 and Cys992) and this 
is accompanied by a conformational change due to the formation of a disulfide bond 
(Kuwabara, Nishino et al. 2003). XDH can also be irreversibly converted to the 
oxidase form by proteolysis at lysine551 by trypsin and by cleavage after leucine219 
and lysine569 (Kuwabara, Nishino et al. 2003; Nishino, Okamoto et al. 2005). The 
major difference between XDH and XO exists in the FAD domain. The conversion of 
XDH to XO form results in a small conformational change near the FAD cofactor 
binding domain which affects the NAD binding site on the FAD accounting for 
XDH’s ability to utilise NAD as an electron acceptor, whereas XO has high reactivity 
towards O2 reducing it to O2
•- and H2O2. However, this structural change does not 
affect the other cofactors (moco and Fe/S centres) or enzyme function (McKelvey, 
Hollwarth et al. 1988; Enroth, Eger et al. 2000; Kuwabara, Nishino et al. 2003; 
Nishino, Okamoto et al. 2008; Tsujii and Nishino 2008).  
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1.7.5  Mechanism of action of XO 
It has been indicated that the overall reaction mechanism catalysed by XO consists of 
two half-reactions taking place at different sites on the enzyme. The reductive half-
reaction occurs first and it takes place at the molybdenum centre by the reduction of 
MoVΙ to MoΙV involving the oxidation of the substrate (McWhirter and Hille 1991; 
Hille, Kim et al. 1993; Kim and Hille 1993; Hille 1994; Kim, Ryan et al. 1996). In 
this half reaction xanthine is converted to uric acid. Then the oxidative half-reaction 
takes place at the FAD centre (Bray and Malmstrom 1964; Komai, Massey et al. 
1969). In this half-reaction O2 is used as the final electron acceptor to generate H2O2 
and O2
•- (Hille and Massey 1981). It is considered that in this half-reaction, re-
oxidation of the reduced XO to the fully-oxidised form of the enzyme occurs (Olson, 
Ballou et al. 1974; Olson, Ballow et al. 1974). The Fe/S centres facilitate the electron 
transfer between the molybdenum and the FAD centres (Nishino and Okamoto 2000). 
The crystallographic data indicates that the pterin portion of the molybdenum cofactor 
is pointing out towards the first Fe/S centre (Hille 2002) therefore, accordingly, XO 
requires an active site sulfur in order to be catalytically active (Massey and 
Edmondson 1970). XO needs 6 electrons to be completely reduced (two on the 
molybdenum centre, one in each of the two Fe/S centres, and two on the FAD centre), 
therefore, it requires three molecules of substrate to become fully reduced (Hille and 
Massey 1981). Re-oxidation of the enzyme takes place in four steps. First, the six 
electron reduced enzyme is oxidised to four electron reduced enzyme and then it loses 
another two electron in the next oxidation step. H2O2 is produced in these two 
oxidation steps. In the last two steps, the enzyme loses two electrons to become fully 
oxidised accompanied by the production of O2
•-. These properties contribute to 
oxidative stress (Repine 1991).  
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Figure 5  
The oxidative and reductive half-reactions of XO 
(A): The oxidative half-reaction. In the first two steps of this reaction, two molecules H2O2 
are produced while in the last two steps, two molecules O2
•- are the product of the reaction.  
(B): The overall reaction of XO. The reductive half-reaction takes place at the moco centre in 
which Mo is reduced from MoVI to MoIV while xanthine is oxidised to uric acid. The oxidative 
half-reaction occurs at the FAD centre, where H2O2 is produced (modified from (Newsholm 
and Leech 1984; Hille and Nishino 1995; Stockert 2004 ). 
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1.7.6  Absorbance spectroscopy of xanthine oxidoreductase enzymes 
The absorption of the FAD and iron-sulfur centres dominates the UV/visible 
absorption spectra of both XO and XDH. It is thought that the difference between the 
absorbance of the two enzymes is likely due to FAD cofactor since the absorption 
spectra of the iron-sulfur centres in both enzymes are essentially identical. Therefore 
it is believed that the difference between the two absorption spectra of XO and XDH 
is due to the absence of the NAD binding site near the FAD centre in XO. It has been 
also reported that the absorbance of the molybdenum centre is virtually 
indistinguishable in the spectrum because of the absorbance of the FAD and Fe/S 
centres (Hille and Nishino 1995; Stockert 2004 ).  
 
    
 
 
 
 
 
 
 
 
 
Figure 6  
The comparative absorbtion spectra of both oxidised and reduced bovine milk XO and 
Rhodobacter capsulatus XDH.  
The maximum absorbance in XO at 450nm is due to both FAD and Fe/S centres whereas in 
XDH this absorbance is shifted to 465nm [adopted form (Stockert 2004 )].  
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1.8  Oxidative DNA damage and its responses 
 
Reactive oxygen species (ROS) are formed as by products during cellular metabolism 
(Halliwell 1989; Halliwell and Gutteridge 1989). These oxygen-derived reactive 
species are able to damage various biomolecules such as lipids, proteins and nucleic 
acids (Halliwell 1989; Halliwell and Gutteridge 1989; Esterbauer, Dieber-Rotheneder 
et al. 1990; Smith, Marks et al. 2004). It has been also reported that the attack on 
lipids and proteins by ROS can lead to the generation of intermediates which are able 
to damage DNA (Esterbauer, Eckl et al. 1990). Since integrity of the genome and cell 
survival is highly preserved among living organisms, cells have evolved multiple 
protective strategies in response to DNA damage. These responses are very complex 
involving a variety of signals and proteins that regulate an intricate network of 
pathways including cell cycle checkpoints, DNA repair, cellular senescence and 
apoptosis (Zhivotovsky and Kroemer 2004; Schmitt, Paquet et al. 2007). 
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1.8.1  Formation of 8-oxoGuanine (8-oxoG) 
The oxidative damage to DNA results in the hydroxylation of DNA bases (Lu, Li et 
al. 2001; Cadet, Douki et al. 2003; Cooke, Evans et al. 2003), mainly guanine, as it 
has the lowest oxidation potential amongst the four bases. The oxidation of guanine 
leads to the formation of a plethora of oxidised guanine products (Neeley and 
Essigmann 2006). 8-oxoG (the oxidised base), identified by Kasai in 1984, is the most 
thoroughly studied oxidised guanine product (Kasai and Nishimura 1984; Kasai and 
Nishimura 1984; Kasai, Crain et al. 1986; Adelman, Saul et al. 1988; Kasai 1997; 
Neeley and Essigmann 2006). Also, oxidation of dGTP in the nucleotide pool in the 
cell prepared for DNA synthesis leads to the formation of the 8-oxo-dGTP, which can 
be subsequently misincorporated into DNA during replication (Akiyama, Maki et al. 
1989; Maki and Sekiguchi 1992; Mo, Maki et al. 1992; Nakano, Kawanishi et al. 
2003). The oxidised DNA generally undergoes repair. Oxidised nucleosides and bases 
are almost water-soluble; therefore after the repair process they appear in the urine 
without further metabolism (Wu, Chiou et al. 2004). Hence 8-oxoG has been 
extensively used as a biological marker for oxidative stress in tissues, saliva, serum 
(plasma) and urine (Kasai, Crain et al. 1986; Fraga, Shigenaga et al. 1990; Loft, 
Vistisen et al. 1992; Loft, Fischer-Nielsen et al. 1993; Ahmed, Ueda et al. 1999; de 
Zwart, Meerman et al. 1999; Helbock, Beckman et al. 1999; Lovell, Gabbita et al. 
1999; Perra, Maxia et al. 2006; Bahar, Feinmesser et al. 2007; Chen, Liou et al. 2007). 
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1.8.2  The mutagenic potential of 8-oxoG 
8-oxo-G potentially has the ability to mimic T functionality in the syn confrontation. 
Therefore, if not removed from the damaged DNA or from the nucleotide pool, it can 
form a stable 8-oxoG/A base pair during DNA replication which, although inaccurate, 
is efficiently bypassed by replicative DNA polymerases inducing G:C to T:A 
transversion. This is potentially mutagenic or even can lead to apoptosis (Floyd 1990; 
Wood, Dizdaroglu et al. 1990; Shibutani, Takeshita et al. 1991; Cheng, Cahill et al. 
1992; Maki and Sekiguchi 1992; Grollman and Moriya 1993; Moriya 1993; Le Page, 
Margot et al. 1995; Johnson, Yu et al. 1996; Hussain and Harris 1998; Sunaga, Kohno 
et al. 2001; Bjelland and Seeberg 2003; Hussain, Hofseth et al. 2003). Therefore, 
oxidative damage to DNA is thought to be a common pathway leading to mutations 
and apoptosis. It is also believed to be one of the major causes of cancer (Hattori-
Nakakuki, Nishigori et al. 1994; Johnson, Yu et al. 1996; Marnett 2000; Cooke, Evans 
et al. 2003; Hussain, Hofseth et al. 2003). Hence, the removal of DNA-oxidised 
lesions or modified bases from the nucleotide pool is extremely vital and required for 
genomic stability and cell survival. 
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1.8.3  Repair of oxidative DNA damage 
In order to minimise the induction of mutations following oxidative damage to DNA 
and to maintain genomic integrity, all cells have evolved an effective machinery to 
remove oxidised bases to prevent their incorporation into DNA during replication 
(Demple and Harrison 1994; Lu, Li et al. 2001; Friedberg 2003; Hazra, Das et al. 
2007). DNA damage signalling pathways are very complex. In a simplified manner, 
in response to genotoxic stress p53 is activated and in turn it transactivates a series of 
its downstream effector genes involved in delaying cell cycle arrest including p21, 
PCNA and Gadd45α, cellular senescence and also apoptosis including pro-apoptotic 
members of Bcl-2 family of proteins such as BAX (Kastan, Onyekwere et al. 1991; 
Bates and Vousden 1996; Chen, Ko et al. 1996; Harris 1996; Ko and Prives 1996; 
Smith and Seo 2002; Mills 2005; Rozan and El-Deiry 2007; Shu, Li et al. 2007).  
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1.8.3.1  Induction of Gadd45α 
Gadd45 family members, are rapidly induced following genotoxic stress and they play 
critical roles as stress sensors in different apoptotic and growth inhibitory pathways 
(Fornace, Alamo et al. 1988; Fornace, Nebert et al. 1989; Papathanasiou, Kerr et al. 
1991; Fornace, Jackman et al. 1992; Beadling, Johnson et al. 1993; Hollander, Alamo 
et al. 1993; Zhan, Fan et al. 1996; Takekawa and Saito 1998; Smith and Mocarski 
2005). These proteins are localised within the nucleus (Carrier, Smith et al. 1994; 
Kearsey, Coates et al. 1995; Vairapandi, Balliet et al. 1996; Zhang, Bae et al. 1999). 
Gadd45α, is one of several growth-arrest and DNA-damage-inducible genes and it 
has been implicated in cell cycle checkpoint in G2/M, DNA repair and apoptosis via 
interaction by other cellular proteins including PCNA, p21, cdc2, cyclinB1 and the 
p38 and JNK stress response kinases (Fornace, Jackman et al. 1992; Kastan, Zhan et 
al. 1992; Smith, Chen et al. 1994; Chen, Smith et al. 1995; Hall, Kearsey et al. 1995; 
Kearsey, Shivji et al. 1995; Harkin, Bean et al. 1999; Wang, Zhan et al. 1999; Zhan, 
Antinore et al. 1999; Sheikh, Hollander et al. 2000; Maeda, Hanna et al. 2002; Zhan 
2005; Liebermann and Hoffman 2007; Miyake, Takekawa et al. 2007). It has been 
also shown that Gadd45α is involved in the induction of G2/M cell cycle checkpoint 
following UVB irradiation in epidermal KCs, MCs and also in melanoma cells 
(Maeda, Hanna et al. 2002; Pedeux, Lefort et al. 2002). Based on these results, it has 
been suggested that the activation of Gadd45α in MCs and melanoma cells may play 
a crucial role for their survival due to their ability to efficiently repair UVB-induced 
lesions (Pedeux, Lefort et al. 2002; Fayolle, Pourchet et al. 2006; Fayolle, Pourchet et 
al. 2008; Rajpara, Hu et al. 2008).  
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1.8.3.2  Base-excision repair of oxidative DNA damage 
In living organisms, oxidative DNA damage is predominantly repaired via base-
excision repair (BER) pathways (Sancar 1994; Parikh, Mol et al. 1997; Fortini, 
Parlanti et al. 1999; Dianov, Souza-Pinto et al. 2001; Dogliotti, Fortini et al. 2001; 
Lindahl 2001; Lu, Li et al. 2001; Fromme and Verdine 2004). DNA glycosylases are 
the key enzymes to initiate BER processes which remove the oxidised bases by N-
glycosylic bond hydrolysis between the bases and the deoxyribose moieties of the 
nucleotides leaving apurinic/apyrimidinic (AP) sites in the DNA (Michaels, Tchou et 
al. 1992; Boiteux 1993; van der Kemp, Thomas et al. 1996; Boiteux and Radicella 
1999; Boiteux and Radicella 2000; Lu, Li et al. 2001; Fortini, Pascucci et al. 2003; 
Dizdaroglu 2005; David, O'Shea et al. 2007). These enzymes are responsible to 
specifically recognise and remove different oxidised-bases from the damaged DNA 
(Chetsanga and Lindahl 1979; Tchou, Kasai et al. 1991; Michaels, Tchou et al. 1992). 
Moreover, in order to protect cells and organisms from mutagenesis and 
carcinogenesis induced by 8-oxo-dGTP, there is a mechanism to remove this oxidised 
base from the nucleotide pool so that it cannot be misincorporated into DNA by DNA 
polymerases (Akiyama, Maki et al. 1989; Maki and Sekiguchi 1992; Lu, Li et al. 
2001; Nakano, Kawanishi et al. 2003). BER of 8-oxoG/C pairs is initiated by hOgg1 
(8-oxoGuanine-DNA glycosylase 1), which removes 8-oxoG, leaving an AP site 
(Boiteux and Radicella 1999; Kinoshita, Wanibuchi et al. 2002). However, if at this 
stage the repair of the damaged base does not occur and replication takes place, an 
incorrect 8-oxoG/A mismatch is formed. Therefore the second level of defence is an 
additional post-replication double check to recognise and correct the 8-oxoG/A 
mismatches produced by persistent 8-oxoG residues. In human, this is accomplished 
by DNA glycosylase hMYH, which is responsible to detect and excise the 
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inappropriate A residues misincorporated opposite the unrepaired 8-oxoG during 
replication (Michaels, Tchou et al. 1992; Tajiri, Maki et al. 1995; Lu and Fawcett 
1998; Parlanti, Fortini et al. 2002; Russo, De Luca et al. 2007). Furthermore, hMTH 
in human hydrolyses 8-oxo-dGTP from nucleotide pools thus preventing its 
incorporation into nascent DNA (Colussi, Parlanti et al. 2002). The generated AP site 
is subsequently treated by a repair polymerase in the replication process to form an 8-
oxoG/C substrate for the hOgg1 (Boiteux and Radicella 1999; Boiteux and Radicella 
2000; Bruner, Norman et al. 2000; Shinmura and Yokota 2001; David, O'Shea et al. 
2007).  
Depending on the number of damaged bases, the abasic site is then processed by two 
alternative pathways: short-patch DNA polymeraseβ-dependent BER in which only 
one damaged nucleotide is repaired (Kubota, Nash et al. 1996; Fortini, Parlanti et al. 
1999; Dogliotti, Fortini et al. 2001) and long-patch PCNA-dependent BER involving 
the repair of more damaged nucleotide at the lesion site (Matsumoto, Kim et al. 1994; 
Frosina, Fortini et al. 1996; Klungland and Lindahl 1997; Wilson and Thompson 
1997; Dogliotti, Fortini et al. 2001). The repair mode of oxidative DNA damage is 
predominantly via short-patch BER where DNA polymeraseβ plays a critical role 
although there is evidence suggesting that it is implicated in the long-patch pathway 
as well (Dianov, Prasad et al. 1999; Prasad, Dianov et al. 2000). To complete the 
repair process after the glycosylase action, APE1 (apurinic/apyrimidinic endonuclease 
1) and DNA polymeraseβ are recruited to excise the remaining sugar moiety and to 
reinstall an undamaged nucleotide respectively, and the remaining nick is sealed by 
DNA ligaseI thereby repairing the damaged base site (Parikh, Mol et al. 1997; Gros, 
Saparbaev et al. 2002; Fortini, Pascucci et al. 2003; Chaudhry 2007). It should be 
noted that BER of the oxidised DNA is more complex and it is the result of multiple 
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interactions among various proteins and enzymes that may alter the choice of short- or 
long-patch BER modes and the detailed mechanisms which govern switching between 
these pathways have remained unknown (Dianov, Souza-Pinto et al. 2001; Dogliotti, 
Fortini et al. 2001; Lu, Li et al. 2001; Fortini, Pascucci et al. 2003; Fromme and 
Verdine 2004; Sung and Demple 2006). 
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1.8.4  Apoptosis regulators 
If the damage to DNA is so extensive and DNA is irreparable, apoptosis (programmed 
cell death) would be the major control mechanism by which cells are eliminated. The 
induction and execution of apoptosis are complex, including very well controlled 
processes and involving many proteins (Steller 1995; White 1996; Song and Steller 
1999; Teraki and Shiohara 1999; Zhivotovsky and Kroemer 2004). The Bcl-2 family 
of proteins play crucial roles in the regulation of apoptosis (Kroemer 1997). This 
family of proteins are divided into two subgroups: anti-apoptotic (such as Bcl-2, Bcl-
XL) and pro-apoptotic proteins (such as BAX, BAD and BAK) (Chao and Korsmeyer 
1998). It has been reported that the ratio of Bcl-2 and Bax is important in order to 
study cellular responses to apoptosis (van den Wijngaard, Aten et al. 2000). Gene 
expression of Bcl-2 and BAX proteins can be regulated by p53 (Miyashita, Krajewski 
et al. 1994).   
It has been documented that the activation of Bcl-2 is an essential cellular response to 
suppress the initiation of apoptosis (Kroemer 1997). After receiving the apoptotic 
stimulus, pro-apoptotic members of the Bcl-2 family of proteins which reside on the 
outer membrane of the mitochondrion, are activated. The activation of these proteins 
leads to the release of cytochrome c from the mitochondrion into the cytoplasm which 
in turn leads to the activation of caspase 9 and this functions in the activation of 
caspase 3 where it is a key effector of apoptosis (Boldin, Varfolomeev et al. 1995; 
Steller 1995; Tewari, Quan et al. 1995; Kuida, Zheng et al. 1996; Liu, Kim et al. 
1996; White 1996; Cai, Yang et al. 1998; Skulachev 1998; Song and Steller 1999; 
Abu-Qare and Abou-Donia 2001; Schmitt, Paquet et al. 2007). Therefore cytochrome 
c and caspase 3 have been considered as important biomarkers for apoptosis (Abu-
Qare and Abou-Donia 2001). 
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2.0  AIM 
 
Nowdays, there is accumulating evidence that the entire epidermis of patients with 
vitiligo is under oxidative stress, due to the presence of mM H2O2 concentrations 
(Schallreuter, Moore et al. 1999; Schallreuter, Bahadoran et al. 2008). XO is one of 
the several mechanisms generating H2O2 and O2
•-, from catalysing the last two steps 
of the purine degradation pathway (Parks and Granger 1986). Therefore, this enzyme 
is considered as a major biologic source of oxygen-derived free radicals (ROS) in 
many organs (Manson, Anthenelli et al. 1983; Im, Shen et al. 1984; Parks and 
Granger 1986; Picard-Ami, MacKay et al. 1991). 
To the best of our knowledge, the presence of XO in the human epidermis has not 
been demonstrated so far. Therefore the aim of this research was to show the presence 
and function of this enzyme in normal and healthy epidermal melanocytes and 
keratinocytes. Moreover, we wanted to know whether this system differs in patients 
with vitiligo compared to controls. 
Due to the presence of severe oxidative stress in the epidermis of this patient group, 
oxidative DNA damage and / or apoptosis would be highly expected. Consequently, 
this study aimed to address this senario in vitiligo in more detail.    
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3.0  MATERIALS AND METHODS 
 
 
 
3.1  Cell culture 
 
3.1.1  Establishment of epidermal primary cell cultures 
Epidermal melanocytes and keratinocytes were primarily cultured from full thickness 
of normal human skin (skin phototype III, Fitzpatrick classification) (Kiistala 1968) 
obtained as surgical waste after cosmetic or non-cosmetic operations such as facelifts, 
breast and abdomen reductions. Briefly, fat was removed from the skin following a 
quick wash in a PBS solution containing 5% penicillin/streptomycin (P/S) (Gibco 
Invitrogen, Paisley, UK) and 5% fungisone (Gibco Invitrogen, Paisley, UK). To 
facilitate the separation of the epidermis from the dermis, incisions were made on the 
epidermis using a scalpel. The tissue samples were then incubated in dispase (Roche 
Applied Science, Roche Diagnostics Corporation, Indianapolis, USA) containing, 5% 
P/S and 5% fungisone for approximately 12 hours at 4°C. 
The next day the epidermal sheets were separated from the underlying dermis and 
placed in a solution of 1x RPMI media (RPMI 1640, Gibco Invitrogen, Paisley, UK) 
containing 5% P/S and 5% fungisone until the separation was completed. In order to 
prepare a cell suspension solution, the separated sheets of epidermis were incubated in 
x1 (0.05%) trypsin/EDTA (Gibco Invitrogen, Paisley, UK) at 37°C for 10 minutes. 
Trypsinisation was neutralised by the addition of either FBS (Gibco Invitrogen, 
Paisley, UK) or RPMI media containing 5% P/S, with the volume of almost 4 times of 
the trypsin volume. The mixture was gently pipetted up and down a few times in order 
to get a single cell solution followed by centrifugation at 200 x g for 10 minutes at 
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4°C in a Heraeus Sepatech bench-top centrifuge (Heraeus Instruments, Hannover, 
Hamburg, Germany). 
In order to obtain primary co-cultures of both melanocytes and keratinocytes, the cell 
pellets were re-suspended in a 50/50 mixture of the medium for each cell type. i.e. for 
MCs, MC Medium 254 (Cascade Biologics, Mansfield, Nottinghamshire, UK) 
containing 1% P/S and 1% supplied growth factor (HMGS, Human Melanocyte 
Growth Supplement), (Cascade Biologics, Mansfield, Nottinghamshire, UK), and for 
KCs, Defined K-SFM keratinocyte medium (Gibco, Invitrogen, Paisley, UK) 
containing 1% P/S and growth supplements provided by the same company. After re-
suspension, the cells were seeded into 25cm2 cell culture flasks containing 5ml of the 
mixed media (Scientific Laboratory Supplies, Nottingham, UK). Cells were allowed 
to attach at 37°C, 5% CO2 and 95% humidity. The medium was changed every 2-3 
days. 
 
3.1.2  Separation of MC and KC cell cultures and their maintenance     
Once the co-cultured cells were confluent around 80%, keratinocytes and melanocytes 
were separated via selective trypsinisation to obtain single cell populations. Briefly, 
the medium was aspirated and the cells were washed gently with PBS to remove any 
medium proteins that could otherwise inhibit the trypsin. Cells were then incubated 
with 1x trypsin at 37°C. This process was carefully monitored under phase 
microscopy using a Leica DMIRB inverted microscope (Leica Microsystems Ltd, 
Milton Keynes, Buckinghamshire, UK), until the cells were rounding up and 
detached. MCs detach from the flask in approximately 2 minutes whereas KCs need 5 
to 15 minutes. The separated cell types were transferred into their specific media and 
allowed to attach and proliferate. Once confluent by 80%, both cell types were split 
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and passaged 1:3 into 75cm2 flasks. This step repeated up to passage 3-4. In order to 
promote differentiation of KCs, 2mM calcium chloride was added into the medium. 
 
3.1.3  Preparation of MC and MC cell extracts 
In order to prepare whole cell extracts, the cells were harvested via trypsinisation 
and/or scraping followed by centrifugation as described above. After removing the 
supernatant, the pellet was re-suspended in reaction buffer (KH2PO4, 0.05 M, pH 7.5) 
(Sigma, Pool, Dorset, UK). Extracts were made by grinding the suspension with sand 
using a pestle and mortar. Once completed, the solution was centrifuged at 14000 x g 
for 10 minutes using a Heraeus Kendro Biofuge fresco microcentrifuge (Heraeus 
Instruments, Hannover, Hamburg, Germany). The supernatant was aliquoted and 
stored at -80°C until further use. 
 
3.1.4  Preparation of whole cell extracts from epidermal suction blister tissues 
Epidermal suction blister tissues were obtained from patient’s lesional and non-
lesional skin and also healthy controls after written consent using the method of 
Kiistala (Kalb and Bernlohr 1977). All probands had skin phototype III, Fitzpatrick 
classification. This study was approved by the local Ethics Committees and was in 
agreement with the declaration of Helsinki. In order to prepare whole cell extracts 
from the epidermis, deep frozen tissues were ground with sand in a pestle and mortar 
containing 100 to 200µl of Tris-buffer (Sigma, Pool, Dorset, UK) (0.05M, pH7.5). 
The rest of the procedure was as described above. This method allows a very gentle 
extraction without the danger of any protein denaturation. Samples were aliquoted and 
stored at -80°C. 
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3.1.5  Determination of protein content 
The protein content of cell extracts was determined either spectrophotometrically at 
280 nm with a Beckman DU-64 UV spectrophotometer (Beckman Coulter Ltd, High 
Wycombe, Buckinghamshire, UK) as described by Kalb and Bernlohr (Xu, 
Huecksteadt et al. 1996) or using the Bradford assay as described in the 
manufacturer’s protocol (BioRad Laboratories Ltd., Hemel Hempstead, Herts., UK) 
with a standard curve of BSA 0.2-1.6 mg/ml (Sigma, Poole, Dorset, UK).  
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3.2  Reverse transcriptase polymerase chain reaction (RT-PCR) 
 
3.2.1  Isolation of total RNA 
Following the manufacturer’s protocol, total RNA was extracted from cultured 
epidermal melanocytes and keratinocytes before the fourth passage using the Ambion 
total RNA isolation kit (AMS Biotechnology, Oxon, UK). 
 
3.2.2  cDNA formation  
Using the above obtained RNA, reverse transcription was carried out using the 
reverse transcription system (Promega, Southampton, UK). cDNA was synthesised in 
20µl aliquots containing 1µg of isolated RNA, 5mM MgCl2, 1x reverse transcription 
buffer, 1mM dNTP mixture, 1U/µl RNasinribonuclease inhibitor, 0.5µg of random 
primer and 15U of AMV Reverse Transcriptase per µg of RNA. The conditions used 
to synthesis the cDNA were as follows; 1 hour at 42°C, 5 minutes at 95°C and 5 
minutes at 4oC.  The resulting cDNA was stored at -20°C until required.        
 
3.2.3  PCR of XDH 
For PCR amplification of XDH we used the primers reported earlier (Wilson and 
Walker 2005). All primers for the study were obtained from Genosys 
Biotechnologies, Europe Ltd, Pampisford, UK. Primer sequences and thermal 
parameters are described below: 
Forward primer: 5´-CTCCGCACAGATATTGTCATGGAT-3´ 
Reverse primer: 5´-AAATGCCGGGATCTTGTAGGTGCT-3´ 
The amplification conditions for XDH were 5 minutes denaturing at 95oC, followed 
by 35 cycles of 1 minute at 95°C, 1 minute at 59.4°C and 1 minute at 67°C (decrease 
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of 0.5oC each cycle). Once the PCR cycles were completed, the resulting cDNA 
strands were separated in a 1.2% agarose gel containing ethidium bromide for 90 
minutes.  Bands were visualised using a Uvitec camera (Uvitec, Cambridge, UK).    
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3.3  Immunofluorescence labelling 
 
Immunofluorescence allows detecting the location and relative abundance of any 
protein or cellular antigen expressed in cells or tissues by using specific antibodies. 
Therefore the high sensitivity of the technique is based on the specificity of the 
antibody-antigen interaction. 
 
3.3.1  Indirect immunofluorescence staining 
In this method a primary unlabelled antibody binds to a specific protein. The primary 
antibody is then bound to a secondary fluorochrome-conjugated antibody that can be 
visualised using a fluorescence microscope. Immuno-reactivity  can be documented 
by photographing. 
 
3.3.2  Preparation of cryosections 
3 mm punch biopsies of normal skin from consented volunteers and from lesional, 
non-lesional and repigmenting skin of patients with vitiligo (before and after 
treatment with a narrowband UVB-activated pseudocatalase, PC-KUS) were obtained 
under local anaesthesia taken from inner forearm. Samples were embedded in optimal 
cutting temperature compound (O.C.T) (Sakura, RA Lamb, Eastbourne, UK) and kept 
at -80°C. Once the skin samples were frozen, 3-5 µm thicknesses cryosections were 
cut using a Leica CM3050 S cryostat (Leica Microsystems Ltd, Milton Keynes, 
Buckinghamshire, UK) and placed onto slides coated with poly-L-Lysine (Sigma, 
Pool, Dorset, UK) and stored at -80°C until required for immuno-staining. 
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3.3.3  Preparation of chamber slides from epidermal cells  
For in vitro immuno-reactivity studies, keratinocytes or melanocytes were seeded into 
8-well chamber slides (Lab-Tek®II, Chamber Slide™ System, Nalge Nunc 
International Corp, Naperville, IL, USA) and allowed to attach for 48 hours. This was 
followed by changing the medium until each well was almost 60-70% confluent. Each 
well contained 100µl cell suspention (approximately 1x104 cells) and 400µl medium. 
Cells were fixed in ice-cold methanol for 5 minutes in -20°C and kept at -20°C until 
required. 
 
3.3.4  In situ single immuno-fluorescence staining 
Frozen slides were taken out of -80°C freezer and allowed to defrost at RT for 5 
minutes. After being fixed in ice-cold methanol for 5 minutes at -20°C, slides were 
rehydrated in PBS for 5 minutes and blocked with 10% normal donkey serum (NDS) 
(Jackson Immuno Research Laboratories, Cambridgeshire, UK) blocking solution 
diluted in PBS for 90 minutes at RT. After a quick wash in PBS for 5 minutes, the 
primary antibody (already diluted to the desired concentration in 1% NDS/PBS) was 
added to the sections and slides were incubated overnight 4°C. The following day, 
slides were washed twice in PBS for 5 minutes and once in PBS containing 0.05% 
Tween-20 (Bio-Rad Laboratories, Life Science Group, CA, USA) in between for 5 
minutes. Slides were then air-dried and incubated with a fluorescent secondary 
antibody in a dilution of 1:100 in 1% NDS/PBS for 1 hour. The choice of secondary 
fluorescein antibody, depends on the colour preferred [green = FITC (flluorescein 
isothiocyanate) or red = TRITC (tetrametyhl rhodamine isothiocyanate)] and also in 
which animal the primary antibody was raised (donkey anti- mouse, rabbit, sheep or 
goat, depending on the primary antibody). Secondary antibodies were from Jackson 
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Immuno Research Laboratories, Cambridgeshire, UK. After a washing process, slides 
were finally dried and mounted in Vectashield Mounting Medium with 4,6-diamino-
2-phenylindole (DAPI) (Vector Laboratories, CA, USA) and covered with a 
coverslip. Sections were viewed using a Leica DMIRB/E fluorescence microscope 
(Leica Microsystems Ltd, Milton Keynes, Buckinghamshire, UK) and 
photodocumented using a computer-assisted 3-CCD colour video camera and the 
Image Grabber PCI graphics program (both from Optivision, Osset, West Yorkshire, 
UK). In addition, some pictures were captured using a Nikon Eclipse 80i microscope 
with a DS-U101 Nikon camera coupled to a Nikon ACT-2U capture program (Nikon 
UK Limited, Kingston upon Thames, Surrey, UK).  
 
3.3.5  Clarification of acute vitiligo 
To characterise acute vitiligo we determined catalase levels in the epidermis of the 
same patients. Epidermal catalase levels are too low in the presence of 10-3M H2O2 
compared to healthy controls. Therefore this protein provides a useful marker for 
oxidative stress in vitiligo (Schallreuter, Wood et al. 1991; Maresca, Roccella et al. 
1997; Maresca, Flori et al. 2008; Schallreuter, Bahadoran et al. 2008).    
 
3.3.6  In situ double immuno-fluorescent labelling 
In situ double immuno-fluorescence allows the detection of two specific markers 
within one section. The protocol was used as described above with some slight 
modifications. After incubation with the secondary antibody and a brief rinse in PBS, 
the sections were blocked again and the described procedure was followed again step 
by step. Paint Shop ProTM 9 (Jasc Software, Inc, Eden Prairie, Minnesota, USA) was 
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utilized to merge the two different fluorochromes (FITC and TRITC) in order to 
follow possible co-localization. 
 
The primary antibodies used for in situ staining were mouse monoclonal to XDH/XO 
(Abcam, Cambridge, UK), in a dilution of 1:10, goat polyclonal to tyrosinase (Santa 
Cruz Biotechnology, Inc. Santa Cruz, CA, U.S.A), mouse monoclonal anti 8-oxoG 
(Alpha Diagnostic International, San Antonio, TX, USA) in a dilution of 1:20, sheep 
polyclonal to cytochrome c (Abcam, Cambridge, UK) in a dilution of 1:50, mouse 
monoclonal to caspase 3 (Abcam, Cambridge, UK), in a dilution of 1:10, mouse 
monoclonal anti-gadd45α (Santa Cruz Biotechnology, Inc. Santa Cruz, CA, U.S.A) in 
a dilution of 1:25. In all negative control studies the primary antibody was omitted 
from the staining procedure and substituted with 1% NDS/PBS. 
 
3.3.7  In vitro immuno-fluorescence labelling of KCs and MCs     
To perform in vitro staining of cultured cells, apart from fixation with methanol, the 
above-described procedure was followed. The washing processes were shortened as 
prolonged washing led to bursting of cells. Both keratinocytes and melanocytes were 
again incubated overnight with mouse monoclonal anti XDH/XO antibody (Abcam, 
Cambridge, UK) at the dilution of 1:20 at 4°C. In order to follow possible expression 
in melanosomes, melanocytes were incubated with tyrosinase antibody (goat 
polyclonal, Santa Cruz Biotechnology, Inc. Santa Cruz, CA, U.S.A) overnight at 4°C 
in the dilution of 1:20. 
 
 
 
 99 
3.3.8  Quantification of fluorescence intensity 
 
For quantification of XO fluorescence intensity, ImageJ version 1.37 was used 
(supplied online by NIH at http://rsb.info.nih.gov/ij/index.html). For quantification, 
the target region was highlighted, and the mean intensity was calculated. This was 
repeated for all sections. The calculated mean values were plotted. The fluorescence 
was expressed in arbitrary units.  
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3.4  Western blot analysis 
 
Western blotting is an analytical technique which is often used to detect expression of 
proteins in cells, tissues or a complex mixture of biomolecules using specific probes 
such as labelled antibodies. The proteins are first denatured via SDS and then 
separated according to their molecular weight. 
 
3.4.1 Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) 
A 5, 10 or 13% polyacrylamide resolving gel of 1mm in thickness was prepared and 
allowed to polymerise in a mini cassette (NC2010 cassettes 1mm, Invitrogen, 
Carlsbad, CA, USA) for about 90 minutes at RT. Then a 3% stacking gel was 
prepared (see the appendix) and poured over the resolving gel to which a 10 or 15-
well comb was inserted and allowed to set for 30 minutes at RT. The cassette was 
then placed in a NOVEX EI 900-XCELL IITM Mini cell gel system (NOVEX® 
NuPAGE, San Diego, CA, USA). The chamber was filled with running buffer (see the 
appendix) and the comb was removed. Sample buffer (see the appendix) was added to 
all protein samples prior to loading onto the gel in order to visualise the separation 
while running the gel. Then 10µl biotinylated protein ladder (Cell Signalling 
Technologies) and 15µl of each sample containing 5-15µg protein (depending on the 
protein of interest) were loaded onto the gel. A power supply (Gibco, Invitrogen, 
Paisley, UK) was connected to the apparatus and set at 100 volts. The gel was allowed 
to run for approximately 120 minutes until the separation completed when the dye 
reached to the bottom of the gel. 
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3.4.2  Western blotting 
Once the separation of proteins was completed, the power was disconnected. In order 
to expose the protein of interest to the probe, using a NOVEX blot module the 
proteins were transferred by electro-blotting to a 0.45µm pore size polyvinylidene 
difluoride membrane (PVDF) (Immobilon-P, Millipore, MA, USA). The transferring 
process was started by opening the gel cassette and removing the stacking gel. A 
blotting sandwich was assembled consisting of transfer buffer-soaked blotting pads, 
filter paper in transfer buffer (see the appendix), filter paper in methanol, pre-soaked 
PVDF membrane in methanol and transfer buffer, the polyacrylamide gel, filter paper 
in methanol, filter paper in transfer buffer and finally transfer buffer-soaked blotting 
pads. The blotting sandwich was placed into the transfer chamber (Novex, San 
Diego, CA, USA) filled with transfer buffer. A voltage of 25 volts was applied using 
the same power supply. The transfer was allowed to take place for around 2 hours. 
During the electro-blotting, the chamber was placed on ice to avoid the heat produced 
by the transfer. 
 
3.4.3  Blocking 
Once the transfer was completed, the acrylamide gel was stained with coomassie blue, 
and de-stained with a 40% methanol / 7% acetic acid solution to visualise any bands 
present. At the same time, the PVDF membrane containing all transferred proteins 
was blocked in order to prevent non-specific protein interactions between the 
membrane and the antibody protein. This was done by placing the membrane in a 
solution of 5% non-fat dried milk in PBS/0.4% Tween 20, or 0.5% gelatine (Sigma, 
Pool, Dorset, UK) dissolved in Tris buffered saline / 0.2% Tween 20 (TBS/Tween) 
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for around 2 hours at RT. N.B without blocking, the probe would bind non-
specifically to the membrane. 
 
3.4.4  Immuno- reactivity detection 
After blocking, the membrane was incubated with the primary antibody overnight at 
4°C. The primary antibody was diluted in 2.5% non-fat dried milk in PBS/0.4% 
Tween 20 in the case of XDH/XO (rabbit polyclonal, Abcam, Cambridge, UK) 
(1:10000) and caspase 3 (mouse monoclonal, Abcam, Cambridge, UK) (1:100), and 
in 0.05% gelatine in TBS/0.2%Tween 20 in the case of Gadd45α (mouse monoclonal, 
Santa Cruz Biotechnology, Inc. Santa Cruz, CA, U.S.A) (1:300), APE1 (mouse 
monoclonal, Abcam, Cambridge, UK) (1:2000), hOgg1 (rabbit polyclonal, Abcam, 
Cambridge, UK) (1:500), DNA polymerase β (rabbit polyclonal, Abcam, Cambridge, 
UK)  (1:250) and FEN1 (rabbit polyclonal, Abcam, Cambridge, UK) (1:500). The 
following day the membrane was washed 6 times each time 10 minutes for a total of 
60 minutes in either TBS/0.2%Tween 20 or 2.5% milk in PBS / 0.4% Tween 20.  
Horseradish peroxidase conjugated anti-biotin (Cell Signaling Technology Inc, 
Danvers, MA, USA) (1:4000) was used to detect the biotinylated ladder. Horseradish 
peroxidase conjugated anti-mouse secondary antibody (Sigma, Pool, Dorset, UK) 
(1:5000) was used for the detection of primary antibody for Gadd45α, Caspase 3 and 
APE1. Anti-rabbit (Cell Signaling Technology Inc, Danvers, MA, USA) (1:5000) was 
used for detection of the primary antibody for XDH/XO, hOgg1, DNA polymerase β 
and FEN1. 5µl of anti-biotin (1:4000) and 4µl (1:5000) of anti-mouse or anti-rabbit 
(secondary antibody) was added to 20ml of the relevant solution used to dilute 
primary antibody in each case and the membrane was incubated with the secondary 
antibodies for 60 minutes at RT. 
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After incubation with the secondary antibodies, the same washing procedure was 
repeated as described above. To visualize the bands, the PVDF membrane was placed 
into an enhanced chemiluminescent solution containing ECL-1 and ECL-2 solutions 
in equal quantities and shaken for 2 minutes at RT. These solutions react with the 
labeled probe and makes visualization of the protein possible. Finally the membrane 
was placed into a developer cassette (Sigma, Poole, Dorset, UK) and taken to a dark 
room where it was exposed to a film sheet (Kodak, Sigma, Pool, Dorset, UK) for 30 
seconds in the case of XDH/XO and around 10 to 20 minutes for other proteins. After 
developing the film in developer and fixer, the protein of interest can be seen as 
bands. 
 
3.4.5  Western blot and statistical analysis 
For evaluation of the bands we utilised Image J version 1.37 (supplied online by NIH 
at http://rsb.info.nih.gov/ij/index.html). Each band was highlighted, and the intensity 
was calculated. This was repeated for each band. Statistical analysis was performed 
using Graph pad prism version 4 and 1-way ANOVA with Bonferroni analysis. The 
mean of the calculated values were used for demonstration in the figures. 
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3.5  Dot blot analysis 
 
Dot blotting is a technique for detecting, analysing and identifying proteins, similar to 
the Western blot technique but differing in that protein samples are not separated 
electrophoretically but are spotted directly onto the membrane. The dissolved samples 
are pulled through the membrane by absorption. Proteins bind to the membrane while 
the other sample components pass through. The proteins on the membrane are then 
available for analysis.   
 
3.5.1  Dot blotting for XO 
The aim of using this technique was to study whether H2O2 (30%, Fluka, Sigma, Pool, 
Dorset, UK) can affect XO binding ability to the antibody. For this purpose, 0.4µg 
XO (Sigma, Pool, Dorset, UK) was exposed to different concentration of H2O2 (1, 5, 
10, and 100mM) and the samples were incubated for 60 minutes at RT. Then they 
were spotted in a row onto a previously methanol soaked PVDF membrane and 
allowed to dry for 15 minutes at RT. Thereafter, the membrane was incubated in 
blocking solution containing 3% BSA (Bovine Serum Albumin) (Sigma, Pool, Dorset, 
UK) in TBS/Tween 20 and left on a shaker overnight at 4°C. The next day the 
membrane was incubated with the primary antibody (rabbit polyclonal to XDH/XO, 
Abcam, Cambridge, UK) at the dilution of 1:10000 for 4 hours. The rest of the 
experiment including the washing procedures and incubation with the secondary 
antibody and finally the developing process were all exactly the same as Western 
blotting as described above. 
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3.6  XO protein purification 
 
Gel filtration chromatography is a technique for the separation of proteins on the basis 
of their molecular size. It involves passing the sample which contains the analyte in 
the mobile phase, often in a stream of solvent through the stationary phase. Smaller 
molecules enter a porous media and take longer to exit the column; whereas larger 
particles leave the column first (Wilson and Walker 2005). 
 
3.6.1  Purification of XO 
Due to some impurities of XO purchased from Sigma which affected 
spectrophotometric enzyme oxidation analysis, it was decided to re-purify the 
enzyme. In order to do so, an S-200 column (Pharmacia Biotech, Amersham, 
Buckinghamshire, UK) was used. The flow rate was adjusted to 0.4ml/min and 1.5ml 
eluent was collected in each fraction of a total of 96 fractions. The chart speed (pen 
recorder) was set at 1 whereas absorbance sensitivity on the detector was adjusted to 
0.5 absorbance unit. The column was washed extensively and then equilibrated with 
buffer containing 0.1M pyrophosphate (Sigma, Pool, Dorset, UK) and 0.3mM EDTA 
(Sigma, Pool, Dorset, UK) in which pH was adjusted to 8.5 (Stockert 2004 ). Then 60 
mg XO was dissolved in 800µl dH2O and loaded onto the column which was allowed 
to run overnight. The next day the suspected fractions were collected according to 
their absorbance on the chromatograph and the UV-absorbance of suspected fractions 
was measured at 276 and 450nm spectrophotometrically. The ratio of A276 over A450 
was calculated. Enzyme with a ratio < 6.0 was considered pure (Stockert 2004 ). It 
was aliquoted and kept in -80°C until required for further experiments. 
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3.7  Spectrophotometric studies of XO 
 
XO activity was determined under different conditions by measuring the rate of 
oxidation of xanthine to uric acid spectrophotometrically at 290nm. The compounds 
used in following assays were all purchased from Sigma (Sigma, Pool, Dorset, UK). 
All reactions were started by addition of enzyme (XO) and were performed at RT (25 
± 0.2°C). The reaction mixtures were placed in a cuvette, mixed thoroughly and the 
absorbance of uric acid formation was measured over time. The total volume of 
reaction mixture in all experiments was 1ml. All the reactions were done in 
duplicates. 
 
3.7.1  Standard assays 
Since XO activity generates H2O2, standard assays were run in the presence and 
absence of catalase. The reaction mixture without catalase contained 970µl potassium 
phosphate buffer (KH2PO4, 0.05M, pH 7.5), 10µl of 10mM xanthine solution 
(100µM) and 20µl of 6mg/ml XO (120µg).  
Next, we ran the same reaction in the presence of catalase. The reaction mixture 
contained 965µl buffer, 100µM xanthine, 120µg XO and 5µl of 5mg/ml catalase 
(25µg). The two reactions were studied over 7 minutes at 290nm using a UV/visible 
spectrophotometer (Pharmacia Biotech, Ultrospec 2000, Amersham, 
Buckinghamshire, UK) and the absorption was recorded every minute. 
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3.7.2  Inhibition of XO by its substrate 
In order to study the rate of the reaction between a constant enzyme concentration 
(purified and not-purified XO) with varying concentrations of xanthine (substrate), 
the reaction product (uric acid) was determined in the presence and absence of 
catalase. In the case of not-purified XO, the reactions contained 10µl of the 6mg/ml 
XO solution (60µg) and 25, 50, 100, 200, 300 and 400µM final concentrations of 
xanthine, in a total volume of 1ml reaction mixture. Uric acid formation was 
spectrophotometrically followed at 290nm where the absorptions were recorded every 
two minutes. 
In the case of purified XO (0.5mg/ml), 20µl of the enzyme (10µg) was used in all 
reactions. Substrate (xanthine) concentrations were: 25, 50, 100 and 200µM in the 
total volume of 1ml reaction mixtures. 5µl of 10mg/ml solution of catalase was added 
to all reaction mixtures in order to remove H2O2 produced during the reactions. Buffer 
(KH2PO4, 0.05M pH 7.5) was used to make the final volume to 1ml. The reactions 
were followed over 10 minutes and the rate of the reaction/min was calculated.  
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3.7.3  Effects of H2O2 on XO activity 
Due to the presence of mM concentrations of H2O2 in the epidermis of patients with 
vitiligo (Wilson and Walker 2005), it was decided to study the effects of this ROS on 
XO activity. In order to do this, a series of spectrophotometric experiments were 
carried out and the effects of different H2O2 concentrations from µM to mM on XO 
activity were studied. All the concentrations have been calculated in the total volume 
of 1ml reaction mixture. Buffer (KH2PO4, 0.05M pH 7.5) was used to make the final 
volume to 1ml. 
 
3.7.3.1  XO activity in the presence of low H2O2 concentrations 
In order to study the effects of low concentrations of H2O2 on XO activity, the 
enzyme reaction containing 20µl of 6mg/ml XO (120µg) and 100µM substrate was 
followed over 10 minutes in the presence of different H2O2 concentrations (0, 25, 50, 
75, 100, 150 and 200µM) which were directly added into the reaction. Uric acid 
formation was recorded every minute and the rate/min for all reactions was calculated 
from the linear region. 
 
3.7.3.2  XO activity in the presence of high H2O2 concentrations 
In order to study XO functionality under severe oxidative conditions, two different 
sets of experiments were designed in the presence of mM H2O2 concentrations.  
Firstly, XO activity was spectrophotometrically determined when mM H2O2 
concentrations (0, 1.25, 2.5, 5, 10 and 20mM in total volume of 1ml reaction mixture) 
were directly added into the reaction mixture as described above. All reactions were 
carried out over 10 minutes and the rate/2min was calculated from the linear region. 
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Secondly, functionality of oxidised XO was followed after the enzyme incubated with 
H2O2 in the mM range for 2 hours prior to the experiment. In order to do so, 25µg of 
purified XO (50µl of 0.5mg/ml) was incubated with different H2O2 concentrations (0, 
5, 10, 20 and 30 mM) in a total volume of 200µl at RT for 2 hours. In this set of 
experiments, buffer (KH2PO4, 0.05M pH 7.5) was used to dilute H2O2 to the desirable 
concentrations. After incubation, the residual H2O2 was removed from the mixture 
utilising Zebatm mini Desalt Spin chromatography Column (Pierce Biotechnology Inc, 
Rockford, IL, USA). The mixture was placed into the column and the column was 
placed in a lidless 1ml microtube followed by centrifugation using a Heraeus Kendro 
Biofuge fresco microcentrifuge (Heraeus Instruments, Hannover, Hamburg, 
Germany) at 14000 x g for 15min at 4°C. After the removal of H2O2, the activity of 
the oxidised enzyme was measured spectrophotometrically at 290nm over 10 minutes. 
100µg catalase (10µl of 10mg/ml solution) was added to all the reaction mixtures to 
remove the produced H2O2 during the reaction. A 200µl mixture of the purified XO 
(25µg) with buffer (150µl) was incubated at RT as control. Again the absorption was 
recorded every minute and the rate/min for all the reactions was calculated from the 
linear region. 
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3.7.4  Computer modelling of native and oxidised XO  
The crystal structure of XO was obtained from the protein data bank which is 
available online at: http://www.rcsb.org/pdb/home/home.do. Using the molecular 
modelling program “HyperChem” (Hypercube, Inc, Gainesville, FL, USA), Met and 
Trp residues in the FAD binding domain, molybdopterin co-factor binding domain 
and the active site were oxidised to methionine sulfoxide (MetSO) and 5-hydroxy-
tryptophan (5-OH Trp) respectively. Minimisation was performed to obtain the most 
thermodynamically stable structure. DeepView analysis was used to compare and 
analyse changes between the native and oxidised states of the protein (with 
acknowledgement to Dr. Nicholas Gibbons for his molecular modelling). 
 
3.7.5  Determination of H2O2-mediated oxidation of XO 
Furthermore, in order to find out more about the alterations in the structure of the 
enzyme’s main domains after oxidation by H2O2, 250µg purified XO (500µl of 
0.5mg/ml) was incubated with a very high concentration of H2O2 (1.5M in a total 
volume of 600µl) and the oxidised enzyme was scanned spectrophotometrically every 
15 minutes in a range from 200nm to 600nm to see the ongoing alterations in the main 
domains via the spectra while the enzyme is being oxidised. This of course was 
compared with the UV-absorbance spectrum of the reduced enzyme. 
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3.8  Determination of XO activity using TLC 
 
Thin layer chromatography (TLC) is a method for separation and identifying 
compounds. Using this technique, it is also possible to determine the purity of a 
compound and to follow the progress of a reaction. This technique involves spotting 
the samples to be analysed on a sheet of glass or plastic that is coated with a thin layer 
of a special adsorbent (0.25-2mm) which is stationary phase. Depending on the size of 
the molecule of interest components of the samples will separate in this phase. The 
sheet is placed in a covered tank containing a reservoir of solvent (mobile phase) 
which travels up the stationary phase, carrying and separating the samples with it 
(Shalbaf, Gibbons et al. 2008). Once the separation is completed, in order to visualise 
the separated spots the plate can be either exposed to UV light (350nm) or they can be 
developed by heat or special agents. 
 
3.8.1  Separation of xanthine, uric acid and allantoin 
20x20cm cellulose coated TLC plates were purchased from Fluka (Fluka, Sigma, 
Pool, Dorset, UK). Due to the UV absorption of xanthine, uric acid and allantoin, a 
saturated solution (approximately 5-10mg/ml) of these compounds (all from Sigma, 
Pool, Dorset, UK) in NH4OH (Sigma, Pool, Dorset, UK) was prepared for 
identification of these compounds. Using a glass pipette one spot xanthine, one spot 
uric acid (5 times applied as it had a weaker UV absorption compared to xanthine) 
and one spot xanthine and uric acid on top of each other (together) were spotted on 
the TLC plate to optimise the separation and the solvent system. To study the 
separation of allantoin, the same procedure was repeated but since allantoin has a very 
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weak UV absorption compared to the other two compounds, it was applied in higher 
concentrations in each spot to increase its visualisation under UV light (350nm).     
After optimisation, a solvent was chosen containing 66.5% 1-propanol (Sigma, Pool, 
Dorset, UK), 20% of 8N NH4OH and 13.5% dH2O. After spotting the samples, the 
TLC plate was air-dried and placed in a covered tank containing the solvent system. It 
was allowed to run for around 3-4 hours at RT until the solvent reached the top of the 
plate. Then the plate was removed from the tank, air-dried and the separated 
components were visualized using a UV lamp (350nm). Rf values of these compounds 
were 0.31 ± 0.02 for xanthine, 0.25 ± 0.02 for allantoin and 0.2 ± 0.02 for uric acid. 
 
3.8.2  Determination of XO activity 
The XO activity was determined via a modified TLC method using [14C]xanthine 
(47.5µCi/500µl activity in original stock) (Sigma, Pool, Dorset, UK) where the 
production of [14C]uric acid by the activity of XO was measured. A [14C]xanthine 
working solution was made up of 20µl [14C]xanthine (from the original stock) diluted 
in 1ml of 10mM cold xanthine solution in NH4OH. This working solution contained 
0.2µCi/1ml.  
 
3.8.2.1  Standard enzyme assay 
According to the method described above, the plate was spotted separately from the 
saturated solutions of xanthine and uric acid on top of each other as a series of 7 spots 
for each time point. The standard reaction solutions contained 5µl of radioactive 
working solution (0.5mM cold xanthine and 1nCi [14C]xanthine), 25µg XO (5µl of 
5mg/ml) with or without 25µg catalase (5µl of 5mg/ml) made up to a final volume of 
100µl with reaction buffer (KH2PO4 0.05M pH 7.5) Immediately after the reaction 
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was started by the addition of XO, using a timer and a UV lamp, at various time 
points (2, 5, 10, 15, 20, 30 and 40min) an aliquot of 2µl out of the reaction mixture 
was applied on top of each spot. After spotting the last time point at 40min, the plate 
was developed twice at RT as described before up to a distance of 16cm. Once the 
separation was completed, under a UV lamp the separated uric acid and allantoin 
spots were visualised, marked with a pencil, cut and placed in scintillation vials 
containing 3ml scintillation liquid (Ready SafeTM, Beckman Coulter Ltd, Fullerton, 
CA, USA). Then the rack containing the vials was placed in [14C] channel in a 
scintillation analyser (Packard, Tri-Carb 2100TR, Liquid Scintillation Analyser, 
Packard Instrument Co., Meriden, CT, USA) in order to count the radioactivity 
present in each spot which represent 14[C]uric acid or 14[C]allantoin production in the 
reaction that depends on XO activity. 
 
3.8.2.2  Determination of XO activity in normal KC and MC cell extracts 
XO activity of epidermal KC and MC cell extracts was determined via the above 
described method. The reaction mixture contained 50µl of KC cell extract (5mg/ml) 
or 90µl of MC cell extract (0.4mg/ml) cell extract instead of 5µl XO in the above 
standard assay and 5µl of radioactive working solution (0.5mM cold xanthine as well 
as 1nCi activity) in the final volume of 100µl using reaction buffer KH2PO4. The rest 
of the experiment was the same as described above. Due to differences in protein 
contents of cell extracts and in order to compare XO activity in them, each value was 
standardised per mg protein related cell extract.   
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3.9  HPLC analysis of allantoin 
 
H2O2 oxidises uric acid to allantoin (Newsholm and Leech 1984) which is considered 
as a biomarker for oxidative stress (Grootveld and Halliwell 1987; Kaur and Halliwell 
1990; Benzie, Chung et al. 1999; Yardim-Akaydin, Sepici et al. 2004; Yardim-
Akaydin, Sepici et al. 2006). Allantoin was determined in whole cell extracts from 
epidermal suction blister tissue materials from both healthy controls and vitiligo 
patients using high performance liquid chromatography (HPLC) described by George 
et al. (George, Dipu et al. 2006). 
 
3.9.1  Principle of detection 
Allantoin was purchased from Sigma (Sigma, Pool, Dorset, UK). Analysis was 
conducted using a Waters 510 pump (Waters Ltd, Elstree Hertfordshire, UK) with a 
Sphereclone 250x4.60mm C-18 reverse-phase column (Phenomenex, Macclesfield, 
Cheshire, UK) maintained at 22°C coupled to a Waters 486 UV detector (Waters Ltd, 
Elstree, Hertfordshire, UK) set at a wavelength of 220nm. The mobile phase was 10 
mM potassium dihydrogen phosphate buffer (KH2PO4 pH 4.7) in HPLC grade water 
(Fisher Chemicals, Loughborough, Leics, UK). The flow rate was maintained at 1.0 
ml/min with a pressure of 1900 ± 200 psi. To identify the allantoin peak, 20µl of 
0.04µg allantoin (standard solution prepared 1mg/ml) was injected into the 
instrument. The allantoin peak appeared at a retention time of 3.5 minutes. 
 
 
 
 
 115 
3.9.2  Detection of allantoin in epidermal suction blister tissue material 
3.9.2.1  Sample preparation 
60µl of each epidermal suction blister cell extracts from acute lesional (n=10) and 
non-lesional (n=10) vitiligo as well as controls (n=5) were de-proteinated by the 
addition of 10µl 2N perchloric acid (HClO4) on ice for 15 minutes followed by 
centrifugation at 14000g for 10 minutes at 4°C.  
 
3.9.2.2  Detection of allantoin  
20µl of the obtained supernatant from each sample was diluted 1:10 in mobile phase 
buffer and the final volume of 200µl was injected into the HPLC. Fractions covering 
the retention time range 3-4 min, where allantoin elutes, were collected for each 
sample. 200µl of each fraction was re-analysed via HPLC to see any suspected peak 
for allantoin. In order to confirm the presence of allantoin in any positive samples, 
another aliquot of 200µl of each collected fraction was re-analysed in the presence of 
0.04µg allantoin. Between each run, the column was washed for 30 minutes. All 
experiments were carried out in duplicates (Shalbaf, Gibbons et al. 2008). The 
presence of allantoin in positive samples was re-confirmed by mass spectroscopy 
using a Quattro Ultima mass spectrometer (Waters, Elstree, Hertsfordshire, UK) (with 
acknowledgement to Dr. Derek J. Maitland for his co-operation on mass 
spectroscopy). 
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3.10  Inhibition of XO by pterins 
 
Pteridine derivatives [neopterin, 6-biopterin, xanthopterin, leukopterin and 
tetrahydrobiopterin (6BH4)] inhibit XO activity in a concentration-dependent manner 
(Kalckar, Kjeldgaard et al. 1948; Kalckar and Klenow 1948; Hofstee 1949; Lowry, 
Bessey et al. 1949; Kalckar, Kjeldgaard et al. 1950; Isaka 1952; Wede, Altindag et al. 
1998; Oettl and Reibnegger 1999). So far there has been no report of inhibiting XO 
activity by 7BH4 or 7-biopterin. The aim of this study was to see whether these 
compounds have inhibitory effects on the activity of this enzyme.  
In order to do this, a set of experiments were designed where uric acid production 
from the reaction between xanthine and XO was spectrophotometrically measured at 
290nm in the presence of different concentrations of pterins. All the pterins used in 
this study were purchased from Dr. Schirck’s Laboratory (Schirck’s Laboratories, 
Jona, Switzerland). 
Firstly, inhibition of XO activity by different 6BH4 concentrations (0, 10, 20, 50, 100 
and 200µM) was studied by calculating the rate/min for each pterin concentration and 
the results were compared to the inhibition by the same concentrations of 7BH4. The 
reaction mixture contained 120µg XO, 100µM xanthine, 100µg catalase and either 
6BH4 or 7BH4. The final volume of the reaction mixtures was made up to 1ml using 
reaction buffer (KH2PO4, 0.05M pH 7.5).  
Secondly, the inhibitory effects of different concentrations of 6-biopterin (0, 10, 20, 
50, 100, 200 and 500µM) on XO activity was compared to XO inhibition by the same 
concentration of 7-biopterin. The reaction mixtures used the above concentrations of 
enzymes and substrate but 6 & 7-biopterin instead of 6 & 7BH4. 
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3.11  [
3
H]6BH4 binding to XO 
 
The aim of this experiment was to confirm 6BH4 binding to XO. To do this 
experiment radio-labelled 6BH4 ([
3H]6BH4) (a generous gift from E. Werner, 
University of Innsbruck, Austria) was employed. First 10mg XO (Sigma, Pool, 
Dorset, UK) was dissolved in 2.5ml dH2O with 200µM final concentration of cold 
6BH4 (Schirck’s Laboratories, Jona, r,Switzerland). Then 5µl of [
3H]6BH4 containing 
approximately 5nCi activity (250000 counts) was added into the mixture. This 
mixture was then placed in the dark at RT for 1 hour to allow binding of the labelled 
6BH4 to XO after which it was added to a G-25 sephadex column (GE Healthcare Ltd, 
Amersham, Buckinghamshire, UK) equilibrated with distilled water. The total of 40 
fractions (500µl) were collected and 100µl of each fraction was counted in 3ml 
scintillation fluid (Ready SafeTM, Beckman Coulter Ltd, Fullerton, CA, USA) in the 
[3H]-channel of the scintillation analyser (Packard, Tri-Carb 2100TR, Liquid 
Scintillation Analyser, Packard Instrument Co., Meriden, CT, USA). The remaining 
400µl was used for protein determination via Bradford assay as described in the 
manufacturer’s protocol (BioRad Laboratories Ltd., Hemel Hempstead, Herts., UK).   
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3.12  Reactivation of inhibited tyrosinase by XO 
 
The aim of this study was to see whether XO is able to reactivate 6BH4 / 7BH4-
inhibited tyrosinase. All pteridines used in this study were purchased from Dr. 
Schirck’s Laboratory (Schirck’s Laboratories, Jona, Switzerland). 
 
The standard tyrosinase reaction mixture contained 1mM (100µl of 0.01M solution 
pH 9) L-tyrosine (Sigma, Pool, Dorset, UK) and 40µl (containing 84 units) mushroom 
tyrosinase (Sigma, Pool, Dorset, UK) in the total volume of 1ml using reaction buffer 
(KH2PO4, 0.05M pH 7.5) where L-dopachrome formation was followed 
spectrophotometrically at 475nm.  
 
In order to see the capability of XO for reactivation of the 6BH4 / or 7BH4 / tyrosinase 
inhibitor complex, the standard assay was repeated in the presence of final 
concentrations of 200µM either 6BH4 (19µl of 10.8mM stock solution) or 7BH4 (26µl 
of 7.8mM stock solution) in 1ml reaction mixture to inhibit the reaction (Wood, 
Schallreuter-Wood et al. 1995; Spencer, Chavan et al. 2005; Spencer 2007). After 15 
minutes, when the inhibition was observed, 100µg XO (100µl of 1mg/ml stock) was 
added into the reaction and formation of dopachrome was followed at 475nm 
(reaction volume now increased to 1.1ml).   
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3.13  Enzyme-linked immunosorbent assay (ELISA) 
 
ELISA is used for rapid detection and quantification of a protein or an antigen in a 
sample (Wilson and Walker 2005). We utilised this technique to detect plasma levels 
of 8-oxoG using OxiSelectTM Oxidative DNA Damage ELISA kit obtained from Cell 
Biolabs (Cell Biolabs, Inc, Cambridge Bioscience Ltd., Cambridge, UK). The 
experiment was carried out according to the manufacturer’s protocol.  
 
3.13.1  Preparation of the microtiter plate 
All wells of a 96-well plate were first coated with 100µl of the 10µg/ml 8-oxoG 
conjugate and the plate was incubated overnight at 4°C. The next day 8-oxoG coating 
solution was removed from the wells and the plate was washed once using dH2O. The 
plate was then blocked using 200µl assay diluent (provided in the kit) in each well for 
1 hour at 37°C after which the plate was transferred to 4°C until used. 
 
3.13.2  Preparation of the samples 
To obtain a standard curve, a series of 8-oxoG dilutions (0, 0.1, 0.3125, 0.625, 1.25, 
2.5, 5 and 10ng/ml) in assay diluent were prepared. Plasma samples of 10 healthy 
individuals and 10 patients with acute vitiligo were centrifuged at 3000g for 10 
minutes prior to analysis. All the samples including unknown and standard were 
assayed in duplicate. 
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3.13.3  Assay protocol  
Assay diluent (blocking solution) was removed and 50µl of 8-oxoG standards as well 
as controls and acute patients were pipetted to the wells in order. The plate was 
incubated on a shaker at RT for 10 minutes. Followed by addition of 50µl anti- 8-
oxoG (at a dilution of 1:500 with assay diluent) to each well and incubation at RT for 
1 hour. Since 8-oxoG in the sample or standard competes with 8-oxoG bound on the 
plate for 8-oxoG monoclonal antibody binding sites, higher 8-oxoG concentrations in 
the sample cause reduced binding of the antibody to the 8-oxoG on the plate.   
After incubation, the plate was washed 3 times for 20 minutes using washing solution 
provided in the kit. Antibodies bound to the 8-oxoG in the sample are washed out of 
the well, while those bound to the 8-oxoG coated on the plate remain.  
After the last wash, 100µl of the enzyme-labelled secondary antibody (at a dilution of 
1:1000 with assay diluent) was added to each well and the plate was incubated for 1 
hour at RT in order to allow the secondary binding to the primary antibody that 
remained on the plate. The washing process was repeated in order to remove the 
unbound enzyme-labelled secondary antibody. 
Next 100µl of pre-warmed (at RT) substrate solution (which is a chromogen) was 
added to each well and the plate was incubated on a shaker at RT for approximately 
15 minutes. During this time, the colour developed in proportion to the amount of 
antibody bound to the plate. The enzyme reaction was stopped by the addition of 
100µl stop solution (provided in the kit) to each well. Using a plate reader 
spectrophotometer, the absorbance of each well was read at 450nm and the graph was 
plotted. The sensitivity of the kit was 0.1 to 10ng/ml. 
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4.0  RESULTS 
 
4.1  The presence of XDH/XO protein in the human epidermis 
(Shalbaf, Gibbons et al. 2008) 
 
4.1.1  Epidermal mRNA of XDH is expressed in human MCs and KCs  
PCR is a technique used to demonstrate whether a gene is transcribed into mRNA. 
Using this technique we showed that XDH mRNA is expressed in human epidermal 
MCS and KCs (Shalbaf, Gibbons et al. 2008). Figure 7 shows a strong band at 177bp 
corresponding to the presence of the XDH mRNA in human epidermal MCs and KCs.  
 
 
      
         
 
 
 
 
 
Figure 7  
XDH mRNA expression in the human epidermis   
PCR amplification of epidermal cell cDNA gave rise to a specific 177 base pair product 
confirming the expression of XDH transcript in both epidermal MCs and KCs. This 
experiment was done in duplicates (n=2) using primary cell cultures (passages 1-3). 
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4.1.2  XDH/XO protein is expressed in situ in the human epidermal cells 
In order to show the presence of XDH/XO protein expression in the human epidermis 
in situ, immunofluorescence staining of full skin biopsies from normal healthy control 
skin phototype III (Fitzpatrick classification) was performed using a specific 
XDH/XO antibody. The results indicate that this enzyme is highly expressed 
throughout the entire epidermis of normal skin; in both the stratum basale and in 
suprabasal layers (Figure 8b). 
 
In order to test whether this enzyme is present within melanocytes, XDH/XO was 
double stained with a specific tyrosinase antibody. Tyrosinase is the key enzyme in 
melanogenesis which is present in the melanosomes. The result showed that XDH/XO 
enzyme is present in melanocytes and within melanosomes (Figure 8; c&d).    
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Figure 8  
In situ distribution of XDH/XO in the human epidermis and its localisation in MCs and 
melanosomes 
 (a) DAPI, (b) FITC labelling of XDH/XO; the positive immuno-reactivity demonstrates that 
the enzyme is expressed throughout the entire epidermis in both the stratum basale and 
suprabasal layers, (c) TRITC labelling of tyrosinase identifies melanosomes (d) XDH/XO 
was double stained with tyrosinase where co-localisation was observed in a sub-population of 
melanocytes suggesting its presence within this pigment producing cell (x 400 magnification). 
Labelling was carried out in three different healthy individuals and was done in duplicates 
(n=2). 
 
50µm
a b
c d
 124 
4.1.3  XDH/XO protein is expressed in vitro in human epidermal MCs and KCs 
After confirmation of XDH/XO protein expression throughout the entire epidermis in 
situ, the presence of this enzyme was investigated in epidermal derived cells under in 
vitro conditions. The results showed that this enzyme is present in both epidermal 
MCs and KCs in a granular pattern (Figure 9b). Moreover, co-localisation with 
tyrosinase was detected indicating the presence of the enzyme within melanosomes in 
a perinuclear granular pattern (Figure 9; d&e). Another interesting observation was 
XO localisation in the nucleus of both MCs and KCs, while is shown by merging of 
XDH/XO and DAPI (Figure 9; f&g and Figure 10).  
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Figure 9  
In vitro distribution of XO in human epidermal MCs  
The staining results show that XO is expressed throughout MCs derived from normal human 
skin phototype III (Fitzpatrick classification), where (a) is DAPI, (b) is FITC-labelled XO (c) 
is TRITC-labelled tyrosinase (d&e) merging of b and c depicts the predominant perinuclear 
co-localisation of XO and tyrosinase in melanosomes suggesting the presence of XO within 
this organelle, while less co-localisation is observed in the dendrites and (f&g) close up of 
two MCs suggesting the possible localisation of XO in the nucleus (a, b, c, d, & e x 200 and f, 
& g x 400 magnification respectively). Two different cell lines were used in this experiment 
and labelling was done in duplicates (n=2). 
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Figure 10  
In vitro expression of XO in human epidermal KCs 
Undifferentiated epidermal KCs derived from normal healthy human skin phototype III 
(Fitzpatrick classification) where (a&c) show a pronounced granular expression of FITC-
labelled XO throughout the cell and (b&d) suggest that similar to MCs, XO resides in the 
nucleus (magnification of x 400). Two different cell lines were used in this experiment and 
labelling was done in duplicates (n=2). 
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4.1.4  in situ protein expression of XO in vitiligo 
In order to show the presence of XDH/XO protein expression in the epidermis of 
vitiligo patients, we utilised in situ immunofluorescence staining of full skin biopsies 
from normal healthy control as well as patients with vitiligo all skin phototype III 
(Fitzpatrick classification). The results revealed that XO protein expression in the 
epidermis of patients with vitiligo is not affected compared to healthy controls. This 
result is presented in Figure 11 A&B. 
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Figure 11  
In situ protein expression of XO is not affected in vitiligo 
(A) FITC labelling of XO; positive immuno-reactivity demonstrates that XO protein 
expression in the epidermis of patients with vitiligo is not affected compared to control (x 400 
magnification). (B) Image analysis of staining intensities. The graph shows XO protein 
expression in vitiligo is significantly different (ns) compared to control. This experiment was 
done in duplicates (n=2). 
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4.1.5  Confirmation of XDH/XO in epidermal MCs and KCs by Western blot 
analysis  
In order to substantiate the presence of XDH protein in epidermal cells, Western blot 
analysis was employed. The protein was detected in cell extracts from MCs and KCs. 
Bands at the 145 kDa molecular weight marker corresponded to the monomer of 
XDH/XO (Figure 12). 
 
 
 
 
 
Figure 12  
Western blot analysis of XO in human epidermal MCs and KCs 
A): The Western blot confirms the presence of XO in epidermal MCs and KCs. Cell cultures 
were in passage 1-3 and the experiment was done in duplicates (n=2). 
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4.2  XO activity 
 
4.2.1  Uric acid is produced from the oxidation of xanthine by XO 
Purine nucleotide catabolism yields uric acid. In the last two steps of its degradation 
pathways, hypoxanthine is oxidized to xanthine and then further, xanthine to uric 
acid, by XO. H2O2 is formed as a byproduct in these two oxidation reactions (McCord 
and Fridovich 1968; Granger, Rutili et al. 1981; Granger and Parks 1983; Parks and 
Granger 1983; McCord 1985; McCord, Roy et al. 1985). In the human epidermis, 
DNA damage after UVR exposure leads to release of purine bases (Sancar 1994; 
Sancar 1996; Friedberg 2003; Fromme and Verdine 2004; Friedberg, Aguilera et al. 
2006; O'Neil and Rose 2006) which in turn are degraded by XO (Dixon and Lemberg 
1934; Parks and Granger 1986). As previously described, this enzyme contains two 
Fe2+ atoms in its structure which under oxidative conditions such as oxidative stress in 
vitiligo, can react with H2O2 via the Fenton reaction to produce OH
• (Haber and 
Weiss 1932). This is the most potent ROS reacting with nucleotide bases resulting in 
turn in irreversible damage of DNA, peptides, proteins and lipids (Halliwell 1989; 
Halliwell and Gutteridge 1989; Esterbauer, Dieber-Rotheneder et al. 1990; Smith, 
Marks et al. 2004; Schallreuter, Bahadoran et al. 2008). Both H2O2 and OH
• have 
been shown to be able to oxidise amino acids in the structure of peptides and proteins 
(for review see (Schallreuter, Bahadoran et al. 2008). 
In order to study XO activity, the standard assay was performed 
spectrophotometrically both in the presence and absence of catalase over 20 minutes 
at 290nm as outlined in the method section. 
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Figure 13  
Uric acid formation from the oxidation of xanthine by XO at 290nm in the absence (-cat) 
and presence (+cat) of catalase  
Catalase converts H2O2 to H2O and harmless oxygen. This result shows that H2O2 produced 
during the reaction (-cat) increases XO activity. This assumption is supported because in the 
presence of catalase the reaction is slower (+cat). The assay was carried out in triplicate and 
the results show the mean values taken from three independent experiments.    
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4.2.2  XO activity depends on the availability of its substrate (xanthine) 
4.2.2.1  Substrate inhibition of XO 
In order to follow whether the enzyme was influenced by its own substrate, we 
repeated the assay with different concentrations of the substrate (xanthine) in the 
absence of catalase. Given that 1 molecule of xanthine produces 2 molecules of H2O2, 
the result obtained, suggested the oxidation of the reaction product (uric acid) or 
inhibition of the enzyme or both. The result is shown in Figure 13. 
 
 
                        
 
 
 
 
 
 
 
Figure 14  
[V] (velocity) versus [S] analysis of XO  
The result shows that in the absence of catalase, the increase in concentration of substrate 
(xanthine) decreases the reaction rate. First it was proposed that the decrease in uric acid 
production was due to its oxidation to allantoin by H2O2 as this ROS is able to oxidise uric 
acid to allantoin (Newsholm and Leech 1984). Therefore it was decided to repeat the 
experiment in the presence of catalase (see Figure 14). The results shown in the figure are the 
values obtained from a single determination in one experiment. They are representative of one 
other experiment.    
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In order to explore the causes for the decrease in uric acid formation in the reaction 
between XO and different concentrations of xanthine in more detail, the above 
experiment was repeated, but this time under different experimental conditions in the 
presence of catalase to remove H2O2 produced in the reaction. The result showed that 
the increase in the concentration of the substrate has an inhibitory effect on enzyme 
activity. This proves substrate inhibition of XO activity (Figure 14). 
 
 
           
 
 
 
 
 
 
Figure 15  
Substrate inhibition of XO 
The plot shows that with the increase in the concentration of substrate (xanthine), the rate of 
uric acid formation decreases. Catalase was included in all the reaction mixtures to remove 
H2O2 produced during the reaction. Therefore the decrease in uric acid formation cannot be 
attributed to its oxidation to allantoin by H2O2. Hence this result indicates that XO activity is 
inhibited by its own substrate since the enzyme is more active at lower concentrations 
xanthine (Shalbaf, Gibbons et al. 2008). The results shown in the figure are the values 
obtained from a single determination in one experiment. They are representative of one other 
experiment.  
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4.2.3  XO is activated by H2O2 in a concentration dependent manner  
In order to further elucidate the effect of low H2O2 concentrations on the reaction 
between XO and xanthine, we repeated the assay in the presence of µM H2O2 
concentrations. The result showed activation of the enzyme by low H2O2 
concentrations (25-100µM). As suggested in Figure 15, XO activity decreases in the 
presence of 25-100µM concentrations of H2O2. 
 
         
         
 
 
 
 
 
 
Figure 16  
[V] (velocity) versus [I] (inhibitor) analysis of XO 
The graph shows in the presence 25-100µM H2O2 concentrations, XO activity is higher than 
<25µM H2O2 concentration, indicating XO activation in the presence of low H2O2 
concentrations (within the range of 25-100µM). This result is supported by the data presented 
in Figure 12, where uric acid formation was decreased upon the addition catalase to remove 
H2O2 produced during the reaction. The results shown in the figure are the values obtained 
from a single determination in one experiment. They are representative of one other 
experiment.  
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4.2.4  Inhibition of XO activity by high H2O2 concentrations 
In order to further substantiate the effect of high concentrations of H2O2 on the 
reaction, we repeated the assay in the presence of mM H2O2 where was directly added 
into the reaction mixture. Importantly, this assay could not be performed in the 
presence of catalase because H2O2 was used as the inhibitor. The assay was performed 
in the presence of saturating substrate (100µM xanthine in 1ml reaction mixture). The 
result shown in Figure 16 indicates decrease of enzyme activity in the presence of 
H2O2. This decrease is dose dependent. 
 
            
 
 
 
 
 
 
 
Figure 17  
[V] versus [I] analysis of XO when H2O2 was directly added into the reaction   
The effects of 10-3M H2O2 concentrations on XO activity. The graph shows with the increase 
in the concentration of H2O2, the rate of uric acid formation decreases. It was first assumed 
that H2O2 directly affects XO activity. Later during this study this assumption was dismissed, 
since it was revealed that the decrease in uric acid formation is not based on XO inhibition by 
H2O2. It is indeed due its oxidation to allantoin by this ROS (Newsholm and Leech 1984). 
The assay was carried out in duplicate. The results shown in the figure are the values obtained 
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from a single determination in one experiment. They are representative of one other 
experiment.  
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4.2.5  H2O2 concentrations in the10
-3
M range decrease enzyme activity only 37% 
The previous result demonstrated that XO (crude enzyme) is activated by 25-100µM 
concentrations of H2O2, whereas the enzyme seems to be inhibited by >100µM H2O2 
concentrations. To find out more about the activity of this enzyme under severe 
oxidative conditions, it was decided to incubate different concentrations of purified 
XO with different H2O2 concentrations in 10
-3M range. According to the method 
described before, 25µg of purified enzyme was incubated with 0, 5, 20 and 30mM 
H2O2 concentrations for 2 hours at RT while 10µl catalase (10mg/ml) was added to all 
reaction mixtures to stop further oxidation. Free H2O2 was separated from the 
oxidised enzyme using Zebatm Desalt Spin chromatography Column as described in 
methods. Activity of the enzyme (uric acid formation) was assessed at 290nm over 10 
minutes. The results showed that XO is still functioning after 2 hours exposure to 
H2O2 in the mM range. However, there is a loss of activity after pre-incubation with 
5-10mM H2O2 suggesting a direct effect on the enzyme structure. The rates/min were 
calculated from the linear plots for each minute over 10 minutes of all assays. 
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Figures 18  
The activity of XO after pre-incubation with 10
-3
M range of H2O2 concentrations  
The results showed that after pre-incubation of XO with different 10-3M H2O2 concentrations, 
the H2O2-oxidised enzyme maintains almost 75% of its original activity. As described in the 
methods, 25µg of purified XO was first oxidised with different 10-3M H2O2 concentrations 
and then free H2O2 was removed from the oxidised enzyme and catalase was included in all 
the reactions to prevent further XO oxidation/inhibition and also to prevent the oxidation of 
the reaction product (uric acid) to allantoin by H2O2. This allowed measurement of the real 
activity of oxidised XO. The results shown in the figure are the values obtained from a single 
determination in one experiment. They are representative of one other experiment.    
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4.3  H2O2 directly affects the co-factor FADH2 
 
4.3.1  Absorbance spectroscopy of reduced and oxidised XO 
In the above results we showed that high concentrations of H2O2 can directly affect 
XO activity. In order to support these results, we decided to study the effects of high 
H2O2 concentrations on the co-factor binding sites of the enzyme 
spectrophotometrically. As it was explained before, XO consists of three domains; the 
molybdopterin cofactor domain, the FADH2 binding domain and the iron-sulfur 
domain which have all different UV absorbance spectra. Figures 19&20 demonstrate 
the spectra of both native and oxidised XO, revealing that FADH2 is indeed oxidised 
to FAD as indicated by the increase in absorbance at 450nm. However, this is also the 
region of the iron-sulfur centres, which might also come into the game. Unfortunately, 
the absorbance from the moco-binding domain is small and difficult to observe on the 
spectrum due to the large absorption of the FAD and iron-sulfur centers. These results 
are in agreement with the results of the computer modelling (Figure 20).  
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Figure 19  
The UV/visible spectrum of native purified XO (0.45mg/ml) 
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Figure 20  
H2O2-oxidised XO spectrum  
225µg purified XO (500µl, 0.45mg/ml) was incubated with 100µl 30% H2O2 (1.5M final 
concentration of H2O2) and the mixture was scanned every 15min for 1 hour. The maximum 
absorbance at 450nm is due both to the H2O2-oxidised FAD and iron-sulfur centres whereas 
changes in moco domain’s absorbance (approximately between 400-500nm) are very small 
and difficult to be identified on the spectra (Ryan, Ratnam et al. 1995; Maiti, Tomita et al. 
2003). This result shows that FADH2 is oxidised to FAD indicating that H2O2 does indeed 
affect the cofactor on XO.  
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4.4  H2O2 does not affect the antibody binding site of XO 
 
The spectrophotometric spectra of oxidised XO revealed that H2O2 directly affects the 
oxidation of FADH2 to FAD and also oxidises the iron-sulfur centres. In order to 
ensure that our antibody was recognising the oxidised protein, we investigated the 
antigen recognition of the oxidised XO using dot blotting. In order to do this, 0.4µg 
purified XO was exposed to different concentrations of H2O2 for 1 hour. The result 
showed that the epitope binding sites for the antibody are not affected by H2O2. 
    
         
 
 
 
Figure 21 
The effects of H2O2- mediated oxidation on the epitope binding site of XO 
H2O2-mediated oxidation does not affect XO epitope binding site for the antibody (Dot blot 
analysis 0.4 µg XO/dot). This result indicates that the antibody is able to detect the oxidised 
XO as well as the native enzyme. The results shown are representatation of one other 
experiment.   
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4.5  Determination of XO activity by TLC 
 
4.5.1  Separation of xanthine and uric acid 
In purine nucleotide catabolism XO catalyses the oxidative hydroxylation of 
hypoxanthine to xanthine and finally to uric acid. Under normal condition this 
reaction yields two molecules H2O2 which are converted by catalase to H2O and O2.    
In the case of oxidative stress as observed in the epidermis of patients with vitiligo 
(Schallreuter, Moore et al. 1999; Schallreuter, Bahadoran et al. 2008), due to the 
presence of H2O2 accumulation in the mM range in association with defective 
antioxidant defence (Schallreuter, Wood et al. 1991; Schallreuter 2005; Schallreuter, 
Bahadoran et al. 2008), it was tempting to postulate that XO is oxidised by H2O2. 
Hence uric acid production should be altered. Moreover, due to the presence of an 
iron-sulfur domain in the enzyme’s active site, OH• formation via the Fenton reaction 
is expected (Haber and Weiss 1932; Beauchamp and Fridovich 1970; Bannister, 
Bannister et al. 1982; Britigan, Pou et al. 1990; Schallreuter 2005). This in turn would 
increase the oxidative stress. To further substantiate uric acid formation under 
oxidative stress condition, we used TLC and [14C]xanthine. 
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Figure 22  
Separation of xanthine and uric acid utilising TLC 
The figure demonstrates separation of xanthine and uric acid in a solvent system containing 
66.5 % 1-propanol, 20% NH4OH (8N), and 13.5% dH2O. In this solvent system xanthine and 
uric acid are well sepatated. Rf values for both xanthine and uric acid were 0.31 and 0.19 
respectively. The results shown are representatation of one other experiment.   
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4.5.2  Standard assay to measure uric acid production over time 
In order to follow whether H2O2 produced during the reaction could interfere with 
uric acid formation, we studied enzyme activity using XO and [14C]xanthine by 
following product formation over time in the presence and absence of catalase via 
TLC. The spots were visualised with a UV lamp (350nm), marked and the marked 
area was cut and transferred into scintillation liquid followed by counting [14C]uric 
acid. In the absence of catalase the results showed that uric acid formation increased 
up to 5min followed by a significant decrease. 
    
              
 
                         
 
 
 
 
 
 
Figure 23  
Time dependent [
14
C]uric acid formation (0-40 minutes) 
The graph shows in the absence of catalase, there is an initial increase in uric acid formation 
up to 5 minutes, which then drops significantly over time, whereas in the presence of catalase 
uric acid production increases over time. In Figure 18, it was demonstrated that under severe 
oxidative conditions, XO activity is only partially affected. Therefore the decrease in uric acid 
formation in the absence of catalase in this Figure is not due to XO inhibition by H2O2 and is 
based on the oxidation of uric acid to allantoin by H2O2 produced during the reaction as it was 
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shown and described in Figure 17. The results shown in the figure are from a single 
determination in one experiment and are representative of the two others.  
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4.5.3  The question of interest was what happened to the uric acid formation 
under oxidising conditions? 
Purine metabolism in primates is ended by the production of uric acid which is then 
excreted in urine. However, in other mammals, turtles and molluscs uric acid is 
further oxidised by urate oxidase (uricase) to allantoin which is then excreted 
(Newsholm and Leech 1984). Allantoin is oxidised to allantoate by allantoinase in 
some fishes but in other fishes and in amphibian allantoate is oxidised to glyoxylate 
and urea by allantoicase (Newsholm and Leech 1984). Primates lack this enzyme 
which oxidises uric acid. In fact, uricase is not the only factor to oxidise uric acid. In 
humans, allantoin is formed non-enzymatically by the oxidation of uric acid under 
oxidative conditions, thus, it is considered as a biomarker for oxidative stress 
(Grootveld and Halliwell 1987; Kaur and Halliwell 1990; Benzie, Chung et al. 1999; 
Yardim-Akaydin, Sepici et al. 2004; Yardim-Akaydin, Sepici et al. 2006).Under 
oxidative condition, as observed in vitiligo (Schallreuter, Moore et al. 1999), due to 
accumulation of mM range of H2O2 produced from the oxidation of hypoxanthine to 
xanthine and xanthine to uric acid by the enzyme XO in association with H2O2 from 
other sources, allantoin production was expected (Grootveld and Halliwell 1987; Kaur 
and Halliwell 1990; Benzie, Chung et al. 1999; Simoyi, Falkenstein et al. 2003). 
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4.5.4  Separation of xanthine, uric acid and allantoin 
To test whether uric acid is oxidised to allantoin by H2O2 in our system, we followed 
the separation of xanthine, uric acid and allantoin via TLC. The technique revealed a 
good separation of these three compounds on one plate as shown in Figure 23. 
 
 
 
 
 
 
 
 
 
 
 
Figure 24  
Separation of xanthine, uric acid and allantoin by TLC  
To separate allantoin from xanthine and uric acid we utilised cellulose-coated TLC plate and 
the same solvent system as described in Figure 22. Rf value for allantoin was 0.25. The 
results shown are representative of three experiments. 
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4.5.5  H2O2 yields oxidation of uric acid to allantoin 
In order to test the formation of uric acid and its possible oxidation/degradation to 
allantoin by H2O2 over time, we used TLC and [
14C]xanthine in the presence and 
absence of catalase. The result showed uric acid formation is time dependent. In the 
presence of catalase uric acid formation increases constantly (Figure 23), whereas in 
the absence of catalase after an initial increase, uric acid production decreases due to 
its oxidation to allantoin as shown in here in Figure 25. 
 
 
 
 
 
 
 
 
           
Figure 25  
H2O2-mediated oxidation of uric acid to allantoin 
As it was shown in Figure 23, in the absence of catalase uric acid is oxidised to allantoin by 
H2O2 produced during the reaction between xanthine and XO. Now within this graph we 
show that [14C]allantoin formation increases over time, followed by a decrease. Allantoin is 
hydrolysed to glyoxylate and thereafter to urea. These two compounds do not have UV 
absorption thus they are not detectable under UV light. The results shown in the figure are 
from a single determination in one experiment and are representative of one other. 
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4.6  Computer stimulation of native and oxidised XO 
 
4.6.1  H2O2-mediated oxidation of the binding domain for the flavin ring of 
FADH2 suggests oxidation of the co-factor 
In order to further substantiate our results on XO oxidation we employed computer 
stimulation. The result indicated that oxidation very likely affects the FADH2 binding 
site of XO which is in turn supports our FADH2 binding experiments (Figure 26).  
 
 
 
 
 
 
 
 
 
Figure 26  
(A): Native   
Flavin ring of FADH2 is bound via Hydrogen bonds from Asp
351, Glu360, and Lys422 and via π-
π stacking interactions with the phenyl ring of Phe337  
(B): Oxidised  
oxidation of Met and Trp residues around the FADH2 binding (most noticeably Trp
336 shown 
here) disrupts π-π stacking of Phe337 and the H-bonding network to a small extent. While this 
is not enough to significantly affect the affinity of XO for FAD, it may affect the vulnerability 
of FAD to oxidation (with kind permission from Dr. Gibbons). 
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4.6.2  H2O2-mediated oxidation of the molybdopterin binding domain does not 
alter co-factor binding  
Since XO is a Molybdopterin containing enzyme, we wanted to know whether this 
cofactor is possibly affected by H2O2-mediated oxidation. Computer stimulation 
reveals that despite oxidation of Met and Trp residues, the cofactor binding is not 
affected. The result is shown in Figure 27.  
 
 
 
 
 
 
 
 
 
 
Figure 27  
(A): Molybdopterin is bound by H-bonds from the residues Gln112, Gly797, Phe798, Met1038, 
Ser1082 & Gln1194.  
(B): Oxidation of Met and Trp residues does not adversely affect binding, with only 1 H-bond 
being lost from Gln112 and several new ones being formed: one addition bond is formed from 
both Met1038 & Gln1194 and two completely new H-bonds form Cys150 and Gly1039 (with kind 
permission from Dr.Nicholas Gibbons). 
 
 
 
A B
 153 
4.6.3 H2O2-mediated oxidation of the active site of XO affects the enzyme kinetics 
Next we wanted to explore whether the active site of XO could be affected by H2O2. 
While both normal Phe914 and Phe1009 are not affected Gln767 and Glu802 are shifted, 
favouring possibly a stronger binding of the cofactor. The shift of Arg880 and Glu1261 
could explain the change in the enzyme rate and catalysis as shown in our experiment 
(Figure 28).  
 
 
 
 
 
 
 
 
 
Figure 28  
(A) Native - 6 residues are involved in the active site of XO. Glu1261 is the crucial catalytic 
residue, while Gln767 and Glu802 are involved in aiding in catalysis. Arg880, Phe914 and Phe1009 
are involving in forming a binding site for the substrates or inhibitors. Arg880 acts to form H-
bonds/salt bridges while Phe914 and Phe1009 are involved in π-π stacking interaction with the 
aromatic rings of substrates/inhibitors.  
(B) Oxidised - oxidation of Met and Trp residues around the active site causes shifts in the 
positions of several residues. Phe914 & Phe1009 do not seem to be affected at all, while Gln767& 
Glu802 appear to be shifted into positions that may enable them to interact more strongly with 
the Moco-factor. Arg880 and Glu1261 are shifted away from their positions, affecting reaction 
rate and catalysis (with permission from Dr. Gibbons). 
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4.7  XO activity in epidermal MCs and KCs 
 
4.7.1  XO activity is significantly higher in epidermal KCs compared to MCs 
XO activity was determined in cell extracts from epidermal MCs and KCs by 
following uric acid formation in the absence of catalase. A maximum in [14C]uric acid 
production was reached at 2 minutes. The results showed that KCs have a 
significantly higher XO activity compared to MCs (Figure 28).  
 
  
 
 
 
 
 
 
 
Figure 29  
[
14
C]uric acid formation in human epidermal KCs and MCs  
(A): Time dependent uric acid formation in the absence of catalase. Uric acid production 
increases up to 2 minutes thereafter decreases due to its oxidation to allantoin by H2O2 
produced during the reaction. (B): Comparison of 14[C]uric acid formation in human 
epidermal KCs and MCs after 2 minutes. The result indicates that both epidermal cells have 
XO activity. It appears that KCs show double of XO activity. This experiment was done in 
triplicates (n=3) using three different primary cell cultures (passage 1-3). 
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4.8  Presence of allantoin in vitiligo 
 
4.8.1  Allantoin is present in the epidermis of patients with acute vitiligo 
Since allantoin is a marker for H2O2-mediated oxidation of uric acid and since 
epidermal H2O2-concentrations in patients with vitiligo exceed mM concentrations of 
this ROS, we decided to test the formation of allantoin in epidermal cell extracts from 
suction blister tissue originating from acute vitiligo (n=10). Allantoin was determined 
via high performance liquid chromatography (HPLC) and the correct assignment was 
confirmed by mass spectrometry (Dr. Derek Maitland, data not shown). The results of 
this study confirmed that allantoin is indeed present in both lesional and non lesional 
epidermis of acute vitiligo (n=10), whereas healthy controls (n=5) do not show this 
metabolite (Figure 30).  
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Figure 30 
(A): HPLC proves the presence of allantoin in the epidermis of vitiligo 
(a) Standard, 20µl allantoin solution (0.04µg allantoin) was injected and allantoin eluted at a  
retention time of 3min. (b) Healthy control extract does not show any allantoin. (c) The 
presence of allantoin in lesional epidermis of acute vitiligo was detected at 3 minutes. (d) 
Sample spiked with allantoin standard confirmed the correct retention time. (e) The presence 
of allantoin in non-lesional epidermis of acute vitiligo was detected at 3 minutes). (f) Sample 
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spiked with allantoin standard confirmed the correct retention time. (  )Uncharacterized peak 
(under investigation), arrows indicate allantoin peak.  
(B) Allantoin levels are absent in healthy controls. Levels in lesional skin of patients with 
vitiligo are significantly higher compared to non lesional skin (∗p<0.05, ∗∗p<0.01, 
∗∗∗p<0.001, mean ± SD). 
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4.9  XO can re-activate pterin-inhibited tyrosinase 
 
Pterins have been reported to bind to XO and inhibit its activity in a concentration-
dependent manner (Kalckar, Kjeldgaard et al. 1948; Kalckar and Klenow 1948; 
Hofstee 1949; Lowry, Bessey et al. 1949; Kalckar, Kjeldgaard et al. 1950; Isaka 1952; 
Wede, Altindag et al. 1998; Oettl and Reibnegger 1999). As shown by immuno-
staining, co-localisation of XO with tyrosinase was detected, indicating the presence 
of this enzyme within melanosomes (Shalbaf, Gibbons et al. 2008). Tyrosinase is the 
key enzyme in melanogenesis (Lerner, Fitzpatrick et al. 1948) and 6BH4 forms an 
inhibitor complex with this enzyme (Wood, Schallreuter-Wood et al. 1995; Wood, 
Chavan et al. 2004). In vitiligo, due to oxidative stress, 6BH4 is oxidised to 6-
biopterin (Schallreuter, Wood et al. 1994). Therefore this question was raised, what is 
the function of XO in melanosome? Could XO play a role in pigmentation? To 
answer these questions a set of experiments were designed, where uric acid 
production from the reaction between xanthine and XO was spectrophotometrically 
monitored at 290nm in the presence of different concentrations of pterins. 
 
 
 
 
 
 
 
 
 
 159 
4.9.1  Inhibition of XO by 7BH4 and 7-biopterin 
As shown earlier, pterins are able to inhibit XO activity but so far there has been no 
report of inhibiting XO activity by 7BH4 or by its oxidised form, 7-biopterin. 
Therefore it was of interest to test whether these pterins have also an inhibitory effect 
on the activity of XO. The results showed that both pterins are able to inhibit XO 
activity in a concentration dependent manner. In all reactions catalase was used to 
remove H2O2 produced during the reaction to avoid allantoin formation (Shalbaf, 
Gibbons et al. 2008).  
 
 
 
 
 
 
 
 
 
 
 
Figure 31 
Inhibition of XO activity by 6&7BH4 and their oxidised forms 6 & 7-biopterin 
The graph shows that 6-biopterin at 200µM is the strongest inhibitor of XO activity compared 
to 7-biopterin, 6BH4 and 7BH4 (51.3%, 45.8%, 40.5% and 28.3% inhibition, respectively). 
For more details please see Materials and Methods’ section.  
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4.9.2  Reactivation of 6&7BH4-inhibited tyrosinase by XO 
Since 6BH4 acts as an uncompetitive inhibitor for the rate limiting enzyme in 
melanogenesis, tyrosinase (Wood, Schallreuter-Wood et al. 1995; Wood, Chavan et 
al. 2004) and since XO is present in melanosomes, it was tempting to test whether this 
protein could possibly reactivate the 6&7BH4/tyrosinase inhibitor complex. Therefore 
we followed dopachrome formation of tyrosinase at 475nm in the presence and 
absence of XO. The results showed that XO binds 6&7BH4 from the inhibitor 
complex leading to reactivation of tyrosinase (Figures 32; A&B).  
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Figure 32  
Reactivation of the 6&7BH4/tyrosinase inhibitor complex by XO 
(A) XO can to re-activate tyrosinase inhibited by 6BH4 and (B) 7BH4. 84U of tyrosinase and 
1mM of L-tyrosine was added together with either 200µM of 6BH4 (a) or 7BH4 (b) in a total 
volume of 1ml 0.05M potassium phosphate buffer pH 7.5. L-dopachrome formation was 
measured at OD475nm. When L-dopachrome formation was inhibited, 100µl of XO (1mg/ml) 
was added. The figure demonstrates that after addition of XO, tyrosinase activity was 
recovered (n=2). XO does not react with L-tyrosine (data not shown).   
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4.9.3  XO binds to [
3
H]6BH4 
The above results imply that XO is able to bind to and remove both 6BH4 and 7BH4 
from the tyrosinase inhibitory complex. In order to further substantiate our 
observation we incubated XO with [3H]6BH4. Our result showed that XO has the 
ability to bind to the radio-labelled 6BH4 (Figure 33). Importantly, this result is in 
agreement with earlier data (Kalckar, Kjeldgaard et al. 1948; Kalckar and Klenow 
1948; Hofstee 1949; Lowry, Bessey et al. 1949; Kalckar, Kjeldgaard et al. 1950; Isaka 
1952; Wede, Altindag et al. 1998; Oettl and Reibnegger 1999). However, at that time 
there was no radio-labelled 6BH4 available. This observation is very interesting 
because it offers an additional mechanism to α-MSH in control of the 6BH4-
tyrosinase inhibitor complex (Moore, Wood et al. 1999; Schallreuter, Moore et al. 
1999). 
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Figure 33  
Binding of [
3
H]6BH4 to XO  
2.5ml of XO solution (4mg/ml) was incubated with 200µM final concentration of cold 6BH4 
containing 5nCi of [3H]6BH4. The mixture was separated on a G25 sephadex column 
equilibrated with distilled water. 500µl fractions were collected of which 100µl was counted 
(─■─) while the remaining fraction was used for protein determination (─●─). The result 
proves that XO is able to bind 6BH4 (n=1). 
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4.10  DNA damage in vitiligo 
 
Reactive oxygen species (ROS) are formed as by-products of the normal cellular 
metabolism. Oxygen-derived free radicals have been shown to be a major source for 
nuclear and mitochondrial DNA damage as they are able to attack DNA leading to the 
hydroxylation of DNA bases. The most prominent one is 8-oxoGuanine (8-oxoG) 
(Kasai, Crain et al. 1986; Adelman, Saul et al. 1988; Wagner, Hu et al. 1992; Smith, 
Marks et al. 2004). Under normal physiological conditions ROS are eliminated by 
various antioxidants (Smith, Marks et al. 2004). Since the entire epidermis of patients 
with vitiligo is under oxidative stress due to accumulation of mM H2O2 concentrations 
(Schallreuter, Moore et al. 1999; Schallreuter 2005; Schallreuter, Bahadoran et al. 
2008), DNA damage in epidermal cells would be highly expected in these patients.  
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4.10.1  Increased in situ expression of 8-oxoG in vitiligo 
As mentioned earlier, 8-oxoG is the most readily oxidised of the four native 
deoxyribonucleotides. Therefore it is regarded a ubiquitous and stable biomarker for 
evaluation of oxidative DNA damage in individuals (Kasai and Nishimura 1984; Loft, 
Fischer-Nielsen et al. 1993; Steenken and Jovanovic 1997; Bruner, Norman et al. 
2000; Kasai 2002; Ichihashi, Ueda et al. 2003; Perra, Maxia et al. 2006). Since the 
entire epidermis of patients with vitiligo is under constant oxidative stress 
(Schallreuter, Moore et al. 1999; Schallreuter, Bahadoran et al. 2008), increased levels 
of 8-oxoG was postulated. Our results showed that 8-oxoG levels are indeed increased 
in situ in the epidermis of patients with acute vitiligo compared to healthy controls. 
Because catalase can be considered as a representative biomarker for H2O2-mediated 
oxidative stress (Schallreuter, Bahadoran et al. 2008) individual expression of this 
protein was used as an internal standard for determining the level of H2O2 in all the 
patients and controls. The results showed that low catalase levels in lesional and non 
lesional epidermis of vitiligo are correlating with increased epidermal 8-oxoG 
expression (Figure 34; A,B&C).  
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Figure 34:  
Increased in situ expression of 8-oxoG in patients with vitiligo 
(A): The figure shows that 8-oxoG levels are increased in acute vitiligo in both lesional and 
non lesional epidermis compared to controls (skin phototype III, Fitzpatrick classification). 
N.B. there is hardly any 8-oxoG present in the controls.  
(C): Image analysis of staining intensities. The graph shows that 8-oxoG in vitiligo is 
significantly increased compared to controls indicating the high level of DNA damage caused 
by the mM level of H2O2, as correlated to low catalase levels in the same patients (B&D) (∗∗∗ 
p<0.001, ∗∗ p<0.01, mean ± SD). 
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4.10.2  Increased in vitro expression of 8-oxoG in vitiliginous MCs 
The in situ results showed that 8-oxoG levels were significantly increased throughout 
the human epidermis. In order to further explore under in vitro conditions, we used 
cultured vitiliginous MCs originated from lesional skin of acute vitiligo.  The staining 
showed that 8-oxoG levels were even increased vitiliginous MCs in the nucleus and 
cytoplasm compared to healthy MCs (Figure 35; A,B,C&D). This result is in 
agreement with the in situ observations, suggesting a control cellular problem and not 
just a regular response.  
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Figure 35 
Increased in vitro expression of 8-oxoG in MCs originated from lesional vitiligo 
(A): FITC staining of 8-oxoG in healthy MCs; (B): overlay of DAPI and FITC; (C): over 
expression of 8-oxoG in cultured vitiliginous MCs in the cytoplasm and in the nucleus (inset); 
(D): overlay of DAPI and FITC, shows the co-localisation of 8-oxoG with DAPI in the 
nucleus (inset). The result shows that 8-oxoG levels are increased even under in vitro 
conditions compared to control. 
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4.10.3  Increased plasma levels of 8-oxoG in vitiligo 
Once 8-oxoG is formed, it is excised from the damaged DNA (Chung, Kasai et al. 
1991; Chung, Kim et al. 1991; Tchou, Kasai et al. 1991; Boiteux 1993; Boiteux and 
Radicella 1999) and it is finally excreted in the urine without being further 
metabolised (Wu, Chiou et al. 2004). Therefore determination of 8-oxoG levels in 
different tissues, blood and also urine allows to monitor the extent of oxidative DNA 
damage (Nakano, Kawanishi et al. 2003; Wu, Chiou et al. 2004; Dincer, Erzin et al. 
2007). Inspired by our in situ and in vitro findings, we wanted to know whether 
plasma levels of this compound would be increased in vitiligo patients. Using ELISA 
technique, our results revealed that plasma levels of 8-oxoG were significantly 
increased in all 20 patients examined in our experiment compared to the controls 
(Figure 36). Taken together, our results indicate that this patient group deals with 
significant DNA damage due to H2O2-mediated oxidative stress. 
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Figure 36  
Increased plasma levels of 8-oxoG in vitiligo  
The figure shows that 8-oxoG levels is significantly increased in the plasma of acute vitiligo 
(n=20) compared to the controls (n=10) (∗ p<0.05, mean ± SD). 
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4.11  DNA repair in vitiligo 
 
Genomic stability is highly controlled amongst living organisms; hence most 
organisms have evolved DNA repair mechanisms. Oxidative damage to DNA is 
repaired in living cells mainly via base-excision repair (BER) mechanisms (Boiteux 
and Radicella 1999).  
 
4.11.1  hOgg1 expression in vitiligo 
Once 8-oxoG is formed on DNA strands under oxidative stress, it has to be removed. 
This base lesion is recognised and excised from the damaged DNA by a glycosylase 
called hOgg1 initiating BER pathways (Boiteux 1993; van der Kemp, Thomas et al. 
1996; Boiteux and Radicella 1999; Boiteux and Radicella 2000; Fortini, Pascucci et 
al. 2003; David, O'Shea et al. 2007). Consequently it was decided to investigate the 
expression of hOgg1 in epidermal cells in vitiligo. Western blot analysis proved the 
presence of this important enzyme in vitiligo. Notably, the results revealed that hOgg1 
expression was not increased in vitiligo compared to controls (Figure 37; A,B&C). 
This result suggests that the expression of hOgg1 protein is independent of H2O2-
induced oxidative stress in vitiligo. Our results are in agreement with previously 
published data by Saitoh et al. in 2001 (Saitoh, Shinmura et al. 2001; Fortini, Pascucci 
et al. 2003). These data emphasise the absolute importance of hOgg1 / BER for cell 
survival.   
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Figure 37  
Protein expression of hOgg1 in human epidermal suction blister tissue cell extract 
(A): hOgg1 protein is expressed in vitiliginous epidermal cell extracts (n=6) as well as in 
control (n=2). hOgg1 expression is not increased in vitiligo compared to controls (p>0.05). 
The numbers reflect the number of patients. (B): GAPDH staining of the same membrane to 
show protein loading. (c): Densitometry of the bands was performed to determine the 
percentage of hOgg1 expression related to GAPDH expression for each band (Plots are mean 
± SD). 
From these results we can conclude that despite increased 8-oxoG levels (oxidative 
DNA damage) in the epidermis as well as in the plasma of the patients with vitiligo, 
the efficient BER mechanisms seems to be intact.  
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4.11.2  Increased epidermal expression of APE1 and DNA polymeraseβ in vitiligo 
In order to substantiate the presence of an effective BER mechanism as shown by the 
presence of an unaltered hOgg1, we wanted to explore DNA polymeraseβ as well as 
APE1. It has been reported that a core of four enzymes are required to complete the 
repair of 8-oxoG. This includes besides hOgg1, APE1, DNA polymeraseβ and DNA 
ligase I (Parikh, Mol et al. 1997; Fortini, Parlanti et al. 1999; Fortini, Pascucci et al. 
2003; Chaudhry 2007). To address this scenario in more detail, again we utilised 
Western blot analysis of cell extracts from epidermal suction blister tissues from both 
controls and vitiligo patients. Our results revealed increased protein expression of 
these two enzymes.  
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Figure 38 
Increased APE1 and DNA polymeraseβ expression in vitiligo 
(A): APE1 protein expression in vitiligo cell extracts and in controls. (C): DNA polymeraseβ 
protein expression in vitiligo and in controls. The numbers reflect the number of patients 
(B&D): GAPDH staining of the membranes refers to protein loading. (E&F): Evaluation of 
the bands was correlated to loaded protein (GAPDH staining). The results show that both 
enzymes are over expressed in vitiligo compared to controls (∗∗ p<0.01, mean ± SD). 
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Taken together we have shown that patients with vitiligo have considerable DNA 
damage evidenced by increased 8-oxoG. Moreover, this patient group has the capacity 
to repair this DNA damage via hOgg1, APE1 and DNA polymeraseβ. These results 
indicate the presence of efficient DNA repair machinery in patients with vitiligo. 
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4.12  More support for absence of increased apoptosis in vitiligo  
 
DNA-damage responses are very complex involving numerous signals, proteins and 
specific cellular pathways including DNA repair mechanisms, cell cycle check points, 
cellular senescence and apoptosis (Schmitt, Paquet et al. 2007). Since epidermal cells 
have to cope with mM levels of H2O2 in patients with vitiligo (Schallreuter, Moore et 
al. 1999; Schallreuter, Bahadoran et al. 2008) and the results from this thesis showed 
that epidermal DNA damage is increased in these patients, the question of interest was 
how do these patients handle this DNA damage besides DNA repair as shown before. 
In this context  it was reported that epidermal functioning wild-type p53 is increased 
in vitiligo (Schallreuter, Behrens-Williams et al. 2003). Considering the major role of 
this protein in DNA repair and its regulatory role in apoptosis, it was decided to 
investigate a number of the apoptotic/non apoptotic epidermal cell responses in these 
patients despite several authors showed no evidence for increased apoptosis in vitiligo 
(van den Wijngaard, Aten et al. 2000). However, since the presence of increased 
apoptosis has also been shown by some other authors (Boissy and Nordlund 1997; 
Kemp, Waterman et al. 2001; Huang, Nordlund et al. 2002; Boissy and Manga 2004; 
Park, Kim et al. 2007; Ruiz-Arguelles, Brito et al. 2007; Song, Xu et al. 2008), it was 
decided to re-address this issue. 
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4.12.1  Decreased in situ epidermal cytochrome c and caspase 3 expression in 
vitiligo 
To shed some more light on our findings, we turned our interest to epidermal 
cytochrome c and caspase 3 expression. Cytochrome c is an important intermediate in 
apoptosis. Following exposure to apoptotic stimuli, cytochrome c is rapidly released 
from the mitochondria into the cytosol, an event which is required for completion of 
apoptosis (Liu, Kim et al. 1996; Cai, Yang et al. 1998; Skulachev 1998). In turn, 
cytosolic cytochrome c functions in the activation of caspase 3, where it is a key 
effector of apoptosis (Boldin, Varfolomeev et al. 1995; Tewari, Quan et al. 1995; 
Kuida, Zheng et al. 1996; Abu-Qare and Abou-Donia 2001). Within this study, we 
evaluated cytochrome c and caspase 3 levels in the skin of patients with vitiligo as 
well as controls using immunofluorescence reactivity. Our in situ results showed that 
both epidermal cytochrome c and caspase 3 levels in vitiliginous epidermis of patients 
with acute vitiligo are significantly lower than controls. 
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Figure 39  
In situ expression of cytochrome c in both healthy skin and patients with vitiligo (skin 
phototype III, Fitzpatrick classification) 
(A): Decreased in situ expression of cytochrome c in vitiligo compared to control (skin 
phototype III, Fitzpatrick classification). The figure shows that cytochrome c levels are lower 
in both lesional and non lesional skin of patients with acute vitiligo (+H2O2) than controls.  
The presence of H2O2 was verified by low catalase level in these patients (Figure 33; C&D). 
(B): Image analysis reveals significantly lower levels of cytochrome c in acute vitiligo 
compared to the controls ((∗∗ p<0.05, mean ± SD).  
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Figure 40  
Decreased in situ expression of caspase 3 in patients with vitiligo (skin phototype III, 
Fitzpatrick classification)  
(A): Caspase 3 levels are lower in the epidermis of acute vitiligo compared to controls. (B): 
Image analysis shows significantly decreased caspase 3 levels in acute vitiligo compared to 
controls (∗∗ p<0.05, mean ± SD). The presence of H2O2 was monitored by low catalase 
expression (Figure 33; C&D).  
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4.12.2  Increased expression of Gadd45α in vitiligo 
p53 plays a critical role in the normal cell’s response to a variety of stress stimuli 
(Harris 1996). In response to genomic stress including DNA damage, this 
multifunctional protein is activated and in turn transactivates a series of its 
downstream effector genes involved in cell cycle arrest and DNA repair (including 
p21 and Gadd45α) and also apoptosis (including Bcl-2 and Bax) (Harris 1996). 
Gadd45 is a nuclear protein and it functions during cell cycle checkpoint in G2/M, 
DNA repair and in the apoptotic pathway (Fornace, Jackman et al. 1992; Wang, Zhan 
et al. 1999; Sheikh, Hollander et al. 2000; Maeda, Hanna et al. 2002; Zhan 2005). 
Earlier it has been shown that Gadd45α is involved in the induction of G2/M cell 
cycle checkpoint following UVB irradiation in epidermal KCs, MCs and also in 
melanoma cells (Maeda, Hanna et al. 2002; Pedeux, Lefort et al. 2002). Based on 
these results, it has been suggested that the activation of Gadd45α in MCs and 
melanoma cells may play a crucial role for their survival due to their ability to 
efficiently repair UVB-induced lesions (Pedeux, Lefort et al. 2002; Fayolle, Pourchet 
et al. 2006; Fayolle, Pourchet et al. 2008). In order to find out whether epidermal cells 
in vitiligo express Gadd45α in response to oxidative stress, we investigated the 
presence of this protein in patients’ skin. Our results show for the first time that 
Gadd45α is indeed expressed in situ using immunoreactivity and Western blotting. 
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Figure 41  
Gadd45α  is present throughout the epidermis and in the nucleus  
(A): FITC-labelled Gadd45α in healthy controls in which no Gadd45α co-localisation is 
observed (n=3) (B): positive Gadd45α staining (FITC) in the human epidermis, and inset, 
shows the expression of this protein in the nucleus (C&D): Enlargement of the marked area, 
shows Gadd45α’s localisation and its co-localisation with DAPI in the nucleus (n=5) 
(magnification x 200). 
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Figure 42  
Western blot analysis of Gadd45α expression in vitiligo 
(A): The expression of Gadd45α in cell extracts from epidermal suction blister tissue of both 
healthy controls and vitiligo patients. The numbers reflect the number of patients. (B): 
GAPDH staining of the same membrane and (C): Densitometry of the bands was performed 
in correlation with Gadd45α levels and the loaded protein (GAPDH staining). The graph 
shows that Gadd45α is significantly overexpressed in lesional vitiligo compared to controls 
and non lesional epidermis (Plots are mean ± SD).  
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5.0 DISCUSSION 
 
 
 
5.1  The presence of XO in the human epidermis and its regulation 
by H2O2 
 
The role of ROS in the pathogenesis of various diseases has been the subject of 
intensive research during the past decades. In recent years vitiligo has been emerged 
as a biological model disease for epidermal oxidative stress (Schallreuter, Wood et al. 
1991; Maresca, Roccella et al. 1997; Schallreuter 1999; Schallreuter, Moore et al. 
1999; Dell'Anna, Maresca et al. 2001; Dell'Anna, Urbanelli et al. 2003; Hasse, 
Gibbons et al. 2004; Dell'Anna, Ottaviani et al. 2006; Dell'anna and Picardo 2006; 
Dell'Anna, Ottaviani et al. 2007; Maresca, Flori et al. 2008; Schallreuter, Bahadoran 
et al. 2008). The presence of mM H2O2 concentrations in the epidermis of these 
patients, low catalase levels and impaired back-up systems provide ample evidence 
for this hypothesis contributing in turn to the pathogenesis of this disease 
(Schallreuter, Pittelkow et al. 1986; Schallreuter, Hordinsky et al. 1987; Schallreuter, 
Wood et al. 1991; Beazley, Gaze et al. 1999).  
XO has been implicated in free radical-induced damage in a multitude of human 
diseases because this enzyme plays a major role in generating ROS (H2O2, O2
•-). O2
•- 
is generated during the enzyme reaction and thereafter it is converted to H2O2 via the 
action of superoxide dismutase to via spontaneous disproportionation. OH• is 
generated via the Fenton- or Haber-Weiss reaction (Manson, Anthenelli et al. 1983; 
Im, Shen et al. 1984; Chambers, Parks et al. 1985; Parks and Granger 1986; Picard-
Ami, MacKay et al. 1991; Glantzounis, Tsimoyiannis et al. 2005). Therefore the 
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presence and activity of this enzyme in epidermal cells was of two-fold interest, in 
general and in the context of vitiligo. In order to assess XO activity in human MC and 
KC cell extracts, we developed and utilised a very sensitive TLC method using 
[14C]xanthine. The separation of xanthine and uric acid on the chromatogram is 
shown in Figure 22. One example of the standard assay is shown in Figure 23. The 
result shows that in the absence of catalase [14C]uric acid formation increases up to 5 
min, followed by a decrease, implying oxidation of uric acid to allantoin by H2O2 
produced during the reaction. This assumption is supported by the increase in uric 
acid formation in the presence of catalase. 
To the best of our knowledge, we here demonstrated for the first time that mRNA 
expression (Figure 7), protein expression (Figures 8, 9, 10, 11&12) and enzyme 
activity (Figure 29) of XO are present in both epidermal MCs and KCs. In 
melanocytes XO is predominantly distributed around the nucleus in a granular pattern 
(Figure 9b) where it co-localises with tyrosinase suggesting that XO is present in 
melanosomes (Figure 9; c,d&e). Figure 11 demostrates in situ that XO protein 
expression in vitiligo is not different compared to control. This result indicates that 
XO protein expression is not altered in vitiligo supporting that XO expression is not 
affected by H2O2. Also, our kinetic results presented in this thesis showed that XO 
functionality was only partially affected under severe oxidative condition since there 
is only one Trp residue in the flaving ring of FADH2, one Met residue in the moco 
centre and no Met/Trp residue in the active site of XO as shown in Figures 26, 27 & 
28. Met and Trp are the most sensitive amino acids to H2O2-mediated oxidation. 
Therefore the presence of allantoin in the epidermis of patients with vitiligo was 
expected. Our results supported this assumption, as we identified significantly higher 
levels of allantoin in the lesional and non-lesional epidermis of all patients examined, 
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whereas this metabolite was absent in healthy controls (Figure 30). Since humans 
lack the enzyme uricase converting uric acid to allantoin, thus the formation of 
allantoin from uric acid can only be attributed to H2O2 (Figure 43). Taken together, to 
our knowledge, this is the first time that the presence and activity of XO has been 
demonstrated in human epidermal MC and KC cell extracts (Figure 29A). It appears 
that XO activity is higher in KCs compared to MCs (Figure 29B). 
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Figure 43 
The final two steps in purine catabolism pathway  
XO catalyses the oxidation of hypoxanthine to xanthine and further to uric acid. These 
reactions are accompanied by the formation of 2 molecules H2O2 as by-product. Under 
physiological conditions catalase removes H2O2 and uric acid is excreted in the urine (a&b). 
Further metabolism of uric acid in mammals, turtles and molluscs proceeds from uric acid to 
allantoin by urate oxidase. Allantoin is hydrolysed to allantoate by allantoinase followed by 
further hydrolysis to glyoxylate and urea by allantoicase (Newsholm and Leech 1984) (c).  
In humans, under oxidative conditions, as observed in vitiligo, uric acid is oxidised by H2O2 
to allantoin (Grootveld and Halliwell 1987; Kaur and Halliwell 1990; Benzie, Chung et al. 
1999; Yardim-Akaydin, Sepici et al. 2004; Yardim-Akaydin, Sepici et al. 2006). Allantoin is 
hydrolysed to allantoate and the latter to glyoxylate and urea (Newsholm and Leech 1984) 
(d). 
Hypoxanthine xanthine + H2O2
XO catalase
H2O2 + ½ O2
Xanthine uric acid + H2O2
XO catalase
H2O2 + ½ O2
a)
b)
c)
Uric acid allantoin
urate oxidase
glyoxylate + ureaallantoate
allantoinase allantoicase
H2O H2O
d)
Uric acid allantoin glyoxylate + ureaallantoate
H2O H2O
H2O, O2 CO2
H2O2
oxidation
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5.2  The presence of allantoin underlines oxidative stress in vitiligo 
 
This is the first study investigating the levels of allantoin in vitiligo. Our data add to 
the list of oxidative stress in this disease (Shalbaf, Gibbons et al. 2008). The presence 
of epidermal allantoin in acute vitiligo mirrors and emphasises the involvement of 
H2O2-mediated oxidative stress in this disease and also highlights the role of  uric acid 
as an important antioxidant in humans because it can directly react with free radicals 
to produce relatively stable products (Ames, Cathcart et al. 1981; Kaur and Halliwell 
1990; Becker 1993; Glantzounis, Tsimoyiannis et al. 2005). Therefore XO itself can 
contribute to ROS scavenging via the production of uric acid. It is also possible that 
uric acid is involved in scavenging of peroxynitrite (ONOO
-
) which has been 
extensively shown (Hooper, Spitsin et al. 1998; Kean, Spitsin et al. 2000). Since the 
epidermis of patients with vitiligo generates NO in 10-6M range via NOS, this could 
be a relevant mechanism (Schallreuter, Bahadoran et al. 2008). However, since 
oxidative stress via H2O2 and ONOO
-
 is presenting lesional and non-lesional skin, it 
still needs to be shown, why some patches are white, while others remain pigmented. 
Our other observation i.e. melanocyte detachment in vitiligo cannot be explained by 
our data (Gauthier, Cario Andre et al. 2003). Whether this detachment is specific for 
vitiligo is not yet clear. We have data that detachment of melanocytes can also be 
observed in healthy individuals (Schallreuter, unpublished data).      
Figure 24 demonstrates the separation of allantoin by TLC. The oxidation of uric acid 
to allantoin by H2O2 in the absence of catalase is shown in Figure 25. After an initial 
increase in allantoin formation, the production of this metabolite decreases over time. 
Allantoin is further converted to allantoate and allantoate to glyoxylate and urea via 
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basic hydrolysis (Figure 43). However, unfortunately allantoate and glyoxylate do not 
have any UV-absorption, hence they are not detectable by UV light. Therefore it is 
not possible to measure these products using this separation system. 
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5.3  XO is inhibited by its own substrate 
 
Spectrophotometric studies of XO activity with different substrate concentrations in 
the absence of catalase revealed that increase in the concentration of substrate 
decreases the formation of reaction product (Figure 14). As discussed earlier, H2O2 is 
formed during the hydroxylation of hypoxanthine to xanthine and xanthine to uric 
acid (Figure 43). Our result suggests that the decrease in the reaction product could 
be based on its oxidation to allantoin by H2O2 (Newsholm and Leech 1984), or 
inhibition of the enzyme or a combination of both. The cause of the decrease in uric 
acid formation in the above experiment was confirmed after addition of catalase to 
remove H2O2 produced in the reaction (Figure 15). The result revealed that XO 
activity was inhibited in a concentration dependent manner by the substrate, proving 
substrate inhibition of XO activity. However, XO inhibition by its substrate is 
observed in the presence of very high and non-physiological xanthine concentrations.   
This is a novel finding on the regulation of XO activity. 
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5.4  FADH2 is directly affected by H2O2 in XO 
 
As mentioned earlier, unique information about the structure of both native and 
oxidised XO can be obtained from UV/visible spectroscopy (Hille and Nishino 1995; 
Stockert 2004 ). The UV/visible spectra of purified H2O2-oxidised XO (1.5M H2O2) 
showed that FADH2 is oxidised to FAD under those conditions. In the presence of 
lower H2O2 concentrations we could not appreciate the signal. Hence, we can 
conclude that only high non-physiological concentrations of H2O2 can affect the 
FADH2 cofactor of XO (Figures 19&20). These results are in agreement with 
previous work from Hille and Nishino (Hille and Nishino 1995). The UV/visible 
spectroscopic study of XO revealed that the maximum absorbance at 450nm is due 
both to the oxidised Fe-S and the FAD centres. However, the molybdopterin domain’s 
absorbance (500-600nm) is too small (Hille and Nishino 1995; Stockert 2004 ). As 
mentioned earlier, Fe-S centres in the structure of the enzyme are coordinated to four 
cysteine residues, close to the FAD centre and these play a role in electron transfer 
derived from the substrate (Olson, Ballou et al. 1974; Kisker, Schindelin et al. 1997; 
Enroth, Eger et al. 2000). The oxidation of the cysteine residues coordinated to Fe-S 
centres by H2O2 as well as the oxidation of FADH2 to FAD can cause of the changes 
in the UV/visible spectra of the oxidised XO. Subsequently, the oxidation of the Fe-S 
centres and FADH2 co-factor by H2O2 could lead to malfunction in the intra-
molecular electron transfer of XO as it was shown in Figure 18. Since constantly 
H2O2 levels are in the 10
-3M range in acute vitiligo, this mechanism could indeed take 
place.   
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5.5  H2O2 directly affects XO structure 
 
In order to further investigate whether H2O2 alters the structure of XO, we utilised 
computer molecular modelling. Using this tool, all the Met and Trp amino acid 
residues around the FADH2 co-factor, moco and active site of XO were oxidised to 
methionine sulfoxide (MetSO) and 5-OH-Trp, respectively. Then the oxidised binding 
domains were compared to the native states and the changes were analysed. The 
analysis revealed that oxidation of the most noticeable Trp around the FADH2 binding 
site (Trp336) disrupts π-π stacking of Phe337 and the H-bonding network to a small 
extent (Figure 26; A&B).  It seems that this little change does not significantly affect 
the affinity of XO for FADH2, but it may affect the vulnerability of FADH2 to 
oxidation. Moreover, this analysis showed that the oxidation of Met and Trp residues 
does not adversely influence the moco-cofactor binding site, whereas oxidation of 
Met and Trp residues around the active site causes shifts in the positions of several 
amino acid residues, affecting reaction rate and catalysis (Figures 27&28). 
Taken together, these data strongly support our former results. 
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5.6  Inhibition of XO activity by 6/7BH4 and 6/7-biopterin and 
binding of 6/7BH4 to XO: A novel mechanism in regulation of 
melanogenesis? 
 
Earlier studies have already shown that pteridines are able to inhibit XO activity in a 
concentration-dependent manner (Kalckar, Kjeldgaard et al. 1948; Kalckar and 
Klenow 1948; Hofstee 1949; Lowry, Bessey et al. 1949; Kalckar, Kjeldgaard et al. 
1950; Isaka 1952; Wede, Altindag et al. 1998; Oettl and Reibnegger 1999). Amongst 
all pterins, 6-biopterin, the oxidation product of the ubiquitous cofactor (6R)-L-
erythro 5,6,7,8 tetrahydrobiopterin (6BH4) is the most potent inhibitor of XO (Wede, 
Altindag et al. 1998).  
However, to date, there has been no report on inhibition of XO by 7BH4 and/or 7-
biopterin. Within this study, we showed for the first time that both the reduced as well 
as the oxidised 7-isomer of 6BH4 are able to inhibit XO activity in a concentration 
dependent manner (Figure 31). The results confirmed that 6-biopterin is the strongest 
inhibitor of XO followed by 7-biopterin, 6BH4 and 7BH4. Here it is noteworthy that 
6BH4 is composed of a pyrimidine and pyrazine ring with a side-chain attached to the 
6th position (Figure 44). 7BH4 has the same structure as 6BH4 but the side-chain is on 
the 7th position (Figure 44). The difference between the structure of 6&7-biopterin is 
based on the move of the side chain on the pyrazine ring (Figure 44). Moreover,  it 
has been proposed that the inhibitory effect of the pterins on XO activity may be due 
to the structural similarities between the pterins, xanthine and the molybdopterin 
cofactor (Wede, Altindag et al. 1998). Based on these similarities, the pterins may 
occupy the active site of XO, or they may engage moco binding domain without being 
a substrate for the enzyme (Figure 44) (Wede, Altindag et al. 1998).  
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Moreover, it has also been suggested that the possession of a side chain with several –
OH groups in the 6th position could play an important role in pterins’ interactions with 
XO (Wede, Altindag et al. 1998). However, our results with 7BH4 and 7-biopterin 
suggest that the side chain in position 7 of those pterins could be an explanation for 
inhibition of XO activity by the 7-isomer as shown in this thesis. The stronger 
inhibitory effect of the oxidised pterins (6&7-biopterin) compared to their reduced 
state may be attributed to the presence of two double bonds in the pyrazine ring. This 
oxidation dependent interaction with molybdopterin cofactor could influence more 
effectively the electronic properties of the molybdenum cofactor (Schindelin, Kisker 
et al. 1996).  
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Figure 44 
Structure of four pterins compared to molybdopterin cofactor of XO and xanthine 
6-biopterin is the most potent inhibitor of XO activity followed by 7-biopterin, 6BH4 and 
7BH4, respectively. All these pterins have a hydroxylated side chain attached to the either 6
th 
or 7th position of the pyrazine ring. The strong inhibitory effect of these pterins has been 
attributed to presence of this side chain, whereas due to the absence of the side chain in 
leucopterin, the inhibitory effect of this pterin has been shown to be drastically weaker 
compared to pterins with a side chain (Wede, Altindag et al. 1998; Oettl and Reibnegger 
1999). 
 
 
6BH4
7BH4
6-biopterin
7-biopterin
molybdopterin
cofactor
xanthine
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In the context presented herein it is interesting that the presence of both 6BH4 and 
7BH4 has been documented in melanosomes (Schallreuter, Moore et al. 1999; 
Spencer, Chavan et al. 2005). In this thesis we show for the first time that XO is also 
present in this organelle (Figure 9).  
What could be the function of this enzyme in this pigment forming organelle?  
Considering that XO generates O2
•- which in turn is an effective activator of 
tyrosinase (Wood and Schallreuter 1991), and that both 6BH4 and 7BH4 are potent 
inhibitors of tyrosinase and XO, it was tempting to invoke XO in a concerted action 
with tyrosinase and 6BH4/7BH4 in regulation of melanogenesis.  
We therefore wanted to know whether XO have the capacity to act as a possible 
activator of the tyrosinase-6BH4 inhibitor complex as well as the tyrosinase-7BH4 
inhibitor complex. Our results showed that the tyrosinase-inhibitor complex can 
indeed be reactivated upon addition of XO (Figure 32; A&B). We demonstrated that 
the 6BH4-tyrosinase inhibitor complex is very fast reactivated by XO (Figure 32A). 
To further substantiate these observations, we used [3H]6BH4 to follow its binding to 
XO. The result confirmed that XO can bind 6BH4 (Figure 33).  
We then showed that XO can also reactivate the 7BH4-tyrosinase inhibitor complex. 
However, reactivation needs more XO (Figure 32). This result suggests that the pterin 
binding site on XO is different for both pterins.  
To our knowledge, we here show for the first time that XO strongly binds both 6 and 
7BH4 which in turn enables XO to be an activator of the tyrosinase inhibitor complex. 
Hence, the presence of XO in the melanosomes might be important for this reason. 
However, as said above, on one hand XO generates O2
•- which is an activator of 
tyrosinase; on the other hand both pterins inhibit XO (Figure 31). In this context it is 
noteworthy that α-MSH and β-MSH can also bind the pterins with 1: 1 stoichiometry 
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(Moore, Wood et al. 1999; Schallreuter, Moore et al. 1999; Spencer, Chavan et al. 
2005). So far we have not compared the affinity of XO with both α-MSH and β-
MSH. However, the presence of XO, 6BH4 and 7BH4 in the melanosome could 
provide an effective machinery in control of the tyrosinase inhibitor complex. This 
could be another mechanism within the melanocyte, whereby tyrosinase can be re-
activated in a receptor independent manner, as shown earlier by α-MSH and recently 
by β-MSH (Moore, Wood et al. 1999; Spencer, Chavan et al. 2005). 
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Figure 45 
Inhibition/activation of tyrosinase, the key enzyme in melanogenesis 
A: Normal skin. Conversion of the amino acid L-phenylalanine to L-tyrosine via PAH 
initiates melanin synthesis (Schallreuter and Wood 1999). TH I which is situated side by side 
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with TYR on the melanosomal membrane, converts L-tyrosine to L-DOPA (Marles, Peters et 
al. 2003). L-DOPA activates TYR which in turn forms L-Dopachrome yielding finally to 
melanin formation. Both 6 and 7BH4 inhibit TYR (Wood, Schallreuter-Wood et al. 1995). 
This inhibition is reversible by the binding of α-MSH to 6BH4 and β-MSH to 7BH4, thus 
reactivating TYR (Moore, Wood et al. 1999; Spencer, Chavan et al. 2005). In this thesis we 
identified the presence of XO in melanosomes (Figure 9) (Shalbaf, Gibbons et al. 2008). 
Moreover, we showed that both 6 and 7BH4 can bind to XO, inhibiting its activity (Figure 
31). We also showed that the binding of 6 and 7BH4 to XO can reactivate pterin inhibited 
TYR (Figure 32). XO converts xanthine to uric acid. In this reaction O2
•- is produced 
(Newsholm and Leech 1984). TYR’s activity has been shown to be 40-fold higher in the 
presence of O2
•- (Wood and Schallreuter 1991). 
Taken together, interactions between XO, 6BH4, 7BH4, α-MSH, β-MSH and tyrosinase 
provide potential alternative back up mechanisms within the melanocyte/melanosome in the 
regulation of tyrosinase in a receptor-independent manner. 
 
B: Vitiligo. The presence of 10-3M H2O2 within melanocytes, causes the oxidation of 6/7BH4 
to 6-/7-biopterin respectively. H2O2-mediated oxidation of the key enzymes involved in 
melanogenesis tyrosinase (Tyr) and phenylalanine hydroxylase (PAH) alters their structure 
and functionality. Recently it was shown that H2O2-mediated oxidation affects met 374 in the 
active site of tyrosinase leading to deactivation of the enzyme (Wood, Decker et al. 2009) 
which in turn affects melanin biosynthesis. As a result of the deactivation of PAH, L-
phenylalanine levels are increased within the melanocytes. Uric acid, the end product of 
purine degradation pathway is oxidised to allantoin by H2O2. Increased epidermal allantoin 
levels in vitiligo have been shown in this thesis.  
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5.7  Patients with vitiligo combat with high levels of oxidative DNA 
damage in their epidermis 
 
DNA is continuously damaged by ROS generated as a result of normal biochemical 
reactions in metabolic pathways and also generated by various environmental agents, 
leading in turn to the release of purine bases from the damaged DNA.  The purine 
bases need to be degraded (Malins 1993; Hattori-Nakakuki, Nishigori et al. 1994; 
Hattori, Nishigori et al. 1996; Marnett 2000; Ichihashi, Ueda et al. 2003; Smith, 
Marks et al. 2004). 8-oxoG has been regarded as the major oxidative DNA-base 
lesions and they have been used to evaluate the extent of oxidative stress in 
individuals (Kasai and Nishimura 1984; Kasai and Nishimura 1984; Kasai, Crain et 
al. 1986; Adelman, Saul et al. 1988; Loft, Fischer-Nielsen et al. 1993; Kasai 1997; 
Steenken and Jovanovic 1997; Helbock, Beckman et al. 1999; Bruner, Norman et al. 
2000; Kasai 2002; Ichihashi, Ueda et al. 2003; Neeley and Essigmann 2006). Elevated 
levels of this oxidised DNA base have been identified in various diseases caused by 
oxidative stress (Fraga, Shigenaga et al. 1990; Loft, Vistisen et al. 1992; Hattori-
Nakakuki, Nishigori et al. 1994; Hattori, Nishigori et al. 1996; Tsuboi, Kouda et al. 
1998; Ahmed, Ueda et al. 1999; Lovell, Gabbita et al. 1999; Nunomura, Perry et al. 
1999; Nunomura, Perry et al. 1999; Honda, Yamada et al. 2000; Ishizakai, Yoshida et 
al. 2004; Wu, Chiou et al. 2004; Wang, Schmeichel et al. 2005; Perra, Maxia et al. 
2006; Shiihara, Kato et al. 2006; Bahar, Feinmesser et al. 2007; Chen, Wu et al. 2007; 
Chen, Liou et al. 2007; Dincer, Erzin et al. 2007; Kinoshita, Wanibuchi et al. 2007; 
Dong, Cui et al. 2008; Fukuda, Yamauchi et al. 2008; Ku, Jin et al. 2008).  
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Nowadays, there is no doubt that the entire epidermis of patients with vitiligo is under 
oxidative stress due to accumulation of mM range of H2O2 (Schallreuter, Moore et al. 
1999; Schallreuter, Bahadoran et al. 2008). Hence, we postulated high levels of 
oxidative DNA damage resulting in high levels of 8-oxoG in the epidermis of patients 
with vitiligo. 
To the best of our knowledge, so far there has been no report of increased 8-oxoG 
levels in the epidermis of patients with vitiligo. Within this thesis we demonstrate for 
the first time significantly elevated levels of this oxidised DNA base both in situ and 
in vitro in lesional and non-lesional epidermis. Moreover, we also show in vitro 
higher levels in vitiliginous epidermal MCs of patients with acute vitiligo compared to 
healthy controls (Figure 34; A&B and Figure 35; A, B, C&D). Notably, 8-oxoG is 
not degradable, it is finally excreted from plasma in the urine (Wu, Chiou et al. 2004). 
Our immuno reactivity results were backed up by demonstrating significantly elevated 
plasma levels of 8-oxoG in all 20 patients compared to healthy controls (Figure 36). 
These results imply that patients with vitiligo are dealing with high levels of oxidative 
DNA damage due to H2O2-mediated oxidative stress in their epidermis.  
In this context it has been well documented that 8-oxoG lesions induce potentially 
mutagenic G:C to T:A transversion unless repaired prior to DNA replication. Thus it 
is considered to be a pro-mutagenic DNA lesion produced by oxygen radicals (Floyd 
1990; Wood, Dizdaroglu et al. 1990; Shibutani, Takeshita et al. 1991; Cheng, Cahill 
et al. 1992; Maki and Sekiguchi 1992; Grollman and Moriya 1993; Moriya 1993; Le 
Page, Margot et al. 1995; Johnson, Yu et al. 1996; Hussain and Harris 1998; Sunaga, 
Kohno et al. 2001; Bjelland and Seeberg 2003; Hussain, Hofseth et al. 2003). This 
oxidised base is expected to be involved not only in carcinogenesis, but also in 
tumour biology (Hattori, Nishigori et al. 1996). High percentage of G:C to T:A 
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transversion in human skin tumours has been attributed to 8-oxoG formation by 
UVA-generated ROS (Daya-Grosjean, Dumaz et al. 1995). Moreover, this mutagenic 
transversion has been observed in UVB-induced skin cancers in mice (Nishigori, 
Wang et al. 1994) and also in human non-melanoma skin cancer (van der Schroeff, 
Evers et al. 1990). Therefore, oxidative damage to DNA has been assigned to be one 
of the major causes of mutations, apoptosis and cancer (Hattori-Nakakuki, Nishigori 
et al. 1994; Johnson, Yu et al. 1996; Marnett 2000; Cooke, Evans et al. 2003; 
Hussain, Hofseth et al. 2003).  
Taken together, based on all the facts present at this time a high incidence of skin 
cancer would be expected in patients with vitiligo.  
Along this line it was reported that there was no difference in apoptotic regulatory 
molecules in vitiligo compared to healthy controls (Tobin, Swanson et al. 2000; van 
den Wijngaard, Aten et al. 2000), while significantly increased epidermal functioning 
wild-type p53 expression was documented (Schallreuter, Behrens-Williams et al. 
2003). Taking into consideration that the outcome of p53 activation is not only 
apoptosis but also DNA repair (“the two face theory of p53”) (Smith and Fornace 
1997), the presence of increased epidermal oxidative DNA damage, in association 
with increased functioning wild-type p53 along with unchanged apoptotic regulatory 
molecules in vitiligo suggested that only one face of the two face theory needed to be 
proven i.e. “DNA REPAIR”. 
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5.8  Enhanced epidermal DNA repair in vitiligo 
 
5.8.1  Epidermal cells induce Gadd45α expression in vitiligo  
In order to prevent the deleterious effects of DNA oxidation such as mutagenesis and 
carcinogenesis, living organisms have developed protective strategies. The most 
effective strategy in combating oxidative DNA damage is thought to be exclusively 
via base-excision repair (BER) (Demple and Harrison 1994; Boiteux and Radicella 
1999; Dianov, Souza-Pinto et al. 2001). The repair of the damaged DNA involves the 
activation of multiple genes inducing inhibition of cell division and prolongation of 
cell-cycle arrests and checkpoints. Two major kinases are responsible to induce 
cellular checkpoints in response to DNA damage i.e. ATM and ATR (Schmitt, Paquet 
et al. 2007). The induction of these proteins leads to the activation of the “guardian of 
the genom p53” (Kastan, Onyekwere et al. 1991; Schmitt, Paquet et al. 2007) which 
in turn transactivates its downstream effector genes and proteins including p21 and 
Gadd45α leading in turn to the induction and prolongation of G1/S and G2/M phases 
respectively (el-Deiry, Harper et al. 1994; Kearsey, Coates et al. 1995; Wang, Zhan et 
al. 1999). These proteins can be regulated in a p53-dependent pathway as observed 
after ionizing radiation (Kastan, Zhan et al. 1992; Carrier, Smith et al. 1994; Zhan, 
Fan et al. 1996; el-Deiry 1998; Kachnic, Wu et al. 1999; Pedeux, Lefort et al. 2002; 
Smith and Seo 2002; Zhan 2005; Fayolle, Pourchet et al. 2006). These proteins can 
also be regulated in a p53-independent pathway in response to DNA damage caused 
by UV radiation as shown in the case of Gadd45α (Russo, Zambrano et al. 1995; 
Zhan, Fan et al. 1996; Jin, Fan et al. 2001; Zhan 2005). Gadd45α induces G2/M cell 
cycle checkpoint in KCs, MCs and melanoma cells following UVB irradiation 
(Maeda, Hanna et al. 2002; Pedeux, Lefort et al. 2002). Furthermore, melanoma cells 
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can efficiently repair UVB-induced lesions and therefore their survival may be based 
on the activation of Gadd45α (Pedeux, Lefort et al. 2002; Fayolle, Pourchet et al. 
2006; Fayolle, Pourchet et al. 2008). 
As mentioned above, epidermal functioning wild-type p53 is increased in the 
epidermis of patients with vitiligo (Schallreuter, Behrens-Williams et al. 2003). 
Moreover, it has been shown that H2O2 activates p53 and induces Gadd45α 
expression in KCs and HeLa cells (Guyton, Xu et al. 1996; Wan, Wang et al. 2000). 
The data presented within this thesis demonstrate for the first time that Gadd45α is 
significantly over-expressed in the lesional and non-lesional epidermis of patients 
with vitiligo compared to healthy controls as shown by in situ immuno-reactivity and 
Western blotting (Figures 41&42). Since these patients accumulate mM levels of 
H2O2 in their epidermis (Schallreuter, Moore et al. 1999; Schallreuter, Bahadoran et 
al. 2008), the induction of epidermal Gadd45α could be ascribed to H2O2. However, 
the precise mode of action needs yet to be shown.  
Gadd45α directly interacts with both p21 and PCNA and this activity is thought to be 
vital for the modulation of the cell cycles and for the inhibition of DNA replication 
(Smith, Chen et al. 1994; Chen, Smith et al. 1995; Hall, Kearsey et al. 1995; Kearsey, 
Coates et al. 1995; Vairapandi, Balliet et al. 1996; Vairapandi, Azam et al. 2000).  
Salem showed that both epidermal p21 and PCNA expression are also upregulated in 
vitiligo (Salem 2009). 
Taken together our data further highlight a role for Gadd45α in the cellular response 
to increased oxidative DNA damage in vitiligo. 
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5.8.2  Vitiliginous epidermal cells express hOgg1 to excise 8-oxoG from  
8-oxoG/C pairs in DNA 
 
The repair of oxidative DNA damage is exclusively accomplished via BER pathways 
(Sancar 1994; Parikh, Mol et al. 1997; Fortini, Parlanti et al. 1999; Dianov, Souza-
Pinto et al. 2001; Dogliotti, Fortini et al. 2001; Lindahl 2001; Lu, Li et al. 2001; 
Fromme and Verdine 2004). This mechanism is initiated by DNA glycosylases. In 
human, the key enzyme hOgg1 detects and removes 8-oxoG, leaving an AP site 
(Boiteux and Radicella 1999; Kinoshita, Wanibuchi et al. 2002). Using Western blot 
analysis, our results revealed that hOgg1 is indeed expressed in epidermal cells in 
vitiligo. Interestingly, the expression of this enzyme showed no difference between 
vitiligo and controls (Figure 37; A, B&C). These results suggest that H2O2 does not 
alter the protein expression of this key enzyme in vitiligo. These data are in agreement 
with previously published work by Saitoh and colleagues (Saitoh, Shinmura et al. 
2001; Fortini, Pascucci et al. 2003). After the removal of the damaged base by hOgg1 
other steps are needed to complete the repair process. The repair mode of oxidative 
DNA damage is predominantly via short-patch BER where the enzyme DNA 
polymeraseβ plays a critical role (Dianov, Prasad et al. 1999; Prasad, Dianov et al. 
2000). In this pathway, APE1 and DNA polymeraseβ excise the remaining sugar 
moiety and reinstall an undamaged nucleotide respectively. This step is followed by 
DNA ligase I activity sealing the nick thereby repairing the damaged base site 
(Parikh, Mol et al. 1997; Gros, Saparbaev et al. 2002; Fortini, Pascucci et al. 2003; 
Chaudhry 2007). As expected, protein expression of these two enzymes is 
significantly increased in the epidermis of patients with vitiligo (Figure 38).  
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To sum up, these results imply that patients with vitiligo develop effective DNA 
repair machinery via hOgg1, APE1 and DNA polymeraseβ to combat oxidative DNA 
damage as evidenced by increased 8-oxoG levels.  
Earlier it has been suggested that Ogg1 gene is directly involved in tumour prevention 
(Xie, Yang et al. 2004). These authors reported that Myh and Ogg1 knockout mice 
showed 65.7% increase in tumour predisposition, predominantly lung and ovarian 
tumours in addition to lymphomas (Xie, Yang et al. 2004). Given the high levels of 
H2O2 in vitiligo skin, oxidative DNA damage was expected. As said above oxidative 
DNA damage is regarded as one of the major contributors to tumorigenesis (Ames 
1989).  
However, there are only scattered reports of non-melanoma skin cancers (NMCS, 
squamous cell carcinoma and basal cell carcinoma) in patients with vitiligo 
(Calanchini-Postizzi and Frenk 1987; Westerhof and Schallreuter 1997; Schallreuter, 
Tobin et al. 2002). Skin cancer was never diagnosed in 2500 patients with vitiligo 
(Westerhof and Schallreuter 1997), even lower risk of NMCS has been reported in 
this disorder by other authors (Lisi 1972; Ortonne, Pelletier et al. 1978; Schallreuter, 
Tobin et al. 2002).  
Taking into consideration that the patients lack increased development of skin 
cancers, our data suggest that BER is a major player in the hierarchy to combat 
oxidative stress and to prevent ROS-caused tumorigenesis in the epidermis of patients 
with vitiligo. 
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5.9  In vitiligo epidermal cells do not undergo apoptosis in response 
to oxidative DNA damage 
 
Within this thesis we showed that DNA repair is significantly overriding increased 
oxidative DNA damage in epidermal cells of patients with vitiligo compared to 
healthy controls. Moreover, epidermal functioning wild-type p53 is increased 
(Schallreuter, Behrens-Williams et al. 2003). Taking into consideration that the 
activation of p53 is also leading to transactivation of its downstream genes involved 
in apoptosis, we here investigated protein expression of two major apoptotic 
regulators i.e. cytochrome c and caspase 3. The results revealed that in vitiligo, 
epidermal cells express even lower cytochrome c and caspase 3 proteins compared to 
controls (Figures 39&40). Since apoptotic cells show induction of cytochrome c and 
caspase 3 as crucial components in the apoptotic cascade (Liu, Kim et al. 1996; 
Nicholson and Thornberry 1997; Yang, Liu et al. 1997; Finucane, Bossy-Wetzel et al. 
1999; Li, Kolluri et al. 2000; Abu-Qare and Abou-Donia 2001), then decreased levels 
of these two key regulators of apoptosis fuels the hypothesis that epidermal cells in 
vitiligo do not undergo programmed cell death. Based on our data discussed earlier, 
we show that vitiliginous cells seem to combat H2O2-induced oxidative DNA damage 
by induction of the powerful BER machinery.  
However, it is noteworthy that the results presented in this thesis demonstrate protein 
expression of DNA repair enzymes or apoptotic regulators in all epidermal cells and 
not specifically in melanocytes. Considering that almost 80% of the epidermal cell 
population are KCs, the results of this thesis mainly focus on KC responses to 
oxidative DNA damage. The reports in the literature are conflicting, ranging from no 
increased to increased apoptosis in vitiliginous MCs compared to normal controls 
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(Boissy and Nordlund 1997; Tobin, Swanson et al. 2000; van den Wijngaard, Aten et 
al. 2000; Kemp, Waterman et al. 2001; Huang, Nordlund et al. 2002; Boissy and 
Manga 2004; Park, Kim et al. 2007; Ruiz-Arguelles, Brito et al. 2007; Song, Xu et al. 
2008). Our additional data from this thesis provide more support for the absence of 
increased apoptosis in vitiligo. 
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6.0  CONCLUSION 
 
The puzzle comes together 
Given that despite loss of the protecting pigment and the overwhelming evidence for 
H2O2 induced oxidative stress in the epidermis of these patients, there is no increased 
risk or a higher prevalence for sun induced skin cancer (Calanchini-Postizzi and Frenk 
1987; Schallreuter, Tobin et al. 2002).  
 However, vitiligo is associated with DNA damage as evidenced by the presence of 
high 8-oxoG levels in the epidermis and in the plasma of patients. The results of this 
study imply that patients with vitiligo must develop effective DNA repair machinery.  
One way to combat DNA damage is BER repair via the key enzyme hOgg1 followed 
by activities of APE1 and DNA polymeraseβ. Both enzymes are up-regulated in 
vitiligo. Since it has been shown that hOgg1 expression is not different in these 
patients from healthy controls, it can be concluded that 8-oxoG is glycosylated and 
the repair would be completed by APE1 and DNA polymeraseβ. Hence our results 
support enhanced DNA repair in vitiligo by this cascade.  
The presence of increased Gadd45α expression favours cell cycle arrest. However, 
Gadd45α directly interacts with both p21 and PCNA and this activity is thought to be 
vital for the modulation of the cell cycles and for the inhibition of DNA replication 
(Smith, Chen et al. 1994; Chen, Smith et al. 1995; Hall, Kearsey et al. 1995; Kearsey, 
Coates et al. 1995; Vairapandi, Balliet et al. 1996; Vairapandi, Azam et al. 2000). In 
this context it was shown that both PCNA as well as p21 are up-regulated in vitiligo 
(Salem 2009). There is no evidence for apoptosis in this disease (Tobin, Swanson et 
al. 2000; van den Wijngaard, Aten et al. 2000). These results are further substantiated 
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by the absence of caspase 3 and cytochrome c as shown in this thesis. More support 
stems from the up-regulation of the anti-apoptotic protein Bcl-2 (Salem 2009).  
This conclusion is even more supported by earlier report that acetylcholine esterase 
protein expression and activity is very low in epidermal cells in vitiligo compared to 
healthy controls (Schallreuter, Elwary et al. 2004). This enzyme has been shown to be 
an apoptotic regulator since its overexpression inhibits cell proliferation and promots 
apoptosis, whereas the inhibition of acetylcholine esterase gene expression enhanced 
cell proliferation and suppressed apoptosis-associated DNA fragmentation (Soreq, 
Patinkin et al. 1994; Soreq and Seidman 2001; Park, Kim et al. 2004; Jiang and Zhang 
2008). To sum up, all data available at the present time argue against increased 
apoptosis in epidermal cells in vitiligo. 
The crucial question to be answered is why wild-type p53 is up-regulated in vitiligo. 
In this context it was shown that epidermal p76MDM2 in patients with vitiligo is up-
regulated (Salem 2009). This isoform counteracts p90 MDM2 which in turn would 
degrade p53 (Perry, Mendrysa et al. 2000).  
Consequently the question arose, whether p53 could be the master regulator in DNA 
repair. In this context it was shown by Salem that p53 in the presence of H2O2 
together with peroxynitrite enhances the capacity of DNA binding (Salem 2009). It 
was also shown that p53 levels are not affected by the removal of epidermal H2O2 by 
a pseudocatalase PC-KUS (Salem 2009). Since p53 stimulates BER through binding 
of APE1, hOgg1 and DNA polymeraseβ (Sengupta and Harris 2005), our findings 
would strongly support that p53 is of overriding importance in DNA repair in vitiligo 
thus explaining the lack of increased skin cancer. The strength of all results resides in 
the evaluation of the same patient and control group throughout the entire 
investigation on this subject. Our current understanding is summarised in Scheme 1.  
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Scheme 1 
Up-regulated wild type p53 as the main conductor of ROS-mediated DNA damage / 
repair in vitiligo 
ROS – mediated DNA damage in vitiligo leads to increased 8-oxoG levels in the epidermis 
and in plasma of patients with vitiligo. Phosphorylation is a crucial step for p53 stabilization 
to perform its function as a transcription factor (Giaccia and Kastan 1998; Appella and 
Anderson 2001; Ito, Shinkai et al. 2001). In this context it has been shown that 
phosphorylation of p53 protein is initiated by DNA damage. Up regulated wild type p53 is 
phosphorylated on ser9 and ser15, proving functionality of up-regulated ATM in this disease 
(Salem 2009). Acetylation is one step of posttranslational modifications (Polevoda and 
Sherman 2000). Up regulated epidermal PCAF in vitiligo is functioning as shown by the 
presence of acetylated lysine residues at position 373 and 382 (Salem 2009). Both steps 
support functioning stabilised p53 as shown earlier (Schallreuter, Behrens-Williams et al. 
2003). Under normal conditions p53 is degraded by p90MDM2 (Oliner, Kinzler et al. 1992). 
p53w/w
PCAF
p76MDM2
ATM
PCNAp21Gadd45αBCL-2
Apoptosis
Caspase 3
Cytochrome c
p90MDM2
hOgg1
APE1
DNA polβ
DNA damage
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cell cycle arrest
Long-patch BER
DNA REPAIR
DNA polδ
FEN1
Short-patch BER
DNA REPAIR
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The isomer p76MDM2 binds to p90MDM2, preventing binding of p90MDM2 to p53, stopping in turn  
degradation of p53 (Perry, Mendrysa et al. 2000). Our results revealed for the first time high 
epidermal p76MDM2 levels in vitiligo, whereas p90MDM2 expression is not affected in this 
compartment (Salem 2009). Functioning stabilised p53 leads to transcription of p21, 
Gadd45α and PCNA (Smith and Seo 2002; Rozan and El-Deiry 2007; Shu, Li et al. 2007). 
Both p21 and Gadd45α induce cell cycle arrest and both signals are up regulated in vitiligo 
(Salem 2009). Oxidative DNA damage is repaired via BER, which is initiated by hOgg1 
excising 8-oxoG (Michaels, Tchou et al. 1992; Boiteux 1993; Boiteux and Radicella 1999; 
Kinoshita, Wanibuchi et al. 2002). Depending on the type of DNA damage, the repair 
pathways would involve either short- or long-patch BER, although these pathways can switch 
between each other (Wilson and Thompson 1997; Dogliotti, Fortini et al. 2001; Fromme and 
Verdine 2004). PCNA binds to DNA polymeraseδ and works as a processivity factor for this 
enzyme, which together with FEN1 is involved in long-patch BER (Matsumoto, Kim et al. 
1994; Frosina, Fortini et al. 1996; Klungland and Lindahl 1997; Fromme and Verdine 2004). 
Notably, we were unable to detect epidermal DNA polymeraseδ and FEN1 in our patients, 
but we found upregulated epidermal APE1 and DNA polymeraseβ levels. This result favours 
short patch BER in vitiligo. However, DNA polymeraseβ can function in both repair 
pathways (Dianov, Prasad et al. 1999; Prasad, Dianov et al. 2000). In this context it is of 
interest that PCNA can interact directly with APE1 (Dianova, Bohr et al. 2001). Moreover, 
hOgg1, APE1 and DNA polymeraseβ are directly regulated by p53 (Sengupta and Harris 
2005). Therefore it can be concluded that oxidative DNA damage in vitiligo can be repaired 
through short-patch BER in cooperation with a specifised long-patch BER in the absence of 
FEN1 and DNA polymeraseδ. Epidermal programed cell death is ruled out because up 
regulated Bcl-2 favours anti-apoptotic activity which is further supported by decreased levels 
of cytochrome c and caspase 3. These new findings are further supported by unremarkable 
levels of the pro-apoptotic stimulus BAX and low acetylcholine esterase levels/activities in 
vitiligo as shown earlier (van den Wijngaard, Aten et al. 2000; Schallreuter, Elwary et al. 
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2004). Taken together, patients with vitiligo can efficiently combat epidermal H2O2/ONOO
-
 
induced DNA damage with up regulated wildtype p53 as main conductor in the scenario 
(Salem 2009). 
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7.0 FUTURE WORK 
 
The data presented in this thesis has opened a new window in to the repair of 
oxidative DNA damage. Future work could focus on: 
 
1. Investigation of PCNA / DNA polymeraseβ regulation in long-patch DNA repair in 
vitiligo.  
 
2. Since xanthine oxidase appears to be in the nucleus of both epidermal melanocytes 
and keratinocytes, future work could address these questions. 
• What is the purpose of XO in the nucleus? 
• What is its role? 
• Why is the presence of XO in the nucleus of keratinocytes stronger than in 
melanocytes?  
 
3.  Our results showed for the first time that 7BH4 and 7-biopterin are inhibitors of 
XO. Since 6 and 7BH4 have been shown to be present in melanosomes together with 
XO, the possible role for XO in pigmentation needs further investigation.  
 
4.  One major question needs to be answered in future. Why does H2O2/ONOO
- 
mediated oxidative stress affect both lesional and non-lesional skin in vitiligo despite 
only the lesional skin is depigmented?  
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9.0 APPENDIX 
 
Working solutions for SDS-PAGE 
All chemicals were from Sigma, Dorset, UK unless otherwise stated. 
 
Solution B (4x separating buffer or resolving gel): 
1.5M Tris base, 0.4% SDS, pH ???, ??ml final volume made using dH2O. 
 
Solution C (4x stacking buffer): 
0.5M Tris base, 0.4% SDS, pH ???, ??ml final volume made using dH2O. 
 
 
 
    
 
 
 
 
 
Table 3: The quantities of each solution required for preparation of polyacrylamine gels for 
SDS-PAGE. 
 
 
 
 
75 µl90 µl90 µl90 µlAPS (10%)
10 µl8 µl8 µl8 µlTEMED
750 µl10.4 ml8 ml4 mlAcrylamide
1.87 ml 
sol. C
6 ml sol. B6 ml sol. B6 ml sol. BSolution 
B/C
4.87 ml7.2 ml9.6 ml13.6 mldH2O
3% 
stacking gel
13% 
resolving 
gel
10% 
resolving 
gel
5% 
resolving 
gel
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Sample buffer (x5): 10% SDS 4ml, mercaptoethanol 1ml, glycerol 2ml, 0.5M 
Tris/HCl 1ml, distilled water 2ml, and a trace of brilliant blue. 
 
Running buffer (x4): 192mM glycine, 0.025M Tris base, 0.1% SDS, made to a final 
volume of 1L with dH2O. 
 
Transfer buffer (x4): 0.2M glycine, 25mM Tris base, 20% methanol, made to a final 
volume of 1L with dH2O. 
 
TBS/Tween (NATT) buffer (x4): 150mM NaCl, 20mM Tris base, 0.047% Tween 
20, pH 7.4, made to a final volume of 1L with dH2O. 
  
ECL1: 
250mM luminol in DMSO  1ml 
90mM p-coumaric acid in DMSO 0.44ml 
1M Tris base (pH 8.5)   10ml 
dH2O to a final volume of    100 ml 
 
ECL2: 
30% H2O2    64µl  
1M Tris base (pH 8.5)   10ml 
dH2O to a final volume of   100 ml 
 
 
 
